id	sid	tid	token	lemma	pos
ctmj-53	1	1	chinese	chinese	ADJ
ctmj-53	1	2	traditional	traditional	ADJ
ctmj-53	1	3	medicine	medicine	NOUN
ctmj-53	1	4	journal	journal	NOUN
ctmj-53	1	5	|	|	ADV
ctmj-53	1	6	2020	2020	NUM
ctmj-53	2	1	|	|	ADV
ctmj-53	2	2	vol	vol	NOUN
ctmj-53	2	3	3	3	NUM
ctmj-53	2	4	|	|	ADV
ctmj-53	2	5	issue	issue	VERB
ctmj-53	2	6	5	5	NUM
ctmj-53	2	7	issn	issn	X
ctmj-53	2	8	:	:	PUNCT
ctmj-53	2	9	2693	2693	NUM
ctmj-53	2	10	6356	6356	NUM
ctmj-53	2	11	2020	2020	NUM
ctmj-53	2	12	|	|	ADV
ctmj-53	2	13	vol	vol	NOUN
ctmj-53	2	14	3	3	NUM
ctmj-53	2	15	|	|	ADV
ctmj-53	2	16	issue	issue	VERB
ctmj-53	2	17	5	5	NUM
ctmj-53	2	18	ctmj	ctmj	NOUN
ctmj-53	2	19	|	|	ADV
ctmj-53	2	20	traditionalmedicinejournals.com	traditionalmedicinejournals.com	X
ctmj-53	2	21	analyzing	analyze	VERB
ctmj-53	2	22	the	the	DET
ctmj-53	2	23	potential	potential	ADJ
ctmj-53	2	24	effects	effect	NOUN
ctmj-53	2	25	of	of	ADP
ctmj-53	2	26	small	small	ADJ
ctmj-53	2	27	compounds	compound	NOUN
ctmj-53	2	28	involving	involve	VERB
ctmj-53	2	29	msr1	msr1	PROPN
ctmj-53	2	30	and	and	CCONJ
ctmj-53	2	31	c6	c6	NOUN
ctmj-53	2	32	-	-	PUNCT
ctmj-53	2	33	ceramide	ceramide	NOUN
ctmj-53	2	34	on	on	ADP
ctmj-53	2	35	nasopharyngeal	nasopharyngeal	ADJ
ctmj-53	2	36	cancer	cancer	NOUN
ctmj-53	2	37	using	use	VERB
ctmj-53	2	38	gsea	gsea	NOUN
ctmj-53	2	39	dr.d.suryadevarakonda	dr.d.suryadevarakonda	PROPN
ctmj-53	2	40	1	1	NUM
ctmj-53	2	41	,	,	PUNCT
ctmj-53	2	42	d.venkataraman	d.venkataraman	NOUN
ctmj-53	2	43	dra	dra	PROPN
ctmj-53	2	44	2	2	NUM
ctmj-53	2	45	,	,	PUNCT
ctmj-53	2	46	shazia	shazia	PROPN
ctmj-53	2	47	3	3	NUM
ctmj-53	2	48	,	,	PUNCT
ctmj-53	2	49	andol	andol	VERB
ctmj-53	2	50	rajesh	rajesh	PROPN
ctmj-53	2	51	kumar	kumar	PROPN
ctmj-53	2	52	4	4	NUM
ctmj-53	2	53	,	,	PUNCT
ctmj-53	2	54	assistant	assistant	NOUN
ctmj-53	2	55	professor	professor	NOUN
ctmj-53	2	56	1,2,3,4	1,2,3,4	NUM
ctmj-53	2	57	,	,	PUNCT
ctmj-53	2	58	department	department	NOUN
ctmj-53	2	59	of	of	ADP
ctmj-53	2	60	pharmacy	pharmacy	NOUN
ctmj-53	2	61	,	,	PUNCT
ctmj-53	2	62	samskruti	samskruti	PROPN
ctmj-53	2	63	college	college	PROPN
ctmj-53	2	64	of	of	ADP
ctmj-53	2	65	pharmacy	pharmacy	NOUN
ctmj-53	2	66	,	,	PUNCT
ctmj-53	2	67	kondapur	kondapur	NOUN
ctmj-53	2	68	(	(	PUNCT
ctmj-53	2	69	v	v	NOUN
ctmj-53	2	70	)	)	PUNCT
ctmj-53	2	71	,	,	PUNCT
ctmj-53	2	72	ghatkesar	ghatkesar	VERB
ctmj-53	2	73	(	(	PUNCT
ctmj-53	2	74	m	m	NOUN
ctmj-53	2	75	)	)	PUNCT
ctmj-53	2	76	medchal	medchal	ADJ
ctmj-53	2	77	dist	dist	NOUN
ctmj-53	2	78	,	,	PUNCT
ctmj-53	2	79	telangana	telangana	PROPN
ctmj-53	2	80	,	,	PUNCT
ctmj-53	2	81	india	india	PROPN
ctmj-53	2	82	.	.	PUNCT
ctmj-53	3	1	abstract	abstract	ADJ
ctmj-53	3	2	the	the	DET
ctmj-53	3	3	goal	goal	NOUN
ctmj-53	3	4	of	of	ADP
ctmj-53	3	5	this	this	DET
ctmj-53	3	6	study	study	NOUN
ctmj-53	3	7	is	be	AUX
ctmj-53	3	8	to	to	PART
ctmj-53	3	9	identify	identify	VERB
ctmj-53	3	10	therapeutic	therapeutic	ADJ
ctmj-53	3	11	drugs	drug	NOUN
ctmj-53	3	12	and	and	CCONJ
ctmj-53	3	13	targets	target	NOUN
ctmj-53	3	14	that	that	PRON
ctmj-53	3	15	may	may	AUX
ctmj-53	3	16	be	be	AUX
ctmj-53	3	17	useful	useful	ADJ
ctmj-53	3	18	in	in	ADP
ctmj-53	3	19	the	the	DET
ctmj-53	3	20	treatment	treatment	NOUN
ctmj-53	3	21	of	of	ADP
ctmj-53	3	22	nasopharyngeal	nasopharyngeal	ADJ
ctmj-53	3	23	cancer	cancer	NOUN
ctmj-53	3	24	(	(	PUNCT
ctmj-53	3	25	npc).a	npc).a	ADJ
ctmj-53	3	26	combination	combination	NOUN
ctmj-53	3	27	of	of	ADP
ctmj-53	3	28	bioinformatics	bioinformatics	NOUN
ctmj-53	3	29	and	and	CCONJ
ctmj-53	3	30	in	in	ADP
ctmj-53	3	31	vitro	vitro	X
ctmj-53	3	32	experimental	experimental	ADJ
ctmj-53	3	33	validation	validation	NOUN
ctmj-53	3	34	led	lead	VERB
ctmj-53	3	35	to	to	ADP
ctmj-53	3	36	the	the	DET
ctmj-53	3	37	identification	identification	NOUN
ctmj-53	3	38	of	of	ADP
ctmj-53	3	39	many	many	ADJ
ctmj-53	3	40	candidate	candidate	NOUN
ctmj-53	3	41	treatment	treatment	NOUN
ctmj-53	3	42	drugs	drug	NOUN
ctmj-53	3	43	and	and	CCONJ
ctmj-53	3	44	npc	npc	NOUN
ctmj-53	3	45	target	target	NOUN
ctmj-53	3	46	genes	gene	NOUN
ctmj-53	3	47	.	.	PUNCT
ctmj-53	4	1	we	we	PRON
ctmj-53	4	2	found	find	VERB
ctmj-53	4	3	344	344	NUM
ctmj-53	4	4	differentially	differentially	ADV
ctmj-53	4	5	expressed	express	VERB
ctmj-53	4	6	genes	gene	NOUN
ctmj-53	4	7	(	(	PUNCT
ctmj-53	4	8	dges	dge	NOUN
ctmj-53	4	9	)	)	PUNCT
ctmj-53	4	10	that	that	PRON
ctmj-53	4	11	were	be	AUX
ctmj-53	4	12	downregulated	downregulate	VERB
ctmj-53	4	13	and	and	CCONJ
ctmj-53	4	14	26	26	NUM
ctmj-53	4	15	that	that	PRON
ctmj-53	4	16	were	be	AUX
ctmj-53	4	17	upregulated	upregulate	VERB
ctmj-53	4	18	after	after	ADP
ctmj-53	4	19	analyzing	analyze	VERB
ctmj-53	4	20	three	three	NUM
ctmj-53	4	21	datasets	dataset	NOUN
ctmj-53	4	22	of	of	ADP
ctmj-53	4	23	npc	npc	NOUN
ctmj-53	4	24	patients	patient	NOUN
ctmj-53	4	25	.	.	PUNCT
ctmj-53	5	1	we	we	PRON
ctmj-53	5	2	used	use	VERB
ctmj-53	5	3	kegg	kegg	NOUN
ctmj-53	5	4	pathway	pathway	NOUN
ctmj-53	5	5	analysis	analysis	NOUN
ctmj-53	5	6	on	on	ADP
ctmj-53	5	7	the	the	DET
ctmj-53	5	8	dges	dge	NOUN
ctmj-53	5	9	and	and	CCONJ
ctmj-53	5	10	gene	gene	NOUN
ctmj-53	5	11	ontology	ontology	NOUN
ctmj-53	5	12	(	(	PUNCT
ctmj-53	5	13	go	go	VERB
ctmj-53	5	14	)	)	PUNCT
ctmj-53	5	15	to	to	PART
ctmj-53	5	16	compile	compile	VERB
ctmj-53	5	17	their	their	PRON
ctmj-53	5	18	descriptions	description	NOUN
ctmj-53	5	19	.	.	PUNCT
ctmj-53	6	1	the	the	DET
ctmj-53	6	2	identification	identification	NOUN
ctmj-53	6	3	of	of	ADP
ctmj-53	6	4	c6	c6	NOUN
ctmj-53	6	5	-	-	PUNCT
ctmj-53	6	6	ceramide	ceramide	NOUN
ctmj-53	6	7	as	as	ADP
ctmj-53	6	8	a	a	DET
ctmj-53	6	9	small	small	ADJ
ctmj-53	6	10	molecule	molecule	NOUN
ctmj-53	6	11	with	with	ADP
ctmj-53	6	12	significant	significant	ADJ
ctmj-53	6	13	significance	significance	NOUN
ctmj-53	6	14	to	to	ADP
ctmj-53	6	15	npc	npc	PROPN
ctmj-53	6	16	was	be	AUX
ctmj-53	6	17	made	make	VERB
ctmj-53	6	18	possible	possible	ADJ
ctmj-53	6	19	by	by	ADP
ctmj-53	6	20	independently	independently	ADV
ctmj-53	6	21	acquiring	acquire	VERB
ctmj-53	6	22	316	316	NUM
ctmj-53	6	23	drug	drug	NOUN
ctmj-53	6	24	and	and	CCONJ
ctmj-53	6	25	small	small	ADJ
ctmj-53	6	26	molecule	molecule	NOUN
ctmj-53	6	27	target	target	NOUN
ctmj-53	6	28	genes	gene	NOUN
ctmj-53	6	29	from	from	ADP
ctmj-53	6	30	the	the	DET
ctmj-53	6	31	sea	sea	NOUN
ctmj-53	6	32	database	database	NOUN
ctmj-53	6	33	.	.	PUNCT
ctmj-53	7	1	then	then	ADV
ctmj-53	7	2	,	,	PUNCT
ctmj-53	7	3	in	in	ADP
ctmj-53	7	4	order	order	NOUN
ctmj-53	7	5	to	to	PART
ctmj-53	7	6	get	get	VERB
ctmj-53	7	7	macrophage	macrophage	ADJ
ctmj-53	7	8	scavenger	scavenger	NOUN
ctmj-53	7	9	receptor	receptor	NOUN
ctmj-53	7	10	1	1	NUM
ctmj-53	7	11	(	(	PUNCT
ctmj-53	7	12	msr1	msr1	PROPN
ctmj-53	7	13	)	)	PUNCT
ctmj-53	7	14	,	,	PUNCT
ctmj-53	7	15	the	the	DET
ctmj-53	7	16	genes	gene	NOUN
ctmj-53	7	17	that	that	PRON
ctmj-53	7	18	were	be	AUX
ctmj-53	7	19	differentially	differentially	ADV
ctmj-53	7	20	elevated	elevate	VERB
ctmj-53	7	21	were	be	AUX
ctmj-53	7	22	intersected	intersect	VERB
ctmj-53	7	23	with	with	ADP
ctmj-53	7	24	genes	gene	NOUN
ctmj-53	7	25	that	that	PRON
ctmj-53	7	26	may	may	AUX
ctmj-53	7	27	be	be	AUX
ctmj-53	7	28	targets	target	NOUN
ctmj-53	7	29	of	of	ADP
ctmj-53	7	30	c6	c6	NOUN
ctmj-53	7	31	-	-	PUNCT
ctmj-53	7	32	ceramide	ceramide	NOUN
ctmj-53	7	33	small	small	ADJ
ctmj-53	7	34	molecules	molecule	NOUN
ctmj-53	7	35	.	.	PUNCT
ctmj-53	8	1	lastly	lastly	ADV
ctmj-53	8	2	,	,	PUNCT
ctmj-53	8	3	the	the	DET
ctmj-53	8	4	findings	finding	NOUN
ctmj-53	8	5	confirmed	confirm	VERB
ctmj-53	8	6	that	that	SCONJ
ctmj-53	8	7	msr1	msr1	PROPN
ctmj-53	8	8	and	and	CCONJ
ctmj-53	8	9	c6	c6	PROPN
ctmj-53	8	10	-	-	PUNCT
ctmj-53	8	11	ceramide	ceramide	NOUN
ctmj-53	8	12	may	may	AUX
ctmj-53	8	13	play	play	VERB
ctmj-53	8	14	important	important	ADJ
ctmj-53	8	15	roles	role	NOUN
ctmj-53	8	16	in	in	ADP
ctmj-53	8	17	npc	npc	NOUN
ctmj-53	8	18	cell	cell	NOUN
ctmj-53	8	19	lines.the	lines.the	DET
ctmj-53	8	20	outcomes	outcome	NOUN
ctmj-53	8	21	are	be	AUX
ctmj-53	8	22	:	:	PUNCT
ctmj-53	8	23	the	the	DET
ctmj-53	8	24	viability	viability	NOUN
ctmj-53	8	25	of	of	ADP
ctmj-53	8	26	npc	npc	NOUN
ctmj-53	8	27	cells	cell	NOUN
ctmj-53	8	28	was	be	AUX
ctmj-53	8	29	dramatically	dramatically	ADV
ctmj-53	8	30	reduced	reduce	VERB
ctmj-53	8	31	when	when	SCONJ
ctmj-53	8	32	msr1	msr1	PROPN
ctmj-53	8	33	expressions	expression	NOUN
ctmj-53	8	34	were	be	AUX
ctmj-53	8	35	knocked	knock	VERB
ctmj-53	8	36	down	down	ADP
ctmj-53	8	37	.	.	PUNCT
ctmj-53	9	1	a	a	DET
ctmj-53	9	2	substantial	substantial	ADJ
ctmj-53	9	3	decrease	decrease	NOUN
ctmj-53	9	4	in	in	ADP
ctmj-53	9	5	npc	npc	NOUN
ctmj-53	9	6	cell	cell	NOUN
ctmj-53	9	7	viability	viability	NOUN
ctmj-53	9	8	(	(	PUNCT
ctmj-53	9	9	p	p	X
ctmj-53	9	10	<	<	X
ctmj-53	9	11	0.0001	0.0001	NUM
ctmj-53	9	12	)	)	PUNCT
ctmj-53	9	13	was	be	AUX
ctmj-53	9	14	also	also	ADV
ctmj-53	9	15	seen	see	VERB
ctmj-53	9	16	after	after	ADP
ctmj-53	9	17	treatment	treatment	NOUN
ctmj-53	9	18	with	with	ADP
ctmj-53	9	19	10	10	NUM
ctmj-53	9	20	μmol	μmol	NOUN
ctmj-53	9	21	/	/	SYM
ctmj-53	9	22	l	l	NOUN
ctmj-53	9	23	c6	c6	NOUN
ctmj-53	9	24	-	-	PUNCT
ctmj-53	9	25	ceramide	ceramide	NOUN
ctmj-53	9	26	.	.	PUNCT
ctmj-53	10	1	moreover	moreover	ADV
ctmj-53	10	2	,	,	PUNCT
ctmj-53	10	3	the	the	DET
ctmj-53	10	4	overexpression	overexpression	NOUN
ctmj-53	10	5	of	of	ADP
ctmj-53	10	6	msr1	msr1	PROPN
ctmj-53	10	7	in	in	ADP
ctmj-53	10	8	npc	npc	PROPN
ctmj-53	10	9	cells	cell	NOUN
ctmj-53	10	10	was	be	AUX
ctmj-53	10	11	accompanied	accompany	VERB
ctmj-53	10	12	by	by	ADP
ctmj-53	10	13	an	an	DET
ctmj-53	10	14	increase	increase	NOUN
ctmj-53	10	15	in	in	ADP
ctmj-53	10	16	msr1	msr1	PROPN
ctmj-53	10	17	levels	level	NOUN
ctmj-53	10	18	,	,	PUNCT
ctmj-53	10	19	which	which	PRON
ctmj-53	10	20	was	be	AUX
ctmj-53	10	21	reduced	reduce	VERB
ctmj-53	10	22	by	by	ADP
ctmj-53	10	23	c6	c6	NOUN
ctmj-53	10	24	-	-	PUNCT
ctmj-53	10	25	ceramide	ceramide	NOUN
ctmj-53	10	26	(	(	PUNCT
ctmj-53	10	27	p	p	X
ctmj-53	10	28	<	<	X
ctmj-53	10	29	0.0001	0.0001	NUM
ctmj-53	10	30	)	)	PUNCT
ctmj-53	10	31	.	.	PUNCT
ctmj-53	11	1	at	at	ADP
ctmj-53	11	2	the	the	DET
ctmj-53	11	3	same	same	ADJ
ctmj-53	11	4	time	time	NOUN
ctmj-53	11	5	as	as	ADP
ctmj-53	11	6	msr1	msr1	PROPN
ctmj-53	11	7	overexpression	overexpression	NOUN
ctmj-53	11	8	increased	increase	VERB
ctmj-53	11	9	levels	level	NOUN
ctmj-53	11	10	of	of	ADP
ctmj-53	11	11	akt	akt	PROPN
ctmj-53	11	12	and	and	CCONJ
ctmj-53	11	13	pi3k	pi3k	PROPN
ctmj-53	11	14	,	,	PUNCT
ctmj-53	11	15	msr1	msr1	PROPN
ctmj-53	11	16	knockdown	knockdown	PROPN
ctmj-53	11	17	lowered	lower	VERB
ctmj-53	11	18	their	their	PRON
ctmj-53	11	19	expression.in	expression.in	NUM
ctmj-53	11	20	conclusion	conclusion	NOUN
ctmj-53	11	21	,	,	PUNCT
ctmj-53	11	22	msr1	msr1	PROPN
ctmj-53	11	23	controls	control	VERB
ctmj-53	11	24	pi3k	pi3k	PROPN
ctmj-53	11	25	and	and	CCONJ
ctmj-53	11	26	akt	akt	PROPN
ctmj-53	11	27	expression	expression	NOUN
ctmj-53	11	28	to	to	PART
ctmj-53	11	29	affect	affect	VERB
ctmj-53	11	30	npc	npc	NOUN
ctmj-53	11	31	cell	cell	NOUN
ctmj-53	11	32	survival.furthermore	survival.furthermore	NOUN
ctmj-53	11	33	,	,	PUNCT
ctmj-53	11	34	c6	c6	NOUN
ctmj-53	11	35	-	-	PUNCT
ctmj-53	11	36	ceramide	ceramide	NOUN
ctmj-53	11	37	regulates	regulate	VERB
ctmj-53	11	38	msr1	msr1	NOUN
ctmj-53	11	39	expression	expression	NOUN
ctmj-53	11	40	to	to	PART
ctmj-53	11	41	have	have	VERB
ctmj-53	11	42	a	a	DET
ctmj-53	11	43	therapeutic	therapeutic	ADJ
ctmj-53	11	44	impact	impact	NOUN
ctmj-53	11	45	on	on	ADP
ctmj-53	11	46	npc	npc	NOUN
ctmj-53	11	47	.	.	PUNCT
ctmj-53	12	1	these	these	DET
ctmj-53	12	2	results	result	NOUN
ctmj-53	12	3	provide	provide	VERB
ctmj-53	12	4	fresh	fresh	ADJ
ctmj-53	12	5	avenues	avenue	NOUN
ctmj-53	12	6	for	for	ADP
ctmj-53	12	7	research	research	NOUN
ctmj-53	12	8	into	into	ADP
ctmj-53	12	9	the	the	DET
ctmj-53	12	10	treatment	treatment	NOUN
ctmj-53	12	11	of	of	ADP
ctmj-53	12	12	npc	npc	NOUN
ctmj-53	12	13	and	and	CCONJ
ctmj-53	12	14	novel	novel	ADJ
ctmj-53	12	15	approaches	approach	NOUN
ctmj-53	12	16	to	to	ADP
ctmj-53	12	17	its	its	PRON
ctmj-53	12	18	clinical	clinical	ADJ
ctmj-53	12	19	management	management	NOUN
ctmj-53	12	20	.	.	PUNCT
ctmj-53	13	1	these	these	DET
ctmj-53	13	2	findings	finding	NOUN
ctmj-53	13	3	provide	provide	VERB
ctmj-53	13	4	support	support	NOUN
ctmj-53	13	5	for	for	ADP
ctmj-53	13	6	investigating	investigate	VERB
ctmj-53	13	7	ceramides	ceramide	NOUN
ctmj-53	13	8	and	and	CCONJ
ctmj-53	13	9	msr1	msr1	PROPN
ctmj-53	13	10	further	far	ADV
ctmj-53	13	11	as	as	ADP
ctmj-53	13	12	potential	potential	ADJ
ctmj-53	13	13	new	new	ADJ
ctmj-53	13	14	targets	target	NOUN
ctmj-53	13	15	in	in	ADP
ctmj-53	13	16	npc.the	npc.the	DET
ctmj-53	13	17	pi3k	pi3k	PROPN
ctmj-53	13	18	/	/	SYM
ctmj-53	13	19	akt	akt	PROPN
ctmj-53	13	20	pathway	pathway	NOUN
ctmj-53	13	21	,	,	PUNCT
ctmj-53	13	22	cell	cell	NOUN
ctmj-53	13	23	viability	viability	NOUN
ctmj-53	13	24	,	,	PUNCT
ctmj-53	13	25	macrophage	macrophage	ADJ
ctmj-53	13	26	scavenger	scavenger	NOUN
ctmj-53	13	27	receptor	receptor	NOUN
ctmj-53	13	28	1	1	NUM
ctmj-53	13	29	,	,	PUNCT
ctmj-53	13	30	and	and	CCONJ
ctmj-53	13	31	nasopharyngeal	nasopharyngeal	ADJ
ctmj-53	13	32	cancer	cancer	NOUN
ctmj-53	13	33	are	be	AUX
ctmj-53	13	34	all	all	ADV
ctmj-53	13	35	related	related	ADJ
ctmj-53	13	36	terms	term	NOUN
ctmj-53	13	37	.	.	PUNCT
ctmj-53	14	1	introduction	introduction	NOUN
ctmj-53	14	2	the	the	DET
ctmj-53	14	3	nasopharyngeal	nasopharyngeal	ADJ
ctmj-53	14	4	mucosa	mucosa	NOUN
ctmj-53	14	5	can	can	AUX
ctmj-53	14	6	develop	develop	VERB
ctmj-53	14	7	a	a	DET
ctmj-53	14	8	malignant	malignant	ADJ
ctmj-53	14	9	epithelial	epithelial	ADJ
ctmj-53	14	10	tumor	tumor	NOUN
ctmj-53	14	11	called	call	VERB
ctmj-53	14	12	a	a	DET
ctmj-53	14	13	nasopharyngeal	nasopharyngeal	ADJ
ctmj-53	14	14	carcinoma	carcinoma	NOUN
ctmj-53	14	15	(	(	PUNCT
ctmj-53	14	16	npc	npc	NOUN
ctmj-53	14	17	)	)	PUNCT
ctmj-53	14	18	,	,	PUNCT
ctmj-53	14	19	which	which	PRON
ctmj-53	14	20	is	be	AUX
ctmj-53	14	21	common	common	ADJ
ctmj-53	14	22	in	in	ADP
ctmj-53	14	23	southern	southern	ADJ
ctmj-53	14	24	china	china	PROPN
ctmj-53	14	25	and	and	CCONJ
ctmj-53	14	26	southeast	southeast	PROPN
ctmj-53	14	27	asia	asia	PROPN
ctmj-53	14	28	.	.	PUNCT
ctmj-53	15	1	unlike	unlike	ADP
ctmj-53	15	2	other	other	ADJ
ctmj-53	15	3	cancers	cancer	NOUN
ctmj-53	15	4	,	,	PUNCT
ctmj-53	15	5	npc	npc	NOUN
ctmj-53	15	6	cells	cell	NOUN
ctmj-53	15	7	easily	easily	ADV
ctmj-53	15	8	spread	spread	VERB
ctmj-53	15	9	to	to	ADP
ctmj-53	15	10	lymph	lymph	NOUN
ctmj-53	15	11	nodes	node	NOUN
ctmj-53	15	12	and	and	CCONJ
ctmj-53	15	13	other	other	ADJ
ctmj-53	15	14	regions	region	NOUN
ctmj-53	15	15	even	even	ADV
ctmj-53	15	16	in	in	ADP
ctmj-53	15	17	the	the	DET
ctmj-53	15	18	early	early	ADJ
ctmj-53	15	19	stages	stage	NOUN
ctmj-53	15	20	of	of	ADP
ctmj-53	15	21	tumorigenesis	tumorigenesis	NOUN
ctmj-53	15	22	[	[	X
ctmj-53	15	23	1	1	NUM
ctmj-53	15	24	]	]	PUNCT
ctmj-53	15	25	.	.	PUNCT
ctmj-53	16	1	the	the	DET
ctmj-53	16	2	curative	curative	ADJ
ctmj-53	16	3	value	value	NOUN
ctmj-53	16	4	of	of	ADP
ctmj-53	16	5	current	current	ADJ
ctmj-53	16	6	treatments	treatment	NOUN
ctmj-53	16	7	,	,	PUNCT
ctmj-53	16	8	such	such	ADJ
ctmj-53	16	9	as	as	ADP
ctmj-53	16	10	radiation	radiation	NOUN
ctmj-53	16	11	,	,	PUNCT
ctmj-53	16	12	chemotherapy	chemotherapy	NOUN
ctmj-53	16	13	and	and	CCONJ
ctmj-53	16	14	molecular	molecular	ADJ
ctmj-53	16	15	targeted	target	VERB
ctmj-53	16	16	therapy	therapy	NOUN
ctmj-53	16	17	,	,	PUNCT
ctmj-53	16	18	is	be	AUX
ctmj-53	16	19	limited	limit	VERB
ctmj-53	16	20	,	,	PUNCT
ctmj-53	16	21	as	as	SCONJ
ctmj-53	16	22	evidenced	evidence	VERB
ctmj-53	16	23	by	by	ADP
ctmj-53	16	24	the	the	DET
ctmj-53	16	25	high	high	ADJ
ctmj-53	16	26	rates	rate	NOUN
ctmj-53	16	27	of	of	ADP
ctmj-53	16	28	recurrence	recurrence	NOUN
ctmj-53	16	29	,	,	PUNCT
ctmj-53	16	30	metastasis	metastasis	NOUN
ctmj-53	16	31	and	and	CCONJ
ctmj-53	16	32	mortality	mortality	NOUN
ctmj-53	16	33	in	in	ADP
ctmj-53	16	34	npc	npc	NOUN
ctmj-53	16	35	patients	patient	NOUN
ctmj-53	16	36	[	[	X
ctmj-53	16	37	2	2	NUM
ctmj-53	16	38	]	]	PUNCT
ctmj-53	16	39	.	.	PUNCT
ctmj-53	17	1	thus	thus	ADV
ctmj-53	17	2	,	,	PUNCT
ctmj-53	17	3	developing	develop	VERB
ctmj-53	17	4	appropriate	appropriate	ADJ
ctmj-53	17	5	molecular	molecular	ADJ
ctmj-53	17	6	targets	target	NOUN
ctmj-53	17	7	for	for	ADP
ctmj-53	17	8	npc	npc	NOUN
ctmj-53	17	9	therapy	therapy	NOUN
ctmj-53	17	10	is	be	AUX
ctmj-53	17	11	essential	essential	ADJ
ctmj-53	17	12	.	.	PUNCT
ctmj-53	18	1	macrophage	macrophage	ADJ
ctmj-53	18	2	scavenger	scavenger	NOUN
ctmj-53	18	3	receptor	receptor	NOUN
ctmj-53	18	4	1	1	NUM
ctmj-53	18	5	(	(	PUNCT
ctmj-53	18	6	msr1	msr1	PROPN
ctmj-53	18	7	)	)	PUNCT
ctmj-53	18	8	,	,	PUNCT
ctmj-53	18	9	also	also	ADV
ctmj-53	18	10	known	know	VERB
ctmj-53	18	11	as	as	ADP
ctmj-53	18	12	class	class	NOUN
ctmj-53	18	13	a	a	DET
ctmj-53	18	14	scavenger	scavenger	NOUN
ctmj-53	18	15	receptor	receptor	NOUN
ctmj-53	18	16	(	(	PUNCT
ctmj-53	18	17	sr	sr	PROPN
ctmj-53	18	18	-	-	PUNCT
ctmj-53	18	19	a	a	NOUN
ctmj-53	18	20	)	)	PUNCT
ctmj-53	18	21	and	and	CCONJ
ctmj-53	18	22	cluster	cluster	NOUN
ctmj-53	18	23	of	of	ADP
ctmj-53	18	24	differentiation	differentiation	NOUN
ctmj-53	18	25	204	204	NUM
ctmj-53	18	26	(	(	PUNCT
ctmj-53	18	27	cd204	cd204	PROPN
ctmj-53	18	28	)	)	PUNCT
ctmj-53	19	1	[	[	X
ctmj-53	19	2	3	3	NUM
ctmj-53	19	3	]	]	PUNCT
ctmj-53	19	4	,	,	PUNCT
ctmj-53	19	5	is	be	AUX
ctmj-53	19	6	primarily	primarily	ADV
ctmj-53	19	7	produced	produce	VERB
ctmj-53	19	8	in	in	ADP
ctmj-53	19	9	macrophages	macrophage	NOUN
ctmj-53	19	10	.	.	PUNCT
ctmj-53	20	1	its	its	PRON
ctmj-53	20	2	functions	function	NOUN
ctmj-53	20	3	include	include	VERB
ctmj-53	20	4	scavenging	scavenge	VERB
ctmj-53	20	5	and	and	CCONJ
ctmj-53	20	6	modifying	modify	VERB
ctmj-53	20	7	lipoproteins	lipoprotein	NOUN
ctmj-53	20	8	.	.	PUNCT
ctmj-53	21	1	the	the	DET
ctmj-53	21	2	adhesion	adhesion	NOUN
ctmj-53	21	3	and	and	CCONJ
ctmj-53	21	4	phagocytosis	phagocytosis	NOUN
ctmj-53	21	5	of	of	ADP
ctmj-53	21	6	macrophages	macrophage	NOUN
ctmj-53	21	7	are	be	AUX
ctmj-53	21	8	related	relate	VERB
ctmj-53	21	9	to	to	ADP
ctmj-53	21	10	msr1	msr1	PROPN
ctmj-53	21	11	[	[	X
ctmj-53	21	12	4	4	NUM
ctmj-53	21	13	]	]	PUNCT
ctmj-53	21	14	.	.	PUNCT
ctmj-53	22	1	the	the	DET
ctmj-53	22	2	msr1	msr1	PROPN
ctmj-53	22	3	is	be	AUX
ctmj-53	22	4	a	a	DET
ctmj-53	22	5	marker	marker	NOUN
ctmj-53	22	6	of	of	ADP
ctmj-53	22	7	m2	m2	PROPN
ctmj-53	22	8	tumor	tumor	NOUN
ctmj-53	22	9	-	-	PUNCT
ctmj-53	22	10	associated	associate	VERB
ctmj-53	22	11	macrophages	macrophage	NOUN
ctmj-53	22	12	,	,	PUNCT
ctmj-53	22	13	which	which	PRON
ctmj-53	22	14	promotes	promote	VERB
ctmj-53	22	15	the	the	DET
ctmj-53	22	16	development	development	NOUN
ctmj-53	22	17	and	and	CCONJ
ctmj-53	22	18	metastasis	metastasis	NOUN
ctmj-53	22	19	of	of	ADP
ctmj-53	22	20	tumor	tumor	NOUN
ctmj-53	22	21	.	.	PUNCT
ctmj-53	23	1	the	the	DET
ctmj-53	23	2	msr1	msr1	PROPN
ctmj-53	23	3	is	be	AUX
ctmj-53	23	4	also	also	ADV
ctmj-53	23	5	a	a	DET
ctmj-53	23	6	prognostic	prognostic	ADJ
ctmj-53	23	7	biomarker	biomarker	NOUN
ctmj-53	23	8	for	for	ADP
ctmj-53	23	9	glioma	glioma	NOUN
ctmj-53	23	10	(	(	PUNCT
ctmj-53	23	11	lgg	lgg	PROPN
ctmj-53	23	12	)	)	PUNCT
ctmj-53	23	13	,	,	PUNCT
ctmj-53	23	14	uveal	uveal	ADJ
ctmj-53	23	15	melanoma	melanoma	NOUN
ctmj-53	23	16	(	(	PUNCT
ctmj-53	23	17	uvm	uvm	PROPN
ctmj-53	23	18	)	)	PUNCT
ctmj-53	23	19	,	,	PUNCT
ctmj-53	23	20	lung	lung	NOUN
ctmj-53	23	21	squamous	squamous	ADJ
ctmj-53	23	22	cell	cell	NOUN
ctmj-53	23	23	carcinoma	carcinoma	NOUN
ctmj-53	23	24	(	(	PUNCT
ctmj-53	23	25	lusc	lusc	NOUN
ctmj-53	23	26	)	)	PUNCT
ctmj-53	23	27	and	and	CCONJ
ctmj-53	23	28	other	other	ADJ
ctmj-53	23	29	tumor	tumor	NOUN
ctmj-53	23	30	types	type	NOUN
ctmj-53	23	31	[	[	X
ctmj-53	23	32	5	5	NUM
ctmj-53	23	33	]	]	PUNCT
ctmj-53	23	34	,	,	PUNCT
ctmj-53	23	35	but	but	CCONJ
ctmj-53	23	36	the	the	DET
ctmj-53	23	37	function	function	NOUN
ctmj-53	23	38	of	of	ADP
ctmj-53	23	39	msr1	msr1	PROPN
ctmj-53	23	40	in	in	ADP
ctmj-53	23	41	npc	npc	PROPN
ctmj-53	23	42	is	be	AUX
ctmj-53	23	43	not	not	PART
ctmj-53	23	44	clear	clear	ADJ
ctmj-53	23	45	.	.	PUNCT
ctmj-53	24	1	in	in	ADP
ctmj-53	24	2	addition	addition	NOUN
ctmj-53	24	3	,	,	PUNCT
ctmj-53	24	4	msr1	msr1	PROPN
ctmj-53	24	5	,	,	PUNCT
ctmj-53	24	6	as	as	ADP
ctmj-53	24	7	a	a	DET
ctmj-53	24	8	membrane	membrane	NOUN
ctmj-53	24	9	receptor	receptor	NOUN
ctmj-53	24	10	,	,	PUNCT
ctmj-53	24	11	binds	bind	VERB
ctmj-53	24	12	to	to	ADP
ctmj-53	24	13	ligands	ligand	NOUN
ctmj-53	24	14	to	to	PART
ctmj-53	24	15	activate	activate	VERB
ctmj-53	24	16	signaling	signal	VERB
ctmj-53	24	17	pathways	pathway	NOUN
ctmj-53	24	18	including	include	VERB
ctmj-53	24	19	mitogen	mitogen	PROPN
ctmj-53	24	20	chinese	chinese	ADJ
ctmj-53	24	21	traditional	traditional	ADJ
ctmj-53	24	22	medicine	medicine	NOUN
ctmj-53	24	23	journal	journal	NOUN
ctmj-53	24	24	|	|	ADV
ctmj-53	24	25	2020	2020	NUM
ctmj-53	24	26	|	|	ADV
ctmj-53	24	27	vol	vol	NOUN
ctmj-53	24	28	3	3	NUM
ctmj-53	25	1	|	|	ADV
ctmj-53	25	2	issue	issue	VERB
ctmj-53	25	3	5	5	NUM
ctmj-53	25	4	issn	issn	X
ctmj-53	25	5	:	:	PUNCT
ctmj-53	25	6	2693	2693	NUM
ctmj-53	25	7	6356	6356	NUM
ctmj-53	25	8	2020	2020	NUM
ctmj-53	25	9	|	|	ADV
ctmj-53	25	10	vol	vol	NOUN
ctmj-53	25	11	3	3	NUM
ctmj-53	26	1	|	|	ADV
ctmj-53	26	2	issue	issue	VERB
ctmj-53	26	3	5	5	NUM
ctmj-53	26	4	ctmj	ctmj	NOUN
ctmj-53	26	5	|	|	ADV
ctmj-53	26	6	traditionalmedicinejournals.com	traditionalmedicinejournals.com	X
ctmj-53	26	7	activated	activate	VERB
ctmj-53	26	8	protein	protein	NOUN
ctmj-53	26	9	kinase	kinase	NOUN
ctmj-53	26	10	,	,	PUNCT
ctmj-53	26	11	nuclear	nuclear	ADJ
ctmj-53	26	12	factor	factor	NOUN
ctmj-53	26	13	kappa	kappa	PROPN
ctmj-53	26	14	b	b	PROPN
ctmj-53	26	15	(	(	PUNCT
ctmj-53	26	16	nfκbcan	nfκbcan	PROPN
ctmj-53	26	17	)	)	PUNCT
ctmj-53	26	18	and	and	CCONJ
ctmj-53	26	19	pi3k	pi3k	PROPN
ctmj-53	26	20	/	/	SYM
ctmj-53	26	21	akt	akt	PROPN
ctmj-53	27	1	[	[	X
ctmj-53	27	2	6	6	NUM
ctmj-53	27	3	]	]	PUNCT
ctmj-53	27	4	,	,	PUNCT
ctmj-53	27	5	therefore	therefore	ADV
ctmj-53	27	6	affecting	affect	VERB
ctmj-53	27	7	the	the	DET
ctmj-53	27	8	progression	progression	NOUN
ctmj-53	27	9	of	of	ADP
ctmj-53	27	10	cancer	cancer	NOUN
ctmj-53	27	11	.	.	PUNCT
ctmj-53	28	1	ceramides	ceramide	NOUN
ctmj-53	28	2	are	be	AUX
ctmj-53	28	3	a	a	DET
ctmj-53	28	4	class	class	NOUN
ctmj-53	28	5	of	of	ADP
ctmj-53	28	6	bioactive	bioactive	ADJ
ctmj-53	28	7	sphingolipids	sphingolipid	NOUN
ctmj-53	28	8	in	in	ADP
ctmj-53	28	9	cell	cell	NOUN
ctmj-53	28	10	membranes	membrane	NOUN
ctmj-53	28	11	that	that	PRON
ctmj-53	28	12	promotes	promote	VERB
ctmj-53	28	13	apoptosis	apoptosis	NOUN
ctmj-53	28	14	in	in	ADP
ctmj-53	28	15	response	response	NOUN
ctmj-53	28	16	to	to	ADP
ctmj-53	28	17	cell	cell	NOUN
ctmj-53	28	18	stressors	stressor	NOUN
ctmj-53	28	19	and	and	CCONJ
ctmj-53	28	20	have	have	AUX
ctmj-53	28	21	demonstrated	demonstrate	VERB
ctmj-53	28	22	antitumor	antitumor	PROPN
ctmj-53	28	23	activities	activity	NOUN
ctmj-53	28	24	in	in	ADP
ctmj-53	28	25	preclinical	preclinical	ADJ
ctmj-53	28	26	studies	study	NOUN
ctmj-53	28	27	[	[	X
ctmj-53	28	28	7	7	NUM
ctmj-53	28	29	-	-	SYM
ctmj-53	28	30	9	9	NUM
ctmj-53	28	31	]	]	PUNCT
ctmj-53	28	32	.	.	PUNCT
ctmj-53	29	1	c6	c6	NOUN
ctmj-53	29	2	-	-	PUNCT
ctmj-53	29	3	ceramide	ceramide	NOUN
ctmj-53	29	4	is	be	AUX
ctmj-53	29	5	a	a	DET
ctmj-53	29	6	cell	cell	NOUN
ctmj-53	29	7	-	-	PUNCT
ctmj-53	29	8	permeable	permeable	ADJ
ctmj-53	29	9	ceramide	ceramide	NOUN
ctmj-53	29	10	analogue	analogue	NOUN
ctmj-53	29	11	that	that	PRON
ctmj-53	29	12	promotes	promote	VERB
ctmj-53	29	13	apoptosis	apoptosis	NOUN
ctmj-53	29	14	and	and	CCONJ
ctmj-53	29	15	suppresses	suppress	VERB
ctmj-53	29	16	the	the	DET
ctmj-53	29	17	growth	growth	NOUN
ctmj-53	29	18	of	of	ADP
ctmj-53	29	19	various	various	ADJ
ctmj-53	29	20	types	type	NOUN
ctmj-53	29	21	of	of	ADP
ctmj-53	29	22	tumors	tumor	NOUN
ctmj-53	29	23	[	[	X
ctmj-53	29	24	10,11	10,11	NOUN
ctmj-53	29	25	]	]	X
ctmj-53	29	26	.	.	PUNCT
ctmj-53	30	1	however	however	ADV
ctmj-53	30	2	,	,	PUNCT
ctmj-53	30	3	the	the	DET
ctmj-53	30	4	therapeutic	therapeutic	ADJ
ctmj-53	30	5	potential	potential	NOUN
ctmj-53	30	6	and	and	CCONJ
ctmj-53	30	7	mechanisms	mechanism	NOUN
ctmj-53	30	8	of	of	ADP
ctmj-53	30	9	action	action	NOUN
ctmj-53	30	10	of	of	ADP
ctmj-53	30	11	ceramide	ceramide	NOUN
ctmj-53	30	12	analogs	analog	NOUN
ctmj-53	30	13	remain	remain	VERB
ctmj-53	30	14	to	to	PART
ctmj-53	30	15	be	be	AUX
ctmj-53	30	16	elucidated	elucidate	VERB
ctmj-53	30	17	in	in	ADP
ctmj-53	30	18	npc	npc	NOUN
ctmj-53	30	19	.	.	PUNCT
ctmj-53	31	1	ceramides	ceramide	NOUN
ctmj-53	31	2	respond	respond	VERB
ctmj-53	31	3	to	to	ADP
ctmj-53	31	4	various	various	ADJ
ctmj-53	31	5	changes	change	NOUN
ctmj-53	31	6	caused	cause	VERB
ctmj-53	31	7	by	by	ADP
ctmj-53	31	8	biological	biological	ADJ
ctmj-53	31	9	factors	factor	NOUN
ctmj-53	31	10	and	and	CCONJ
ctmj-53	31	11	chemotherapy	chemotherapy	NOUN
ctmj-53	31	12	by	by	ADP
ctmj-53	31	13	inhibiting	inhibit	VERB
ctmj-53	31	14	aktdependent	aktdependent	ADJ
ctmj-53	31	15	mitosis	mitosis	NOUN
ctmj-53	31	16	to	to	PART
ctmj-53	31	17	suppress	suppress	VERB
ctmj-53	31	18	tumor	tumor	NOUN
ctmj-53	31	19	cell	cell	NOUN
ctmj-53	31	20	proliferation	proliferation	NOUN
ctmj-53	31	21	[	[	X
ctmj-53	31	22	7	7	NUM
ctmj-53	31	23	]	]	PUNCT
ctmj-53	31	24	.	.	PUNCT
ctmj-53	32	1	endogenous	endogenous	ADJ
ctmj-53	32	2	ceramides	ceramide	NOUN
ctmj-53	32	3	as	as	SCONJ
ctmj-53	32	4	effector	effector	NOUN
ctmj-53	32	5	molecules	molecule	NOUN
ctmj-53	32	6	enhance	enhance	VERB
ctmj-53	32	7	the	the	DET
ctmj-53	32	8	cytotoxic	cytotoxic	ADJ
ctmj-53	32	9	effects	effect	NOUN
ctmj-53	32	10	of	of	ADP
ctmj-53	32	11	drugs	drug	NOUN
ctmj-53	32	12	on	on	ADP
ctmj-53	32	13	tumor	tumor	NOUN
ctmj-53	32	14	cells	cell	NOUN
ctmj-53	32	15	,	,	PUNCT
ctmj-53	32	16	while	while	SCONJ
ctmj-53	32	17	exogenous	exogenous	ADJ
ctmj-53	32	18	ceramides	ceramide	NOUN
ctmj-53	32	19	demonstrate	demonstrate	VERB
ctmj-53	32	20	greater	great	ADJ
ctmj-53	32	21	cytotoxicity	cytotoxicity	NOUN
ctmj-53	32	22	towards	towards	ADP
ctmj-53	32	23	tumor	tumor	NOUN
ctmj-53	32	24	cells	cell	NOUN
ctmj-53	32	25	compared	compare	VERB
ctmj-53	32	26	to	to	ADP
ctmj-53	32	27	normal	normal	ADJ
ctmj-53	32	28	cells	cell	NOUN
ctmj-53	32	29	[	[	X
ctmj-53	32	30	8	8	NUM
ctmj-53	32	31	]	]	PUNCT
ctmj-53	32	32	.	.	PUNCT
ctmj-53	33	1	additionally	additionally	ADV
ctmj-53	33	2	,	,	PUNCT
ctmj-53	33	3	ceramides	ceramide	NOUN
ctmj-53	33	4	inhibit	inhibit	VERB
ctmj-53	33	5	tumor	tumor	NOUN
ctmj-53	33	6	growth	growth	NOUN
ctmj-53	33	7	in	in	ADP
ctmj-53	33	8	breast	breast	NOUN
ctmj-53	33	9	cancer	cancer	NOUN
ctmj-53	33	10	xenograft	xenograft	NOUN
ctmj-53	33	11	models	model	NOUN
ctmj-53	33	12	[	[	X
ctmj-53	33	13	9	9	NUM
ctmj-53	33	14	]	]	PUNCT
ctmj-53	33	15	.	.	PUNCT
ctmj-53	34	1	ceramides	ceramide	NOUN
ctmj-53	34	2	and	and	CCONJ
ctmj-53	34	3	their	their	PRON
ctmj-53	34	4	analogs	analog	NOUN
ctmj-53	34	5	exhibit	exhibit	VERB
ctmj-53	34	6	antitumor	antitumor	PROPN
ctmj-53	34	7	potential	potential	NOUN
ctmj-53	34	8	,	,	PUNCT
ctmj-53	34	9	but	but	CCONJ
ctmj-53	34	10	their	their	PRON
ctmj-53	34	11	specific	specific	ADJ
ctmj-53	34	12	mechanisms	mechanism	NOUN
ctmj-53	34	13	of	of	ADP
ctmj-53	34	14	action	action	NOUN
ctmj-53	34	15	in	in	ADP
ctmj-53	34	16	npc	npc	PROPN
ctmj-53	34	17	warrant	warrant	NOUN
ctmj-53	34	18	further	further	ADJ
ctmj-53	34	19	investigation	investigation	NOUN
ctmj-53	34	20	.	.	PUNCT
ctmj-53	35	1	this	this	DET
ctmj-53	35	2	study	study	NOUN
ctmj-53	35	3	is	be	AUX
ctmj-53	35	4	aimed	aim	VERB
ctmj-53	35	5	to	to	PART
ctmj-53	35	6	identify	identify	VERB
ctmj-53	35	7	msr1	msr1	PROPN
ctmj-53	35	8	as	as	ADP
ctmj-53	35	9	a	a	DET
ctmj-53	35	10	putative	putative	ADJ
ctmj-53	35	11	target	target	NOUN
ctmj-53	35	12	of	of	ADP
ctmj-53	35	13	c6ceramide	c6ceramide	PROPN
ctmj-53	35	14	in	in	ADP
ctmj-53	35	15	npc	npc	NOUN
ctmj-53	35	16	,	,	PUNCT
ctmj-53	35	17	using	use	VERB
ctmj-53	35	18	a	a	DET
ctmj-53	35	19	bioinformatics	bioinformatics	NOUN
ctmj-53	35	20	method	method	NOUN
ctmj-53	35	21	.	.	PUNCT
ctmj-53	36	1	the	the	DET
ctmj-53	36	2	study	study	NOUN
ctmj-53	36	3	is	be	AUX
ctmj-53	36	4	further	far	ADV
ctmj-53	36	5	aimed	aim	VERB
ctmj-53	36	6	to	to	PART
ctmj-53	36	7	verify	verify	VERB
ctmj-53	36	8	the	the	DET
ctmj-53	36	9	roles	role	NOUN
ctmj-53	36	10	of	of	ADP
ctmj-53	36	11	msr1	msr1	PROPN
ctmj-53	36	12	and	and	CCONJ
ctmj-53	36	13	c6ceramide	c6ceramide	VERB
ctmj-53	36	14	in	in	ADP
ctmj-53	36	15	inhibiting	inhibit	VERB
ctmj-53	36	16	npc	npc	NOUN
ctmj-53	36	17	cell	cell	NOUN
ctmj-53	36	18	viability	viability	NOUN
ctmj-53	36	19	and	and	CCONJ
ctmj-53	36	20	modulating	modulate	VERB
ctmj-53	36	21	pi13	pi13	PROPN
ctmj-53	36	22	/	/	SYM
ctmj-53	36	23	akt	akt	PROPN
ctmj-53	36	24	signaling	signal	VERB
ctmj-53	36	25	.	.	PUNCT
ctmj-53	37	1	experimental	experimental	ADJ
ctmj-53	37	2	data	data	PROPN
ctmj-53	37	3	acquisition	acquisition	NOUN
ctmj-53	37	4	the	the	DET
ctmj-53	37	5	gene	gene	NOUN
ctmj-53	37	6	expression	expression	NOUN
ctmj-53	37	7	matrix	matrix	NOUN
ctmj-53	37	8	of	of	ADP
ctmj-53	37	9	npc	npc	NOUN
ctmj-53	37	10	was	be	AUX
ctmj-53	37	11	retrieved	retrieve	VERB
ctmj-53	37	12	from	from	ADP
ctmj-53	37	13	the	the	DET
ctmj-53	37	14	geo	geo	PROPN
ctmj-53	37	15	database	database	PROPN
ctmj-53	37	16	(	(	PUNCT
ctmj-53	37	17	https://www.ncbi.nlm.nih.gov/geo/	https://www.ncbi.nlm.nih.gov/geo/	PROPN
ctmj-53	37	18	)	)	PUNCT
ctmj-53	37	19	.	.	PUNCT
ctmj-53	38	1	the	the	DET
ctmj-53	38	2	desired	desire	VERB
ctmj-53	38	3	genes	gene	NOUN
ctmj-53	38	4	of	of	ADP
ctmj-53	38	5	pharmaceuticals	pharmaceutical	NOUN
ctmj-53	38	6	and	and	CCONJ
ctmj-53	38	7	small	small	ADJ
ctmj-53	38	8	compounds	compound	NOUN
ctmj-53	38	9	were	be	AUX
ctmj-53	38	10	gathered	gather	VERB
ctmj-53	38	11	from	from	ADP
ctmj-53	38	12	the	the	DET
ctmj-53	38	13	sea	sea	NOUN
ctmj-53	38	14	database	database	NOUN
ctmj-53	38	15	(	(	PUNCT
ctmj-53	38	16	https://sea.bkslab.org/	https://sea.bkslab.org/	ADJ
ctmj-53	38	17	)	)	PUNCT
ctmj-53	38	18	.	.	PUNCT
ctmj-53	39	1	differential	differential	ADJ
ctmj-53	39	2	gene	gene	NOUN
ctmj-53	39	3	expression	expression	NOUN
ctmj-53	39	4	analysis	analysis	NOUN
ctmj-53	39	5	the	the	DET
ctmj-53	39	6	"	"	PUNCT
ctmj-53	39	7	limma	limma	NOUN
ctmj-53	39	8	"	"	PUNCT
ctmj-53	39	9	pack	pack	NOUN
ctmj-53	39	10	in	in	ADP
ctmj-53	39	11	r	r	NOUN
ctmj-53	39	12	was	be	AUX
ctmj-53	39	13	utilized	utilize	VERB
ctmj-53	39	14	to	to	PART
ctmj-53	39	15	perform	perform	VERB
ctmj-53	39	16	bayesian	bayesian	NOUN
ctmj-53	39	17	differential	differential	NOUN
ctmj-53	39	18	expression	expression	NOUN
ctmj-53	39	19	analysis	analysis	NOUN
ctmj-53	39	20	on	on	ADP
ctmj-53	39	21	the	the	DET
ctmj-53	39	22	downloaded	download	VERB
ctmj-53	39	23	npc	npc	NOUN
ctmj-53	39	24	dataset	dataset	NOUN
ctmj-53	39	25	.	.	PUNCT
ctmj-53	40	1	dges	dge	NOUN
ctmj-53	40	2	were	be	AUX
ctmj-53	40	3	identified	identify	VERB
ctmj-53	40	4	based	base	VERB
ctmj-53	40	5	on	on	ADP
ctmj-53	40	6	|log2fc|	|log2fc|	PROPN
ctmj-53	40	7	>	>	SYM
ctmj-53	40	8	0.2	0.2	NUM
ctmj-53	40	9	and	and	CCONJ
ctmj-53	40	10	adjusted	adjust	VERB
ctmj-53	40	11	p	p	NOUN
ctmj-53	40	12	-	-	PUNCT
ctmj-53	40	13	values	value	NOUN
ctmj-53	40	14	<	<	X
ctmj-53	40	15	0.05	0.05	NUM
ctmj-53	40	16	.	.	PUNCT
ctmj-53	41	1	deg	deg	PROPN
ctmj-53	41	2	pathway	pathway	NOUN
ctmj-53	41	3	analysis	analysis	NOUN
ctmj-53	41	4	gene	gene	NOUN
ctmj-53	41	5	ontology	ontology	NOUN
ctmj-53	41	6	(	(	PUNCT
ctmj-53	41	7	go	go	VERB
ctmj-53	41	8	)	)	PUNCT
ctmj-53	41	9	functional	functional	ADJ
ctmj-53	41	10	and	and	CCONJ
ctmj-53	41	11	kegg	kegg	NOUN
ctmj-53	41	12	pathway	pathway	NOUN
ctmj-53	41	13	enrichment	enrichment	NOUN
ctmj-53	41	14	analyses	analysis	NOUN
ctmj-53	41	15	were	be	AUX
ctmj-53	41	16	implemented	implement	VERB
ctmj-53	41	17	by	by	ADP
ctmj-53	41	18	applying	apply	VERB
ctmj-53	41	19	the	the	DET
ctmj-53	41	20	"	"	PUNCT
ctmj-53	41	21	clusterprofiler	clusterprofiler	NOUN
ctmj-53	41	22	"	"	PUNCT
ctmj-53	41	23	package	package	NOUN
ctmj-53	41	24	in	in	ADP
ctmj-53	41	25	r.	r.	NOUN
ctmj-53	41	26	terms	term	NOUN
ctmj-53	41	27	with	with	ADP
ctmj-53	41	28	adjusted	adjust	VERB
ctmj-53	41	29	p	p	X
ctmj-53	41	30	<	<	X
ctmj-53	41	31	0.05	0.05	NUM
ctmj-53	41	32	were	be	AUX
ctmj-53	41	33	considered	consider	VERB
ctmj-53	41	34	significantly	significantly	ADV
ctmj-53	41	35	enriched	enrich	VERB
ctmj-53	41	36	.	.	PUNCT
ctmj-53	42	1	potential	potential	ADJ
ctmj-53	42	2	drug	drug	NOUN
ctmj-53	42	3	analysis	analysis	NOUN
ctmj-53	42	4	the	the	DET
ctmj-53	42	5	t	t	NOUN
ctmj-53	42	6	-	-	PUNCT
ctmj-53	42	7	values	value	NOUN
ctmj-53	42	8	for	for	ADP
ctmj-53	42	9	all	all	DET
ctmj-53	42	10	genes	gene	NOUN
ctmj-53	42	11	in	in	ADP
ctmj-53	42	12	the	the	DET
ctmj-53	42	13	dataset	dataset	NOUN
ctmj-53	42	14	were	be	AUX
ctmj-53	42	15	obtained	obtain	VERB
ctmj-53	42	16	through	through	ADP
ctmj-53	42	17	bayesian	bayesian	NOUN
ctmj-53	42	18	testing	testing	NOUN
ctmj-53	42	19	and	and	CCONJ
ctmj-53	42	20	ranked	rank	VERB
ctmj-53	42	21	.	.	PUNCT
ctmj-53	43	1	the	the	DET
ctmj-53	43	2	genes	gene	NOUN
ctmj-53	43	3	in	in	ADP
ctmj-53	43	4	targets	target	NOUN
ctmj-53	43	5	for	for	ADP
ctmj-53	43	6	medications	medication	NOUN
ctmj-53	43	7	and	and	CCONJ
ctmj-53	43	8	small	small	ADJ
ctmj-53	43	9	compounds	compound	NOUN
ctmj-53	43	10	were	be	AUX
ctmj-53	43	11	acquired	acquire	VERB
ctmj-53	43	12	as	as	ADP
ctmj-53	43	13	set	set	VERB
ctmj-53	43	14	files	file	NOUN
ctmj-53	43	15	from	from	ADP
ctmj-53	43	16	the	the	DET
ctmj-53	43	17	sea	sea	NOUN
ctmj-53	43	18	database	database	NOUN
ctmj-53	43	19	.	.	PUNCT
ctmj-53	44	1	gsea	gsea	PROPN
ctmj-53	44	2	was	be	AUX
ctmj-53	44	3	then	then	ADV
ctmj-53	44	4	performed	perform	VERB
ctmj-53	44	5	to	to	PART
ctmj-53	44	6	identify	identify	VERB
ctmj-53	44	7	potential	potential	ADJ
ctmj-53	44	8	drugs	drug	NOUN
ctmj-53	44	9	and	and	CCONJ
ctmj-53	44	10	target	target	NOUN
ctmj-53	44	11	genes	gene	NOUN
ctmj-53	44	12	associated	associate	VERB
ctmj-53	44	13	with	with	ADP
ctmj-53	44	14	npc	npc	NOUN
ctmj-53	44	15	[	[	X
ctmj-53	44	16	12	12	NUM
ctmj-53	44	17	]	]	PUNCT
ctmj-53	44	18	.	.	PUNCT
ctmj-53	45	1	cell	cell	NOUN
ctmj-53	45	2	culture	culture	NOUN
ctmj-53	45	3	the	the	DET
ctmj-53	45	4	human	human	ADJ
ctmj-53	45	5	normal	normal	ADJ
ctmj-53	45	6	nasopharyngeal	nasopharyngeal	ADJ
ctmj-53	45	7	epithelial	epithelial	ADJ
ctmj-53	45	8	cell	cell	NOUN
ctmj-53	45	9	line	line	NOUN
ctmj-53	45	10	np69	np69	PROPN
ctmj-53	45	11	and	and	CCONJ
ctmj-53	45	12	npc	npc	NOUN
ctmj-53	45	13	cell	cell	NOUN
ctmj-53	45	14	lines	line	NOUN
ctmj-53	45	15	hne-1	hne-1	NOUN
ctmj-53	45	16	,	,	PUNCT
ctmj-53	45	17	hone-1	hone-1	PROPN
ctmj-53	45	18	,	,	PUNCT
ctmj-53	45	19	cne2	cne2	PROPN
ctmj-53	45	20	and	and	CCONJ
ctmj-53	45	21	cne1	cne1	PROPN
ctmj-53	45	22	were	be	AUX
ctmj-53	45	23	obtained	obtain	VERB
ctmj-53	45	24	from	from	ADP
ctmj-53	45	25	the	the	DET
ctmj-53	45	26	atcc	atcc	NOUN
ctmj-53	45	27	.	.	PUNCT
ctmj-53	46	1	hne-1	hne-1	NOUN
ctmj-53	46	2	,	,	PUNCT
ctmj-53	46	3	hon-1	hon-1	PUNCT
ctmj-53	46	4	and	and	CCONJ
ctmj-53	46	5	cne2	cne2	PROPN
ctmj-53	46	6	cells	cell	NOUN
ctmj-53	46	7	were	be	AUX
ctmj-53	46	8	raised	raise	VERB
ctmj-53	46	9	in	in	ADP
ctmj-53	46	10	dmem	dmem	PROPN
ctmj-53	46	11	,	,	PUNCT
ctmj-53	46	12	while	while	SCONJ
ctmj-53	46	13	cne1	cne1	PROPN
ctmj-53	46	14	and	and	CCONJ
ctmj-53	46	15	np69	np69	PROPN
ctmj-53	46	16	were	be	AUX
ctmj-53	46	17	raised	raise	VERB
ctmj-53	46	18	in	in	ADP
ctmj-53	46	19	rpmi-1640	rpmi-1640	ADJ
ctmj-53	46	20	medium	medium	NOUN
ctmj-53	46	21	(	(	PUNCT
ctmj-53	46	22	both	both	CCONJ
ctmj-53	46	23	from	from	ADP
ctmj-53	46	24	gibco	gibco	PROPN
ctmj-53	46	25	,	,	PUNCT
ctmj-53	46	26	usa	usa	PROPN
ctmj-53	46	27	)	)	PUNCT
ctmj-53	46	28	.	.	PUNCT
ctmj-53	47	1	the	the	DET
ctmj-53	47	2	media	medium	NOUN
ctmj-53	47	3	in	in	ADP
ctmj-53	47	4	which	which	PRON
ctmj-53	47	5	the	the	DET
ctmj-53	47	6	cells	cell	NOUN
ctmj-53	47	7	were	be	AUX
ctmj-53	47	8	maintained	maintain	VERB
ctmj-53	47	9	was	be	AUX
ctmj-53	47	10	enriched	enrich	VERB
ctmj-53	47	11	with	with	ADP
ctmj-53	47	12	10	10	NUM
ctmj-53	47	13	%	%	NOUN
ctmj-53	47	14	fbs	fbs	X
ctmj-53	47	15	(	(	PUNCT
ctmj-53	47	16	hyclone	hyclone	PROPN
ctmj-53	47	17	,	,	PUNCT
ctmj-53	47	18	usa	usa	PROPN
ctmj-53	47	19	)	)	PUNCT
ctmj-53	47	20	,	,	PUNCT
ctmj-53	47	21	100	100	NUM
ctmj-53	47	22	μg	μg	NOUN
ctmj-53	47	23	/	/	SYM
ctmj-53	47	24	ml	ml	NOUN
ctmj-53	47	25	streptomycin	streptomycin	PROPN
ctmj-53	47	26	,	,	PUNCT
ctmj-53	47	27	and	and	CCONJ
ctmj-53	47	28	100	100	NUM
ctmj-53	47	29	u	u	NOUN
ctmj-53	47	30	/	/	SYM
ctmj-53	47	31	ml	ml	NOUN
ctmj-53	47	32	penicillin	penicillin	NOUN
ctmj-53	47	33	and	and	CCONJ
ctmj-53	47	34	maintained	maintain	VERB
ctmj-53	47	35	at	at	ADP
ctmj-53	47	36	37	37	NUM
ctmj-53	47	37	°	°	NOUN
ctmj-53	47	38	c	c	NOUN
ctmj-53	47	39	in	in	ADP
ctmj-53	47	40	5	5	NUM
ctmj-53	47	41	%	%	NOUN
ctmj-53	47	42	co	co	NOUN
ctmj-53	47	43	2	2	NUM
ctmj-53	47	44	.	.	PUNCT
ctmj-53	48	1	rna	rna	NOUN
ctmj-53	48	2	isolation	isolation	NOUN
ctmj-53	48	3	and	and	CCONJ
ctmj-53	48	4	qpcr	qpcr	ADV
ctmj-53	48	5	total	total	ADJ
ctmj-53	48	6	rna	rna	NOUN
ctmj-53	48	7	was	be	AUX
ctmj-53	48	8	extracted	extract	VERB
ctmj-53	48	9	from	from	ADP
ctmj-53	48	10	cell	cell	NOUN
ctmj-53	48	11	lines	line	NOUN
ctmj-53	48	12	using	use	VERB
ctmj-53	48	13	trizol	trizol	ADJ
ctmj-53	48	14	reagent	reagent	NOUN
ctmj-53	48	15	(	(	PUNCT
ctmj-53	48	16	invitrogen	invitrogen	PROPN
ctmj-53	48	17	)	)	PUNCT
ctmj-53	48	18	,	,	PUNCT
ctmj-53	48	19	in	in	ADP
ctmj-53	48	20	line	line	NOUN
ctmj-53	48	21	with	with	ADP
ctmj-53	48	22	the	the	DET
ctmj-53	48	23	directions	direction	NOUN
ctmj-53	48	24	provided	provide	VERB
ctmj-53	48	25	by	by	ADP
ctmj-53	48	26	the	the	DET
ctmj-53	48	27	manufacturer	manufacturer	NOUN
ctmj-53	48	28	.	.	PUNCT
ctmj-53	49	1	reverse	reverse	ADJ
ctmj-53	49	2	transcription	transcription	NOUN
ctmj-53	49	3	was	be	AUX
ctmj-53	49	4	performed	perform	VERB
ctmj-53	49	5	with	with	ADP
ctmj-53	49	6	the	the	DET
ctmj-53	49	7	reverse	reverse	ADJ
ctmj-53	49	8	transcriptase	transcriptase	NOUN
ctmj-53	49	9	kit	kit	NOUN
ctmj-53	49	10	(	(	PUNCT
ctmj-53	49	11	madison	madison	PROPN
ctmj-53	49	12	,	,	PUNCT
ctmj-53	49	13	wisconsin	wisconsin	PROPN
ctmj-53	49	14	,	,	PUNCT
ctmj-53	49	15	usa	usa	PROPN
ctmj-53	49	16	)	)	PUNCT
ctmj-53	49	17	and	and	CCONJ
ctmj-53	49	18	qpcr	qpcr	ADV
ctmj-53	49	19	was	be	AUX
ctmj-53	49	20	done	do	VERB
ctmj-53	49	21	by	by	ADP
ctmj-53	49	22	applying	apply	VERB
ctmj-53	49	23	sybr	sybr	ADP
ctmj-53	49	24	green	green	ADJ
ctmj-53	49	25	supermix	supermix	PROPN
ctmj-53	49	26	(	(	PUNCT
ctmj-53	49	27	invitrogen	invitrogen	PROPN
ctmj-53	49	28	)	)	PUNCT
ctmj-53	49	29	on	on	ADP
ctmj-53	49	30	an	an	DET
ctmj-53	49	31	abi	abi	PROPN
ctmj-53	49	32	prism	prism	NOUN
ctmj-53	49	33	7500	7500	NUM
ctmj-53	49	34	system	system	NOUN
ctmj-53	49	35	(	(	PUNCT
ctmj-53	49	36	applied	apply	VERB
ctmj-53	49	37	biosystems	biosystem	NOUN
ctmj-53	49	38	,	,	PUNCT
ctmj-53	49	39	foster	foster	ADJ
ctmj-53	49	40	city	city	NOUN
ctmj-53	49	41	,	,	PUNCT
ctmj-53	49	42	ca	ca	PROPN
ctmj-53	49	43	,	,	PUNCT
ctmj-53	49	44	usa	usa	PROPN
ctmj-53	49	45	)	)	PUNCT
ctmj-53	49	46	.	.	PUNCT
ctmj-53	50	1	relative	relative	ADJ
ctmj-53	50	2	mrna	mrna	PROPN
ctmj-53	50	3	transcription	transcription	NOUN
ctmj-53	50	4	was	be	AUX
ctmj-53	50	5	quantified	quantify	VERB
ctmj-53	50	6	by	by	ADP
ctmj-53	50	7	the	the	DET
ctmj-53	50	8	2	2	NUM
ctmj-53	50	9	-	-	PUNCT
ctmj-53	50	10	△	△	NOUN
ctmj-53	50	11	△	△	X
ctmj-53	50	12	ct	ct	NOUN
ctmj-53	50	13	technique	technique	NOUN
ctmj-53	50	14	with	with	ADP
ctmj-53	50	15	three	three	NUM
ctmj-53	50	16	technical	technical	ADJ
ctmj-53	50	17	replicates	replicate	NOUN
ctmj-53	50	18	.	.	PUNCT
ctmj-53	51	1	based	base	VERB
ctmj-53	51	2	on	on	ADP
ctmj-53	51	3	the	the	DET
ctmj-53	51	4	results	result	NOUN
ctmj-53	51	5	obtained	obtain	VERB
ctmj-53	51	6	,	,	PUNCT
ctmj-53	51	7	two	two	NUM
ctmj-53	51	8	npc	npc	NOUN
ctmj-53	51	9	cell	cell	NOUN
ctmj-53	51	10	lines	line	NOUN
ctmj-53	51	11	were	be	AUX
ctmj-53	51	12	selected	select	VERB
ctmj-53	51	13	for	for	ADP
ctmj-53	51	14	subsequent	subsequent	ADJ
ctmj-53	51	15	experiments	experiment	NOUN
ctmj-53	51	16	.	.	PUNCT
ctmj-53	52	1	western	western	ADJ
ctmj-53	52	2	blotting	blot	VERB
ctmj-53	52	3	cells	cell	NOUN
ctmj-53	52	4	were	be	AUX
ctmj-53	52	5	dissolved	dissolve	VERB
ctmj-53	52	6	in	in	ADP
ctmj-53	52	7	ripa	ripa	ADJ
ctmj-53	52	8	buffer	buffer	NOUN
ctmj-53	52	9	(	(	PUNCT
ctmj-53	52	10	thermo	thermo	NOUN
ctmj-53	52	11	fisher	fisher	PROPN
ctmj-53	52	12	scientific	scientific	PROPN
ctmj-53	52	13	)	)	PUNCT
ctmj-53	52	14	and	and	CCONJ
ctmj-53	52	15	protein	protein	NOUN
ctmj-53	52	16	concentrations	concentration	NOUN
ctmj-53	52	17	measured	measure	VERB
ctmj-53	52	18	using	use	VERB
ctmj-53	52	19	the	the	DET
ctmj-53	52	20	pierce	pierce	PROPN
ctmj-53	52	21	protein	protein	NOUN
ctmj-53	52	22	assay	assay	NOUN
ctmj-53	52	23	kit	kit	NOUN
ctmj-53	52	24	(	(	PUNCT
ctmj-53	52	25	thermo	thermo	NOUN
ctmj-53	52	26	fisher	fisher	PROPN
ctmj-53	52	27	scientific	scientific	PROPN
ctmj-53	52	28	)	)	PUNCT
ctmj-53	52	29	.	.	PUNCT
ctmj-53	53	1	proteins	protein	NOUN
ctmj-53	53	2	were	be	AUX
ctmj-53	53	3	separated	separate	VERB
ctmj-53	53	4	by	by	ADP
ctmj-53	53	5	sds	sds	PROPN
ctmj-53	53	6	-	-	PUNCT
ctmj-53	53	7	page	page	NOUN
ctmj-53	53	8	,	,	PUNCT
ctmj-53	53	9	put	put	VERB
ctmj-53	53	10	on	on	ADP
ctmj-53	53	11	pvdf	pvdf	PROPN
ctmj-53	53	12	membranes	membrane	NOUN
ctmj-53	53	13	and	and	CCONJ
ctmj-53	53	14	detected	detect	VERB
ctmj-53	53	15	by	by	ADP
ctmj-53	53	16	incubation	incubation	NOUN
ctmj-53	53	17	with	with	ADP
ctmj-53	53	18	primary	primary	ADJ
ctmj-53	53	19	antibodies	antibody	NOUN
ctmj-53	53	20	overnight	overnight	ADV
ctmj-53	53	21	at	at	ADP
ctmj-53	53	22	4	4	NUM
ctmj-53	53	23	°	°	NOUN
ctmj-53	53	24	c	c	NOUN
ctmj-53	53	25	.	.	PUNCT
ctmj-53	54	1	proteins	protein	NOUN
ctmj-53	54	2	bands	band	NOUN
ctmj-53	54	3	were	be	AUX
ctmj-53	54	4	visualized	visualize	VERB
ctmj-53	54	5	using	use	VERB
ctmj-53	54	6	westernbrighttm	westernbrighttm	NOUN
ctmj-53	54	7	enhanced	enhance	VERB
ctmj-53	54	8	chemiluminescence	chemiluminescence	NOUN
ctmj-53	54	9	(	(	PUNCT
ctmj-53	54	10	bio	bio	NOUN
ctmj-53	54	11	-	-	PROPN
ctmj-53	54	12	rad	rad	PROPN
ctmj-53	54	13	,	,	PUNCT
ctmj-53	54	14	usa	usa	PROPN
ctmj-53	54	15	)	)	PUNCT
ctmj-53	54	16	.	.	PUNCT
ctmj-53	55	1	cell	cell	NOUN
ctmj-53	55	2	transfection	transfection	NOUN
ctmj-53	55	3	and	and	CCONJ
ctmj-53	55	4	drug	drug	NOUN
ctmj-53	55	5	treatment	treatment	NOUN
ctmj-53	55	6	the	the	DET
ctmj-53	55	7	si	si	NOUN
ctmj-53	55	8	-	-	PUNCT
ctmj-53	55	9	msr1	msr1	PROPN
ctmj-53	55	10	and	and	CCONJ
ctmj-53	55	11	si	si	PROPN
ctmj-53	55	12	-	-	PUNCT
ctmj-53	55	13	nc	nc	PROPN
ctmj-53	55	14	were	be	AUX
ctmj-53	55	15	separately	separately	ADV
ctmj-53	55	16	transfected	transfecte	VERB
ctmj-53	55	17	into	into	ADP
ctmj-53	55	18	cells	cell	NOUN
ctmj-53	55	19	and	and	CCONJ
ctmj-53	55	20	incubated	incubate	VERB
ctmj-53	55	21	for	for	ADP
ctmj-53	55	22	24	24	NUM
ctmj-53	55	23	,	,	PUNCT
ctmj-53	55	24	48	48	NUM
ctmj-53	55	25	,	,	PUNCT
ctmj-53	55	26	72	72	NUM
ctmj-53	55	27	,	,	PUNCT
ctmj-53	55	28	and	and	CCONJ
ctmj-53	55	29	96	96	NUM
ctmj-53	55	30	h.	h.	NOUN
ctmj-53	55	31	the	the	DET
ctmj-53	55	32	https://sea.bkslab.org/	https://sea.bkslab.org/	PROPN
ctmj-53	55	33	chinese	chinese	ADJ
ctmj-53	55	34	traditional	traditional	ADJ
ctmj-53	55	35	medicine	medicine	NOUN
ctmj-53	55	36	journal	journal	NOUN
ctmj-53	55	37	|	|	ADV
ctmj-53	55	38	2020	2020	NUM
ctmj-53	56	1	|	|	ADV
ctmj-53	56	2	vol	vol	NOUN
ctmj-53	56	3	3	3	NUM
ctmj-53	56	4	|	|	ADV
ctmj-53	56	5	issue	issue	VERB
ctmj-53	56	6	5	5	NUM
ctmj-53	56	7	issn	issn	X
ctmj-53	56	8	:	:	PUNCT
ctmj-53	56	9	2693	2693	NUM
ctmj-53	56	10	6356	6356	NUM
ctmj-53	56	11	2020	2020	NUM
ctmj-53	56	12	|	|	ADV
ctmj-53	56	13	vol	vol	NOUN
ctmj-53	56	14	3	3	NUM
ctmj-53	56	15	|	|	ADV
ctmj-53	56	16	issue	issue	VERB
ctmj-53	56	17	5	5	NUM
ctmj-53	56	18	ctmj	ctmj	NOUN
ctmj-53	56	19	|	|	ADV
ctmj-53	56	20	traditionalmedicinejournals.com	traditionalmedicinejournals.com	X
ctmj-53	56	21	absorbance	absorbance	NOUN
ctmj-53	56	22	at	at	ADP
ctmj-53	56	23	450	450	NUM
ctmj-53	56	24	nm	nm	NOUN
ctmj-53	56	25	was	be	AUX
ctmj-53	56	26	read	read	VERB
ctmj-53	56	27	on	on	ADP
ctmj-53	56	28	a	a	DET
ctmj-53	56	29	microplate	microplate	NOUN
ctmj-53	56	30	reader	reader	NOUN
ctmj-53	56	31	following	follow	VERB
ctmj-53	56	32	which	which	PRON
ctmj-53	56	33	cells	cell	NOUN
ctmj-53	56	34	were	be	AUX
ctmj-53	56	35	incubated	incubate	VERB
ctmj-53	56	36	with	with	ADP
ctmj-53	56	37	10	10	NUM
ctmj-53	56	38	ml	ml	NOUN
ctmj-53	56	39	of	of	ADP
ctmj-53	56	40	cck-8	cck-8	PUNCT
ctmj-53	56	41	reagent	reagent	NOUN
ctmj-53	56	42	for	for	ADP
ctmj-53	56	43	2	2	NUM
ctmj-53	56	44	h	h	NOUN
ctmj-53	56	45	at	at	ADP
ctmj-53	56	46	37	37	NUM
ctmj-53	56	47	oc	oc	NOUN
ctmj-53	56	48	with	with	ADP
ctmj-53	56	49	5	5	NUM
ctmj-53	56	50	%	%	NOUN
ctmj-53	56	51	co2	co2	NOUN
ctmj-53	56	52	.	.	PUNCT
ctmj-53	57	1	hone1	hone1	PROPN
ctmj-53	57	2	and	and	CCONJ
ctmj-53	57	3	hne1	hne1	PROPN
ctmj-53	57	4	cells	cell	NOUN
ctmj-53	57	5	were	be	AUX
ctmj-53	57	6	exposed	expose	VERB
ctmj-53	57	7	to	to	ADP
ctmj-53	57	8	varied	varied	ADJ
ctmj-53	57	9	doses	dose	NOUN
ctmj-53	57	10	of	of	ADP
ctmj-53	57	11	c6ceramide	c6ceramide	NOUN
ctmj-53	57	12	for	for	ADP
ctmj-53	57	13	24	24	NUM
ctmj-53	57	14	,	,	PUNCT
ctmj-53	57	15	48	48	NUM
ctmj-53	57	16	,	,	PUNCT
ctmj-53	57	17	72	72	NUM
ctmj-53	57	18	and	and	CCONJ
ctmj-53	57	19	96	96	NUM
ctmj-53	57	20	h	h	NOUN
ctmj-53	57	21	before	before	ADP
ctmj-53	57	22	assessing	assess	VERB
ctmj-53	57	23	cell	cell	NOUN
ctmj-53	57	24	survival	survival	NOUN
ctmj-53	57	25	by	by	ADP
ctmj-53	57	26	cck-8	cck-8	PUNCT
ctmj-53	57	27	assay	assay	VERB
ctmj-53	57	28	.	.	PUNCT
ctmj-53	58	1	cells	cell	NOUN
ctmj-53	58	2	were	be	AUX
ctmj-53	58	3	transfected	transfecte	VERB
ctmj-53	58	4	with	with	ADP
ctmj-53	58	5	pcdna	pcdna	NOUN
ctmj-53	58	6	-	-	PUNCT
ctmj-53	58	7	nc	nc	NOUN
ctmj-53	58	8	,	,	PUNCT
ctmj-53	58	9	pcdna	pcdna	NOUN
ctmj-53	58	10	-	-	PUNCT
ctmj-53	58	11	msr1	msr1	PROPN
ctmj-53	58	12	,	,	PUNCT
ctmj-53	58	13	c6	c6	NOUN
ctmj-53	58	14	-	-	PUNCT
ctmj-53	58	15	ceramide	ceramide	NOUN
ctmj-53	58	16	,	,	PUNCT
ctmj-53	58	17	or	or	CCONJ
ctmj-53	58	18	pcdna	pcdna	NOUN
ctmj-53	58	19	-	-	PUNCT
ctmj-53	58	20	msr1	msr1	NOUN
ctmj-53	58	21	+	+	CCONJ
ctmj-53	58	22	c6	c6	NOUN
ctmj-53	58	23	-	-	PUNCT
ctmj-53	58	24	ceramide	ceramide	NOUN
ctmj-53	58	25	according	accord	VERB
ctmj-53	58	26	to	to	ADP
ctmj-53	58	27	experimental	experimental	ADJ
ctmj-53	58	28	groups	group	NOUN
ctmj-53	58	29	.	.	PUNCT
ctmj-53	59	1	the	the	DET
ctmj-53	59	2	msr1	msr1	PROPN
ctmj-53	59	3	mrna	mrna	PROPN
ctmj-53	59	4	levels	level	NOUN
ctmj-53	59	5	were	be	AUX
ctmj-53	59	6	quantified	quantify	VERB
ctmj-53	59	7	using	use	VERB
ctmj-53	59	8	qpcr	qpcr	ADJ
ctmj-53	59	9	posttransfection	posttransfection	NOUN
ctmj-53	59	10	.	.	PUNCT
ctmj-53	60	1	cells	cell	NOUN
ctmj-53	60	2	were	be	AUX
ctmj-53	60	3	also	also	ADV
ctmj-53	60	4	transfected	transfecte	VERB
ctmj-53	60	5	with	with	ADP
ctmj-53	60	6	msr1	msr1	PROPN
ctmj-53	60	7	knockdown	knockdown	NOUN
ctmj-53	60	8	or	or	CCONJ
ctmj-53	60	9	overexpression	overexpression	NOUN
ctmj-53	60	10	vectors	vector	NOUN
ctmj-53	60	11	while	while	SCONJ
ctmj-53	60	12	pi3k	pi3k	PROPN
ctmj-53	60	13	and	and	CCONJ
ctmj-53	60	14	akt	akt	PROPN
ctmj-53	60	15	mrna	mrna	PROPN
ctmj-53	60	16	levels	level	NOUN
ctmj-53	60	17	were	be	AUX
ctmj-53	60	18	examined	examine	VERB
ctmj-53	60	19	using	use	VERB
ctmj-53	60	20	qpcr	qpcr	ADV
ctmj-53	60	21	.	.	PUNCT
ctmj-53	61	1	statistical	statistical	ADJ
ctmj-53	61	2	analysis	analysis	NOUN
ctmj-53	61	3	statistical	statistical	ADJ
ctmj-53	61	4	analyses	analysis	NOUN
ctmj-53	61	5	were	be	AUX
ctmj-53	61	6	done	do	VERB
ctmj-53	61	7	using	use	VERB
ctmj-53	61	8	spss	spss	PROPN
ctmj-53	61	9	20.0	20.0	NUM
ctmj-53	61	10	software	software	NOUN
ctmj-53	61	11	.	.	PUNCT
ctmj-53	62	1	variations	variation	NOUN
ctmj-53	62	2	between	between	ADP
ctmj-53	62	3	groups	group	NOUN
ctmj-53	62	4	were	be	AUX
ctmj-53	62	5	evaluated	evaluate	VERB
ctmj-53	62	6	using	use	VERB
ctmj-53	62	7	student	student	NOUN
ctmj-53	62	8	's	's	PART
ctmj-53	62	9	t	t	NOUN
ctmj-53	62	10	-	-	PUNCT
ctmj-53	62	11	test	test	NOUN
ctmj-53	62	12	or	or	CCONJ
ctmj-53	62	13	one	one	NUM
ctmj-53	62	14	-	-	PUNCT
ctmj-53	62	15	way	way	NOUN
ctmj-53	62	16	anova	anova	PROPN
ctmj-53	62	17	,	,	PUNCT
ctmj-53	62	18	statistical	statistical	ADJ
ctmj-53	62	19	significance	significance	NOUN
ctmj-53	62	20	was	be	AUX
ctmj-53	62	21	evaluated	evaluate	VERB
ctmj-53	62	22	by	by	ADP
ctmj-53	62	23	p	p	NOUN
ctmj-53	62	24	-	-	PUNCT
ctmj-53	62	25	values	value	NOUN
ctmj-53	62	26	<	<	X
ctmj-53	62	27	0.05	0.05	NUM
ctmj-53	62	28	(	(	PUNCT
ctmj-53	62	29	*	*	PUNCT
ctmj-53	62	30	p	p	X
ctmj-53	62	31	<	<	X
ctmj-53	62	32	0.05	0.05	NUM
ctmj-53	62	33	,	,	PUNCT
ctmj-53	62	34	*	*	PUNCT
ctmj-53	62	35	*	*	PUNCT
ctmj-53	62	36	p	p	X
ctmj-53	62	37	<	<	X
ctmj-53	62	38	0.01	0.01	NUM
ctmj-53	62	39	,	,	PUNCT
ctmj-53	62	40	*	*	PUNCT
ctmj-53	62	41	*	*	PUNCT
ctmj-53	62	42	*	*	PUNCT
ctmj-53	62	43	p	p	X
ctmj-53	62	44	<	<	X
ctmj-53	62	45	0.001	0.001	NUM
ctmj-53	62	46	,	,	PUNCT
ctmj-53	62	47	*	*	PUNCT
ctmj-53	62	48	*	*	PUNCT
ctmj-53	62	49	*	*	PUNCT
ctmj-53	62	50	*	*	PUNCT
ctmj-53	62	51	p	p	X
ctmj-53	62	52	<	<	X
ctmj-53	62	53	0.0001	0.0001	NUM
ctmj-53	62	54	)	)	PUNCT
ctmj-53	62	55	.	.	PUNCT
ctmj-53	63	1	results	result	VERB
ctmj-53	63	2	differential	differential	ADJ
ctmj-53	63	3	gene	gene	NOUN
ctmj-53	63	4	expression	expression	NOUN
ctmj-53	63	5	and	and	CCONJ
ctmj-53	63	6	pathway	pathway	NOUN
ctmj-53	63	7	analysis	analysis	NOUN
ctmj-53	63	8	gene	gene	NOUN
ctmj-53	63	9	expression	expression	NOUN
ctmj-53	63	10	data	datum	NOUN
ctmj-53	63	11	from	from	ADP
ctmj-53	63	12	three	three	NUM
ctmj-53	63	13	npc	npc	NOUN
ctmj-53	63	14	datasets	dataset	NOUN
ctmj-53	63	15	(	(	PUNCT
ctmj-53	63	16	gse12452	gse12452	NOUN
ctmj-53	63	17	,	,	PUNCT
ctmj-53	63	18	gse53819	gse53819	NOUN
ctmj-53	63	19	and	and	CCONJ
ctmj-53	63	20	gse61218	gse61218	NOUN
ctmj-53	63	21	)	)	PUNCT
ctmj-53	63	22	were	be	AUX
ctmj-53	63	23	obtained	obtain	VERB
ctmj-53	63	24	from	from	ADP
ctmj-53	63	25	the	the	DET
ctmj-53	63	26	geo	geo	PROPN
ctmj-53	63	27	database	database	NOUN
ctmj-53	63	28	.	.	PUNCT
ctmj-53	64	1	bayesian	bayesian	NOUN
ctmj-53	64	2	differential	differential	NOUN
ctmj-53	64	3	analysis	analysis	NOUN
ctmj-53	64	4	was	be	AUX
ctmj-53	64	5	performed	perform	VERB
ctmj-53	64	6	to	to	PART
ctmj-53	64	7	identify	identify	VERB
ctmj-53	64	8	dges	dge	NOUN
ctmj-53	64	9	between	between	ADP
ctmj-53	64	10	npc	npc	NOUN
ctmj-53	64	11	and	and	CCONJ
ctmj-53	64	12	control	control	NOUN
ctmj-53	64	13	samples	sample	NOUN
ctmj-53	64	14	in	in	ADP
ctmj-53	64	15	each	each	DET
ctmj-53	64	16	dataset	dataset	NOUN
ctmj-53	64	17	.	.	PUNCT
ctmj-53	65	1	in	in	ADP
ctmj-53	65	2	gse12452	gse12452	NOUN
ctmj-53	65	3	(	(	PUNCT
ctmj-53	65	4	31	31	NUM
ctmj-53	65	5	npc	npc	NOUN
ctmj-53	65	6	and	and	CCONJ
ctmj-53	65	7	10	10	NUM
ctmj-53	65	8	control	control	NOUN
ctmj-53	65	9	)	)	PUNCT
ctmj-53	65	10	,	,	PUNCT
ctmj-53	65	11	7780	7780	NUM
ctmj-53	65	12	downregulated	downregulate	VERB
ctmj-53	65	13	and	and	CCONJ
ctmj-53	65	14	297	297	NUM
ctmj-53	65	15	upregulated	upregulated	ADJ
ctmj-53	65	16	degs	deg	NOUN
ctmj-53	65	17	were	be	AUX
ctmj-53	65	18	identified	identify	VERB
ctmj-53	65	19	(	(	PUNCT
ctmj-53	65	20	figure	figure	NOUN
ctmj-53	65	21	1	1	NUM
ctmj-53	65	22	a	a	NOUN
ctmj-53	65	23	)	)	PUNCT
ctmj-53	65	24	.	.	PUNCT
ctmj-53	66	1	figure	figure	VERB
ctmj-53	66	2	1	1	NUM
ctmj-53	66	3	:	:	PUNCT
ctmj-53	66	4	differential	differential	ADJ
ctmj-53	66	5	gene	gene	NOUN
ctmj-53	66	6	expression	expression	NOUN
ctmj-53	66	7	and	and	CCONJ
ctmj-53	66	8	pathway	pathway	NOUN
ctmj-53	66	9	analysis	analysis	NOUN
ctmj-53	66	10	.	.	PUNCT
ctmj-53	67	1	degs	deg	NOUN
ctmj-53	67	2	between	between	ADP
ctmj-53	67	3	npc	npc	NOUN
ctmj-53	67	4	and	and	CCONJ
ctmj-53	67	5	control	control	NOUN
ctmj-53	67	6	samples	sample	NOUN
ctmj-53	67	7	were	be	AUX
ctmj-53	67	8	identified	identify	VERB
ctmj-53	67	9	by	by	ADP
ctmj-53	67	10	bayesian	bayesian	NOUN
ctmj-53	67	11	analysis	analysis	NOUN
ctmj-53	67	12	in	in	ADP
ctmj-53	67	13	three	three	NUM
ctmj-53	67	14	datasets	dataset	NOUN
ctmj-53	67	15	:	:	PUNCT
ctmj-53	67	16	gse12452	gse12452	NOUN
ctmj-53	67	17	(	(	PUNCT
ctmj-53	67	18	a	a	X
ctmj-53	67	19	)	)	PUNCT
ctmj-53	67	20	,	,	PUNCT
ctmj-53	67	21	gse53819	gse53819	NOUN
ctmj-53	67	22	(	(	PUNCT
ctmj-53	67	23	b	b	NOUN
ctmj-53	67	24	)	)	PUNCT
ctmj-53	67	25	,	,	PUNCT
ctmj-53	67	26	and	and	CCONJ
ctmj-53	67	27	gse61218	gse61218	NOUN
ctmj-53	67	28	(	(	PUNCT
ctmj-53	67	29	c	c	NOUN
ctmj-53	67	30	)	)	PUNCT
ctmj-53	67	31	;	;	PUNCT
ctmj-53	67	32	venn	venn	PROPN
ctmj-53	67	33	diagrams	diagram	NOUN
ctmj-53	67	34	show	show	VERB
ctmj-53	67	35	the	the	DET
ctmj-53	67	36	overlap	overlap	NOUN
ctmj-53	67	37	of	of	ADP
ctmj-53	67	38	upregulated	upregulated	ADJ
ctmj-53	67	39	(	(	PUNCT
ctmj-53	67	40	d	d	NOUN
ctmj-53	67	41	)	)	PUNCT
ctmj-53	67	42	and	and	CCONJ
ctmj-53	67	43	downregulated	downregulate	VERB
ctmj-53	67	44	(	(	PUNCT
ctmj-53	67	45	e	e	NOUN
ctmj-53	67	46	)	)	PUNCT
ctmj-53	67	47	chinese	chinese	ADJ
ctmj-53	67	48	traditional	traditional	ADJ
ctmj-53	67	49	medicine	medicine	NOUN
ctmj-53	67	50	journal	journal	NOUN
ctmj-53	67	51	|	|	ADV
ctmj-53	67	52	2020	2020	NUM
ctmj-53	68	1	|	|	ADV
ctmj-53	68	2	vol	vol	NOUN
ctmj-53	68	3	3	3	NUM
ctmj-53	68	4	|	|	ADV
ctmj-53	68	5	issue	issue	VERB
ctmj-53	68	6	5	5	NUM
ctmj-53	68	7	issn	issn	X
ctmj-53	68	8	:	:	PUNCT
ctmj-53	68	9	2693	2693	NUM
ctmj-53	68	10	6356	6356	NUM
ctmj-53	68	11	2020	2020	NUM
ctmj-53	68	12	|	|	ADV
ctmj-53	68	13	vol	vol	NOUN
ctmj-53	68	14	3	3	NUM
ctmj-53	68	15	|	|	ADV
ctmj-53	68	16	issue	issue	VERB
ctmj-53	68	17	5	5	NUM
ctmj-53	68	18	ctmj	ctmj	NOUN
ctmj-53	69	1	|	|	ADV
ctmj-53	69	2	traditionalmedicinejournals.com	traditionalmedicinejournals.com	PUNCT
ctmj-53	69	3	figure	figure	NOUN
ctmj-53	69	4	1	1	NUM
ctmj-53	69	5	continued	continue	VERB
ctmj-53	69	6	:	:	PUNCT
ctmj-53	69	7	differential	differential	ADJ
ctmj-53	69	8	gene	gene	NOUN
ctmj-53	69	9	expression	expression	NOUN
ctmj-53	69	10	and	and	CCONJ
ctmj-53	69	11	pathway	pathway	NOUN
ctmj-53	69	12	analysis	analysis	NOUN
ctmj-53	69	13	.	.	PUNCT
ctmj-53	70	1	degs	deg	NOUN
ctmj-53	70	2	between	between	ADP
ctmj-53	70	3	npc	npc	NOUN
ctmj-53	70	4	and	and	CCONJ
ctmj-53	70	5	control	control	NOUN
ctmj-53	70	6	samples	sample	NOUN
ctmj-53	70	7	were	be	AUX
ctmj-53	70	8	identified	identify	VERB
ctmj-53	70	9	by	by	ADP
ctmj-53	70	10	bayesian	bayesian	NOUN
ctmj-53	70	11	analysis	analysis	NOUN
ctmj-53	70	12	in	in	ADP
ctmj-53	70	13	three	three	NUM
ctmj-53	70	14	datasets	dataset	NOUN
ctmj-53	70	15	:	:	PUNCT
ctmj-53	70	16	degs	deg	NOUN
ctmj-53	70	17	across	across	ADP
ctmj-53	70	18	the	the	DET
ctmj-53	70	19	three	three	NUM
ctmj-53	70	20	datasets	dataset	NOUN
ctmj-53	70	21	;	;	PUNCT
ctmj-53	70	22	ontology	ontology	NOUN
ctmj-53	70	23	enrichment	enrichment	NOUN
ctmj-53	70	24	analysis	analysis	NOUN
ctmj-53	70	25	revealed	reveal	VERB
ctmj-53	70	26	altered	alter	VERB
ctmj-53	70	27	bp	bp	PROPN
ctmj-53	70	28	(	(	PUNCT
ctmj-53	70	29	f	f	X
ctmj-53	70	30	)	)	PUNCT
ctmj-53	70	31	,	,	PUNCT
ctmj-53	70	32	cc	cc	PROPN
ctmj-53	70	33	(	(	PUNCT
ctmj-53	70	34	g	g	NOUN
ctmj-53	70	35	)	)	PUNCT
ctmj-53	70	36	and	and	CCONJ
ctmj-53	70	37	mf	mf	X
ctmj-53	70	38	(	(	PUNCT
ctmj-53	70	39	h	h	NOUN
ctmj-53	70	40	)	)	PUNCT
ctmj-53	70	41	;	;	PUNCT
ctmj-53	70	42	the	the	DET
ctmj-53	70	43	top	top	ADJ
ctmj-53	70	44	15	15	NUM
ctmj-53	70	45	enriched	enrich	VERB
ctmj-53	70	46	kegg	kegg	NOUN
ctmj-53	70	47	pathways	pathway	NOUN
ctmj-53	70	48	are	be	AUX
ctmj-53	70	49	shown	show	VERB
ctmj-53	70	50	in	in	ADP
ctmj-53	70	51	(	(	PUNCT
ctmj-53	70	52	i	i	NOUN
ctmj-53	70	53	)	)	PUNCT
ctmj-53	70	54	in	in	ADP
ctmj-53	70	55	gse53819	gse53819	NOUN
ctmj-53	70	56	(	(	PUNCT
ctmj-53	70	57	18	18	NUM
ctmj-53	70	58	npc	npc	NOUN
ctmj-53	70	59	and	and	CCONJ
ctmj-53	70	60	18	18	NUM
ctmj-53	70	61	control	control	NOUN
ctmj-53	70	62	)	)	PUNCT
ctmj-53	70	63	,	,	PUNCT
ctmj-53	70	64	7426	7426	NUM
ctmj-53	70	65	downregulated	downregulate	VERB
ctmj-53	70	66	and	and	CCONJ
ctmj-53	70	67	842	842	NUM
ctmj-53	70	68	upregulated	upregulate	VERB
ctmj-53	70	69	degs	deg	NOUN
ctmj-53	70	70	were	be	AUX
ctmj-53	70	71	found	find	VERB
ctmj-53	70	72	(	(	PUNCT
ctmj-53	70	73	figure	figure	NOUN
ctmj-53	70	74	1	1	NUM
ctmj-53	70	75	b	b	NOUN
ctmj-53	70	76	)	)	PUNCT
ctmj-53	70	77	while	while	SCONJ
ctmj-53	70	78	2485	2485	NUM
ctmj-53	70	79	downregulated	downregulate	VERB
ctmj-53	70	80	and	and	CCONJ
ctmj-53	70	81	344	344	NUM
ctmj-53	70	82	upregulated	upregulate	VERB
ctmj-53	70	83	degs	deg	NOUN
ctmj-53	70	84	were	be	AUX
ctmj-53	70	85	identified	identify	VERB
ctmj-53	70	86	in	in	ADP
ctmj-53	70	87	gse61218	gse61218	NOUN
ctmj-53	70	88	(	(	PUNCT
ctmj-53	70	89	10	10	NUM
ctmj-53	70	90	npc	npc	NOUN
ctmj-53	70	91	and	and	CCONJ
ctmj-53	70	92	6	6	NUM
ctmj-53	70	93	control	control	NOUN
ctmj-53	70	94	;	;	PUNCT
ctmj-53	70	95	figure	figure	NOUN
ctmj-53	70	96	1	1	NUM
ctmj-53	70	97	c	c	NOUN
ctmj-53	70	98	)	)	PUNCT
ctmj-53	70	99	.	.	PUNCT
ctmj-53	71	1	the	the	DET
ctmj-53	71	2	overlap	overlap	NOUN
ctmj-53	71	3	of	of	ADP
ctmj-53	71	4	degs	deg	NOUN
ctmj-53	71	5	across	across	ADP
ctmj-53	71	6	the	the	DET
ctmj-53	71	7	three	three	NUM
ctmj-53	71	8	datasets	dataset	NOUN
ctmj-53	71	9	indicated	indicate	VERB
ctmj-53	71	10	26	26	NUM
ctmj-53	71	11	commonly	commonly	ADV
ctmj-53	71	12	upregulated	upregulate	VERB
ctmj-53	71	13	and	and	CCONJ
ctmj-53	71	14	344	344	NUM
ctmj-53	71	15	commonly	commonly	ADV
ctmj-53	71	16	downregulated	downregulate	VERB
ctmj-53	71	17	degs	deg	NOUN
ctmj-53	71	18	(	(	PUNCT
ctmj-53	71	19	figure	figure	NOUN
ctmj-53	71	20	1	1	NUM
ctmj-53	71	21	d	d	NOUN
ctmj-53	71	22	and	and	CCONJ
ctmj-53	71	23	e	e	NOUN
ctmj-53	71	24	)	)	PUNCT
ctmj-53	71	25	.	.	PUNCT
ctmj-53	72	1	go	go	VERB
ctmj-53	72	2	and	and	CCONJ
ctmj-53	72	3	kegg	kegg	NOUN
ctmj-53	72	4	enrichment	enrichment	NOUN
ctmj-53	72	5	analyses	analysis	NOUN
ctmj-53	72	6	were	be	AUX
ctmj-53	72	7	performed	perform	VERB
ctmj-53	72	8	on	on	ADP
ctmj-53	72	9	the	the	DET
ctmj-53	72	10	380	380	NUM
ctmj-53	72	11	degs	deg	NOUN
ctmj-53	72	12	to	to	PART
ctmj-53	72	13	investigate	investigate	VERB
ctmj-53	72	14	altered	altered	ADJ
ctmj-53	72	15	biological	biological	ADJ
ctmj-53	72	16	pathways	pathway	NOUN
ctmj-53	72	17	and	and	CCONJ
ctmj-53	72	18	processes	process	NOUN
ctmj-53	72	19	.	.	PUNCT
ctmj-53	73	1	the	the	DET
ctmj-53	73	2	top	top	ADJ
ctmj-53	73	3	10	10	NUM
ctmj-53	73	4	enriched	enriched	ADJ
ctmj-53	73	5	go	go	NOUN
ctmj-53	73	6	terms	term	NOUN
ctmj-53	73	7	included	include	VERB
ctmj-53	73	8	cilium	cilium	NOUN
ctmj-53	73	9	assembly	assembly	NOUN
ctmj-53	73	10	,	,	PUNCT
ctmj-53	73	11	cilium	cilium	NOUN
ctmj-53	73	12	organization	organization	NOUN
ctmj-53	73	13	and	and	CCONJ
ctmj-53	73	14	microtubulebased	microtubulebase	VERB
ctmj-53	73	15	movement	movement	NOUN
ctmj-53	73	16	for	for	ADP
ctmj-53	73	17	biological	biological	ADJ
ctmj-53	73	18	process	process	NOUN
ctmj-53	73	19	(	(	PUNCT
ctmj-53	73	20	bp	bp	PROPN
ctmj-53	73	21	)	)	PUNCT
ctmj-53	73	22	(	(	PUNCT
ctmj-53	73	23	figure	figure	NOUN
ctmj-53	73	24	1	1	NUM
ctmj-53	73	25	f	f	NOUN
ctmj-53	73	26	)	)	PUNCT
ctmj-53	73	27	;	;	PUNCT
ctmj-53	73	28	nuclear	nuclear	ADJ
ctmj-53	73	29	envelope	envelope	NOUN
ctmj-53	73	30	and	and	CCONJ
ctmj-53	73	31	acrosome	acrosome	VERB
ctmj-53	73	32	for	for	ADP
ctmj-53	73	33	cellular	cellular	ADJ
ctmj-53	73	34	component	component	NOUN
ctmj-53	73	35	(	(	PUNCT
ctmj-53	73	36	cc	cc	NOUN
ctmj-53	73	37	)	)	PUNCT
ctmj-53	73	38	(	(	PUNCT
ctmj-53	73	39	figure	figure	NOUN
ctmj-53	73	40	1	1	NUM
ctmj-53	73	41	g	g	NOUN
ctmj-53	73	42	)	)	PUNCT
ctmj-53	73	43	;	;	PUNCT
ctmj-53	73	44	and	and	CCONJ
ctmj-53	73	45	dynein	dynein	VERB
ctmj-53	73	46	heavy	heavy	ADJ
ctmj-53	73	47	chain	chain	NOUN
ctmj-53	73	48	binding	bind	VERB
ctmj-53	73	49	for	for	ADP
ctmj-53	73	50	molecular	molecular	ADJ
ctmj-53	73	51	function	function	NOUN
ctmj-53	73	52	(	(	PUNCT
ctmj-53	73	53	mf	mf	X
ctmj-53	73	54	)	)	PUNCT
ctmj-53	73	55	(	(	PUNCT
ctmj-53	73	56	figure	figure	NOUN
ctmj-53	73	57	1	1	NUM
ctmj-53	73	58	h	h	NOUN
ctmj-53	73	59	)	)	PUNCT
ctmj-53	73	60	.	.	PUNCT
ctmj-53	74	1	the	the	DET
ctmj-53	74	2	top	top	ADJ
ctmj-53	74	3	15	15	NUM
ctmj-53	74	4	enriched	enrich	VERB
ctmj-53	74	5	kegg	kegg	NOUN
ctmj-53	74	6	pathways	pathway	NOUN
ctmj-53	74	7	included	include	VERB
ctmj-53	74	8	thyroid	thyroid	NOUN
ctmj-53	74	9	hormone	hormone	NOUN
ctmj-53	74	10	signaling	signal	VERB
ctmj-53	74	11	,	,	PUNCT
ctmj-53	74	12	lipid	lipid	ADJ
ctmj-53	74	13	metabolism	metabolism	NOUN
ctmj-53	74	14	,	,	PUNCT
ctmj-53	74	15	atherosclerosis	atherosclerosis	NOUN
ctmj-53	74	16	,	,	PUNCT
ctmj-53	74	17	tnf	tnf	PROPN
ctmj-53	74	18	signaling	signaling	NOUN
ctmj-53	74	19	and	and	CCONJ
ctmj-53	74	20	autophagy	autophagy	ADJ
ctmj-53	74	21	(	(	PUNCT
ctmj-53	74	22	figure	figure	NOUN
ctmj-53	74	23	1	1	NUM
ctmj-53	74	24	i	i	NOUN
ctmj-53	74	25	)	)	PUNCT
ctmj-53	74	26	.	.	PUNCT
ctmj-53	75	1	potential	potential	ADJ
ctmj-53	75	2	drug	drug	NOUN
ctmj-53	75	3	candidates	candidate	NOUN
ctmj-53	75	4	for	for	ADP
ctmj-53	75	5	npc	npc	PROPN
ctmj-53	75	6	chinese	chinese	ADJ
ctmj-53	75	7	traditional	traditional	ADJ
ctmj-53	75	8	medicine	medicine	NOUN
ctmj-53	75	9	journal	journal	NOUN
ctmj-53	75	10	|	|	ADV
ctmj-53	75	11	2020	2020	NUM
ctmj-53	75	12	|	|	ADV
ctmj-53	75	13	vol	vol	NOUN
ctmj-53	75	14	3	3	NUM
ctmj-53	75	15	|	|	ADV
ctmj-53	75	16	issue	issue	VERB
ctmj-53	75	17	5	5	NUM
ctmj-53	75	18	issn	issn	X
ctmj-53	75	19	:	:	PUNCT
ctmj-53	75	20	2693	2693	NUM
ctmj-53	75	21	6356	6356	NUM
ctmj-53	75	22	2020	2020	NUM
ctmj-53	75	23	|	|	ADV
ctmj-53	75	24	vol	vol	NOUN
ctmj-53	75	25	3	3	NUM
ctmj-53	76	1	|	|	ADV
ctmj-53	76	2	issue	issue	VERB
ctmj-53	76	3	5	5	NUM
ctmj-53	76	4	ctmj	ctmj	NOUN
ctmj-53	76	5	|	|	ADV
ctmj-53	76	6	traditionalmedicinejournals.com	traditionalmedicinejournals.com	X
ctmj-53	76	7	to	to	PART
ctmj-53	76	8	identify	identify	VERB
ctmj-53	76	9	potential	potential	ADJ
ctmj-53	76	10	drug	drug	NOUN
ctmj-53	76	11	candidates	candidate	NOUN
ctmj-53	76	12	for	for	ADP
ctmj-53	76	13	npc	npc	NOUN
ctmj-53	76	14	,	,	PUNCT
ctmj-53	76	15	gsea	gsea	NOUN
ctmj-53	76	16	was	be	AUX
ctmj-53	76	17	performed	perform	VERB
ctmj-53	76	18	using	use	VERB
ctmj-53	76	19	the	the	DET
ctmj-53	76	20	316	316	NUM
ctmj-53	76	21	drug	drug	NOUN
ctmj-53	76	22	and	and	CCONJ
ctmj-53	76	23	small	small	ADJ
ctmj-53	76	24	molecule	molecule	NOUN
ctmj-53	76	25	target	target	NOUN
ctmj-53	76	26	gene	gene	NOUN
ctmj-53	76	27	sets	set	NOUN
ctmj-53	76	28	from	from	ADP
ctmj-53	76	29	the	the	DET
ctmj-53	76	30	sea	sea	NOUN
ctmj-53	76	31	database	database	NOUN
ctmj-53	76	32	.	.	PUNCT
ctmj-53	77	1	the	the	DET
ctmj-53	77	2	top	top	ADJ
ctmj-53	77	3	10	10	NUM
ctmj-53	77	4	significantly	significantly	ADV
ctmj-53	77	5	enriched	enrich	VERB
ctmj-53	77	6	drugs	drug	NOUN
ctmj-53	77	7	(	(	PUNCT
ctmj-53	77	8	p	p	X
ctmj-53	77	9	<	<	X
ctmj-53	77	10	0.05	0.05	NUM
ctmj-53	77	11	,	,	PUNCT
ctmj-53	77	12	es	es	X
ctmj-53	77	13	>	>	X
ctmj-53	77	14	0.3	0.3	NUM
ctmj-53	77	15	)	)	PUNCT
ctmj-53	77	16	were	be	AUX
ctmj-53	77	17	identified	identify	VERB
ctmj-53	77	18	in	in	ADP
ctmj-53	77	19	npc	npc	NOUN
ctmj-53	77	20	samples	sample	NOUN
ctmj-53	77	21	for	for	ADP
ctmj-53	77	22	each	each	DET
ctmj-53	77	23	dataset	dataset	NOUN
ctmj-53	77	24	(	(	PUNCT
ctmj-53	77	25	figure	figure	NOUN
ctmj-53	77	26	2	2	NUM
ctmj-53	77	27	)	)	PUNCT
ctmj-53	77	28	.	.	PUNCT
ctmj-53	78	1	the	the	DET
ctmj-53	78	2	top	top	ADJ
ctmj-53	78	3	three	three	NUM
ctmj-53	78	4	enriched	enriched	ADJ
ctmj-53	78	5	drugs	drug	NOUN
ctmj-53	78	6	in	in	ADP
ctmj-53	78	7	gse12452	gse12452	NOUN
ctmj-53	78	8	were	be	AUX
ctmj-53	78	9	c6ceramide	c6ceramide	PROPN
ctmj-53	78	10	,	,	PUNCT
ctmj-53	78	11	bexarotene	bexarotene	NOUN
ctmj-53	78	12	and	and	CCONJ
ctmj-53	78	13	chlorambucil	chlorambucil	NOUN
ctmj-53	78	14	(	(	PUNCT
ctmj-53	78	15	figure	figure	NOUN
ctmj-53	78	16	2	2	NUM
ctmj-53	78	17	a	a	NOUN
ctmj-53	78	18	)	)	PUNCT
ctmj-53	78	19	.	.	PUNCT
ctmj-53	79	1	for	for	ADP
ctmj-53	79	2	gse53819	gse53819	NOUN
ctmj-53	79	3	,	,	PUNCT
ctmj-53	79	4	the	the	DET
ctmj-53	79	5	top	top	ADJ
ctmj-53	79	6	hits	hit	NOUN
ctmj-53	79	7	were	be	AUX
ctmj-53	79	8	c6ceramide	c6ceramide	PROPN
ctmj-53	79	9	,	,	PUNCT
ctmj-53	79	10	cabozantinib	cabozantinib	VERB
ctmj-53	79	11	and	and	CCONJ
ctmj-53	79	12	etoposide	etoposide	NOUN
ctmj-53	79	13	(	(	PUNCT
ctmj-53	79	14	figure	figure	NOUN
ctmj-53	79	15	2	2	NUM
ctmj-53	79	16	b	b	NOUN
ctmj-53	79	17	)	)	PUNCT
ctmj-53	79	18	.	.	PUNCT
ctmj-53	80	1	in	in	ADP
ctmj-53	80	2	gse61218，c6	gse61218，c6	NOUN
ctmj-53	80	3	-	-	PUNCT
ctmj-53	80	4	ceramide	ceramide	NOUN
ctmj-53	80	5	,	,	PUNCT
ctmj-53	80	6	azd6482	azd6482	NOUN
ctmj-53	80	7	and	and	CCONJ
ctmj-53	80	8	ml162	ml162	NOUN
ctmj-53	80	9	were	be	AUX
ctmj-53	80	10	most	most	ADV
ctmj-53	80	11	enriched	enriched	ADJ
ctmj-53	80	12	(	(	PUNCT
ctmj-53	80	13	figure	figure	NOUN
ctmj-53	80	14	2	2	NUM
ctmj-53	80	15	c	c	NOUN
ctmj-53	80	16	)	)	PUNCT
ctmj-53	80	17	.	.	PUNCT
ctmj-53	81	1	venn	venn	PROPN
ctmj-53	81	2	diagram	diagram	PROPN
ctmj-53	81	3	shows	show	VERB
ctmj-53	81	4	c6	c6	NOUN
ctmj-53	81	5	-	-	PUNCT
ctmj-53	81	6	ceramide	ceramide	NOUN
ctmj-53	81	7	as	as	ADP
ctmj-53	81	8	the	the	DET
ctmj-53	81	9	only	only	ADJ
ctmj-53	81	10	drug	drug	NOUN
ctmj-53	81	11	enriched	enrich	VERB
ctmj-53	81	12	across	across	ADP
ctmj-53	81	13	all	all	DET
ctmj-53	81	14	three	three	NUM
ctmj-53	81	15	datasets	dataset	NOUN
ctmj-53	81	16	(	(	PUNCT
ctmj-53	81	17	figure	figure	NOUN
ctmj-53	81	18	2	2	NUM
ctmj-53	81	19	d	d	NOUN
ctmj-53	81	20	)	)	PUNCT
ctmj-53	81	21	.	.	PUNCT
ctmj-53	82	1	the	the	DET
ctmj-53	82	2	enrichment	enrichment	NOUN
ctmj-53	82	3	scores	score	NOUN
ctmj-53	82	4	of	of	ADP
ctmj-53	82	5	c6	c6	NOUN
ctmj-53	82	6	-	-	PUNCT
ctmj-53	82	7	ceramide	ceramide	NOUN
ctmj-53	82	8	in	in	ADP
ctmj-53	82	9	the	the	DET
ctmj-53	82	10	three	three	NUM
ctmj-53	82	11	datasets	dataset	NOUN
ctmj-53	82	12	are	be	AUX
ctmj-53	82	13	presented	present	VERB
ctmj-53	82	14	in	in	ADP
ctmj-53	82	15	figure	figure	NOUN
ctmj-53	82	16	2	2	NUM
ctmj-53	82	17	e	e	NOUN
ctmj-53	82	18	and	and	CCONJ
ctmj-53	82	19	g.	g.	PROPN
ctmj-53	82	20	identification	identification	NOUN
ctmj-53	82	21	of	of	ADP
ctmj-53	82	22	msr1	msr1	PROPN
ctmj-53	82	23	as	as	ADP
ctmj-53	82	24	a	a	DET
ctmj-53	82	25	potential	potential	ADJ
ctmj-53	82	26	target	target	NOUN
ctmj-53	82	27	of	of	ADP
ctmj-53	82	28	c6ceramide	c6ceramide	NOUN
ctmj-53	82	29	in	in	ADP
ctmj-53	82	30	npc	npc	NOUN
ctmj-53	82	31	to	to	PART
ctmj-53	82	32	identify	identify	VERB
ctmj-53	82	33	the	the	DET
ctmj-53	82	34	potential	potential	ADJ
ctmj-53	82	35	therapeutic	therapeutic	ADJ
ctmj-53	82	36	targets	target	NOUN
ctmj-53	82	37	of	of	ADP
ctmj-53	82	38	c6ceramide	c6ceramide	NOUN
ctmj-53	82	39	in	in	ADP
ctmj-53	82	40	npc	npc	NOUN
ctmj-53	82	41	,	,	PUNCT
ctmj-53	82	42	its	its	PRON
ctmj-53	82	43	chemical	chemical	NOUN
ctmj-53	82	44	properties	property	NOUN
ctmj-53	82	45	were	be	AUX
ctmj-53	82	46	first	first	ADV
ctmj-53	82	47	analyzed	analyze	VERB
ctmj-53	82	48	.	.	PUNCT
ctmj-53	83	1	c6	c6	NOUN
ctmj-53	83	2	-	-	PUNCT
ctmj-53	83	3	ceramide	ceramide	NOUN
ctmj-53	83	4	has	have	VERB
ctmj-53	83	5	a	a	DET
ctmj-53	83	6	cas	cas	PROPN
ctmj-53	83	7	registry	registry	NOUN
ctmj-53	83	8	number	number	NOUN
ctmj-53	83	9	of	of	ADP
ctmj-53	83	10	124753	124753	NUM
ctmj-53	83	11	-	-	SYM
ctmj-53	83	12	97	97	NUM
ctmj-53	83	13	-	-	SYM
ctmj-53	83	14	5	5	NUM
ctmj-53	83	15	,	,	PUNCT
ctmj-53	83	16	a	a	DET
ctmj-53	83	17	molecular	molecular	ADJ
ctmj-53	83	18	formula	formula	NOUN
ctmj-53	83	19	of	of	ADP
ctmj-53	83	20	c24h47no3	c24h47no3	PROPN
ctmj-53	83	21	and	and	CCONJ
ctmj-53	83	22	a	a	DET
ctmj-53	83	23	molecular	molecular	ADJ
ctmj-53	83	24	weight	weight	NOUN
ctmj-53	83	25	of	of	ADP
ctmj-53	83	26	397.63	397.63	NUM
ctmj-53	83	27	da	da	NOUN
ctmj-53	83	28	.	.	PUNCT
ctmj-53	84	1	its	its	PRON
ctmj-53	84	2	chemical	chemical	NOUN
ctmj-53	84	3	structure	structure	NOUN
ctmj-53	84	4	is	be	AUX
ctmj-53	84	5	shown	show	VERB
ctmj-53	84	6	in	in	ADP
ctmj-53	84	7	figure	figure	NOUN
ctmj-53	84	8	3	3	NUM
ctmj-53	84	9	a.	a.	NOUN
ctmj-53	84	10	differentially	differentially	ADV
ctmj-53	84	11	upregulated	upregulate	VERB
ctmj-53	84	12	genes	gene	NOUN
ctmj-53	84	13	from	from	ADP
ctmj-53	84	14	the	the	DET
ctmj-53	84	15	three	three	NUM
ctmj-53	84	16	npc	npc	NOUN
ctmj-53	84	17	datasets	dataset	NOUN
ctmj-53	84	18	were	be	AUX
ctmj-53	84	19	intersected	intersect	VERB
ctmj-53	84	20	with	with	ADP
ctmj-53	84	21	the	the	DET
ctmj-53	84	22	potential	potential	ADJ
ctmj-53	84	23	target	target	NOUN
ctmj-53	84	24	genes	gene	NOUN
ctmj-53	84	25	of	of	ADP
ctmj-53	84	26	c6ceramide	c6ceramide	NOUN
ctmj-53	84	27	,	,	PUNCT
ctmj-53	84	28	identifying	identify	VERB
ctmj-53	84	29	msr1	msr1	PROPN
ctmj-53	84	30	as	as	ADP
ctmj-53	84	31	a	a	DET
ctmj-53	84	32	common	common	ADJ
ctmj-53	84	33	target	target	NOUN
ctmj-53	84	34	(	(	PUNCT
ctmj-53	84	35	figure	figure	NOUN
ctmj-53	84	36	3	3	NUM
ctmj-53	84	37	b	b	NOUN
ctmj-53	84	38	)	)	PUNCT
ctmj-53	84	39	.	.	PUNCT
ctmj-53	85	1	molecular	molecular	ADJ
ctmj-53	85	2	docking	docking	NOUN
ctmj-53	85	3	using	use	VERB
ctmj-53	85	4	autodocktools-1.5.6	autodocktools-1.5.6	NUM
ctmj-53	85	5	revealed	reveal	VERB
ctmj-53	85	6	the	the	DET
ctmj-53	85	7	potential	potential	ADJ
ctmj-53	85	8	binding	bind	VERB
ctmj-53	85	9	interaction	interaction	NOUN
ctmj-53	85	10	between	between	ADP
ctmj-53	85	11	msr1	msr1	PROPN
ctmj-53	85	12	and	and	CCONJ
ctmj-53	85	13	c6	c6	PROPN
ctmj-53	85	14	-	-	PUNCT
ctmj-53	85	15	ceramide	ceramide	NOUN
ctmj-53	85	16	(	(	PUNCT
ctmj-53	85	17	figure	figure	NOUN
ctmj-53	85	18	3	3	NUM
ctmj-53	85	19	c	c	NOUN
ctmj-53	85	20	)	)	PUNCT
ctmj-53	85	21	.	.	PUNCT
ctmj-53	86	1	effect	effect	NOUN
ctmj-53	86	2	of	of	ADP
ctmj-53	86	3	msr1	msr1	PROPN
ctmj-53	86	4	on	on	ADP
ctmj-53	86	5	npc	npc	NOUN
ctmj-53	86	6	cells	cell	NOUN
ctmj-53	86	7	the	the	DET
ctmj-53	86	8	levels	level	NOUN
ctmj-53	86	9	of	of	ADP
ctmj-53	86	10	msr1	msr1	PROPN
ctmj-53	86	11	was	be	AUX
ctmj-53	86	12	analyzed	analyze	VERB
ctmj-53	86	13	in	in	ADP
ctmj-53	86	14	four	four	NUM
ctmj-53	86	15	npc	npc	NOUN
ctmj-53	86	16	cell	cell	NOUN
ctmj-53	86	17	types	type	NOUN
ctmj-53	86	18	and	and	CCONJ
ctmj-53	86	19	healthy	healthy	ADJ
ctmj-53	86	20	nasopharyngeal	nasopharyngeal	ADJ
ctmj-53	86	21	epithelial	epithelial	ADJ
ctmj-53	86	22	cells	cell	NOUN
ctmj-53	86	23	by	by	ADP
ctmj-53	86	24	qpcr	qpcr	ADV
ctmj-53	86	25	.	.	PUNCT
ctmj-53	87	1	when	when	SCONJ
ctmj-53	87	2	compared	compare	VERB
ctmj-53	87	3	to	to	ADP
ctmj-53	87	4	typical	typical	ADJ
ctmj-53	87	5	cells	cell	NOUN
ctmj-53	87	6	,	,	PUNCT
ctmj-53	87	7	msr1	msr1	PROPN
ctmj-53	87	8	mrna	mrna	PROPN
ctmj-53	87	9	amounts	amount	NOUN
ctmj-53	87	10	were	be	AUX
ctmj-53	87	11	significantly	significantly	ADV
ctmj-53	87	12	higher	high	ADJ
ctmj-53	87	13	in	in	ADP
ctmj-53	87	14	npc	npc	NOUN
ctmj-53	87	15	cells	cell	NOUN
ctmj-53	87	16	(	(	PUNCT
ctmj-53	87	17	figure	figure	VERB
ctmj-53	87	18	4	4	NUM
ctmj-53	87	19	a	a	NOUN
ctmj-53	87	20	)	)	PUNCT
ctmj-53	87	21	.	.	PUNCT
ctmj-53	88	1	western	western	ADJ
ctmj-53	88	2	blotting	blotting	NOUN
ctmj-53	88	3	(	(	PUNCT
ctmj-53	88	4	wb	wb	PROPN
ctmj-53	88	5	)	)	PUNCT
ctmj-53	88	6	confirmed	confirm	VERB
ctmj-53	88	7	increased	increase	VERB
ctmj-53	88	8	msr1	msr1	NOUN
ctmj-53	88	9	protein	protein	NOUN
ctmj-53	88	10	expression	expression	NOUN
ctmj-53	88	11	in	in	ADP
ctmj-53	88	12	npc	npc	NOUN
ctmj-53	88	13	cells	cell	NOUN
ctmj-53	88	14	versus	versus	ADP
ctmj-53	88	15	normal	normal	ADJ
ctmj-53	88	16	cells	cell	NOUN
ctmj-53	88	17	(	(	PUNCT
ctmj-53	88	18	figure	figure	VERB
ctmj-53	88	19	4	4	NUM
ctmj-53	88	20	b	b	NOUN
ctmj-53	88	21	)	)	PUNCT
ctmj-53	88	22	indicating	indicate	VERB
ctmj-53	88	23	that	that	SCONJ
ctmj-53	88	24	msr1	msr1	PROPN
ctmj-53	88	25	is	be	AUX
ctmj-53	88	26	greatly	greatly	ADV
ctmj-53	88	27	upregulated	upregulate	VERB
ctmj-53	88	28	in	in	ADP
ctmj-53	88	29	npc	npc	NOUN
ctmj-53	88	30	.	.	PUNCT
ctmj-53	89	1	in	in	ADP
ctmj-53	89	2	order	order	NOUN
ctmj-53	89	3	to	to	PART
ctmj-53	89	4	determine	determine	VERB
ctmj-53	89	5	the	the	DET
ctmj-53	89	6	function	function	NOUN
ctmj-53	89	7	of	of	ADP
ctmj-53	89	8	msr1	msr1	PROPN
ctmj-53	89	9	in	in	ADP
ctmj-53	89	10	npc	npc	PROPN
ctmj-53	89	11	,	,	PUNCT
ctmj-53	89	12	two	two	NUM
ctmj-53	89	13	npc	npc	NOUN
ctmj-53	89	14	cell	cell	NOUN
ctmj-53	89	15	lines	line	NOUN
ctmj-53	89	16	were	be	AUX
ctmj-53	89	17	transfected	transfecte	VERB
ctmj-53	89	18	with	with	ADP
ctmj-53	89	19	si	si	PROPN
ctmj-53	89	20	-	-	PUNCT
ctmj-53	89	21	nc	nc	PROPN
ctmj-53	89	22	or	or	CCONJ
ctmj-53	89	23	si	si	NOUN
ctmj-53	89	24	-	-	PUNCT
ctmj-53	89	25	msr1	msr1	PROPN
ctmj-53	89	26	.	.	PUNCT
ctmj-53	90	1	the	the	DET
ctmj-53	90	2	results	result	NOUN
ctmj-53	90	3	of	of	ADP
ctmj-53	90	4	qpcr	qpcr	ADV
ctmj-53	90	5	confirmed	confirm	VERB
ctmj-53	90	6	transfection	transfection	NOUN
ctmj-53	90	7	with	with	ADP
ctmj-53	90	8	simsr1	simsr1	PROPN
ctmj-53	90	9	significantly	significantly	ADV
ctmj-53	90	10	reduced	reduce	VERB
ctmj-53	90	11	msr1	msr1	PROPN
ctmj-53	90	12	mrna	mrna	PROPN
ctmj-53	90	13	compared	compare	VERB
ctmj-53	90	14	to	to	ADP
ctmj-53	90	15	si	si	PROPN
ctmj-53	90	16	-	-	PUNCT
ctmj-53	90	17	nc	nc	PROPN
ctmj-53	90	18	control	control	PROPN
ctmj-53	90	19	cells	cell	NOUN
ctmj-53	90	20	,	,	PUNCT
ctmj-53	90	21	confirming	confirm	VERB
ctmj-53	90	22	the	the	DET
ctmj-53	90	23	efficient	efficient	ADJ
ctmj-53	90	24	knockdown	knockdown	NOUN
ctmj-53	90	25	of	of	ADP
ctmj-53	90	26	msr1	msr1	PROPN
ctmj-53	90	27	(	(	PUNCT
ctmj-53	90	28	figure	figure	VERB
ctmj-53	90	29	4	4	NUM
ctmj-53	90	30	c	c	NOUN
ctmj-53	90	31	)	)	PUNCT
ctmj-53	90	32	.	.	PUNCT
ctmj-53	91	1	cell	cell	NOUN
ctmj-53	91	2	viability	viability	NOUN
ctmj-53	91	3	results	result	NOUN
ctmj-53	91	4	show	show	VERB
ctmj-53	91	5	that	that	SCONJ
ctmj-53	91	6	msr1	msr1	PROPN
ctmj-53	91	7	knockdown	knockdown	VERB
ctmj-53	91	8	inhibited	inhibit	VERB
ctmj-53	91	9	cell	cell	NOUN
ctmj-53	91	10	viability	viability	NOUN
ctmj-53	91	11	in	in	ADP
ctmj-53	91	12	both	both	DET
ctmj-53	91	13	npc	npc	NOUN
ctmj-53	91	14	lines	line	NOUN
ctmj-53	91	15	(	(	PUNCT
ctmj-53	91	16	figure	figure	NOUN
ctmj-53	91	17	4	4	NUM
ctmj-53	91	18	d	d	NOUN
ctmj-53	91	19	)	)	PUNCT
ctmj-53	91	20	.	.	PUNCT
ctmj-53	92	1	chinese	chinese	ADJ
ctmj-53	92	2	traditional	traditional	ADJ
ctmj-53	92	3	medicine	medicine	NOUN
ctmj-53	92	4	journal	journal	NOUN
ctmj-53	92	5	|	|	ADV
ctmj-53	92	6	2020	2020	NUM
ctmj-53	93	1	|	|	ADV
ctmj-53	93	2	vol	vol	NOUN
ctmj-53	93	3	3	3	NUM
ctmj-53	93	4	|	|	ADV
ctmj-53	93	5	issue	issue	VERB
ctmj-53	93	6	5	5	NUM
ctmj-53	93	7	issn	issn	X
ctmj-53	93	8	:	:	PUNCT
ctmj-53	93	9	2693	2693	NUM
ctmj-53	93	10	6356	6356	NUM
ctmj-53	93	11	2020	2020	NUM
ctmj-53	93	12	|	|	ADV
ctmj-53	93	13	vol	vol	NOUN
ctmj-53	93	14	3	3	NUM
ctmj-53	93	15	|	|	ADV
ctmj-53	93	16	issue	issue	VERB
ctmj-53	93	17	5	5	NUM
ctmj-53	93	18	ctmj	ctmj	NOUN
ctmj-53	94	1	|	|	ADV
ctmj-53	94	2	traditionalmedicinejournals.com	traditionalmedicinejournals.com	X
ctmj-53	94	3	figure	figure	NOUN
ctmj-53	94	4	2	2	NUM
ctmj-53	94	5	:	:	PUNCT
ctmj-53	94	6	gsea	gsea	NOUN
ctmj-53	94	7	identifies	identify	VERB
ctmj-53	94	8	c6	c6	PROPN
ctmj-53	94	9	-	-	PUNCT
ctmj-53	94	10	ceramide	ceramide	NOUN
ctmj-53	94	11	as	as	ADP
ctmj-53	94	12	a	a	DET
ctmj-53	94	13	potential	potential	ADJ
ctmj-53	94	14	therapeutic	therapeutic	NOUN
ctmj-53	94	15	for	for	ADP
ctmj-53	94	16	npc	npc	NOUN
ctmj-53	94	17	(	(	PUNCT
ctmj-53	94	18	a	a	DET
ctmj-53	94	19	-	-	PUNCT
ctmj-53	94	20	c	c	NOUN
ctmj-53	94	21	)	)	PUNCT
ctmj-53	94	22	the	the	DET
ctmj-53	94	23	top	top	ADJ
ctmj-53	94	24	10	10	NUM
ctmj-53	94	25	enriched	enriched	ADJ
ctmj-53	94	26	drugs	drug	NOUN
ctmj-53	94	27	in	in	ADP
ctmj-53	94	28	nasopharyngeal	nasopharyngeal	ADJ
ctmj-53	94	29	carcinoma	carcinoma	NOUN
ctmj-53	94	30	samples	sample	NOUN
ctmj-53	94	31	from	from	ADP
ctmj-53	94	32	the	the	DET
ctmj-53	94	33	three	three	NUM
ctmj-53	94	34	datasets	dataset	NOUN
ctmj-53	94	35	figure	figure	NOUN
ctmj-53	94	36	2	2	NUM
ctmj-53	94	37	continued	continue	VERB
ctmj-53	94	38	:	:	PUNCT
ctmj-53	94	39	gsea	gsea	NOUN
ctmj-53	94	40	identifies	identify	VERB
ctmj-53	94	41	c6	c6	PROPN
ctmj-53	94	42	-	-	PUNCT
ctmj-53	94	43	ceramide	ceramide	NOUN
ctmj-53	94	44	as	as	ADP
ctmj-53	94	45	a	a	DET
ctmj-53	94	46	potential	potential	ADJ
ctmj-53	94	47	therapeutic	therapeutic	NOUN
ctmj-53	94	48	for	for	ADP
ctmj-53	94	49	npc	npc	NOUN
ctmj-53	94	50	(	(	PUNCT
ctmj-53	94	51	d	d	NOUN
ctmj-53	94	52	)	)	PUNCT
ctmj-53	94	53	venn	venn	PROPN
ctmj-53	94	54	diagram	diagram	PROPN
ctmj-53	94	55	showing	show	VERB
ctmj-53	94	56	c6	c6	NOUN
ctmj-53	94	57	-	-	PUNCT
ctmj-53	94	58	ceramide	ceramide	NOUN
ctmj-53	94	59	as	as	ADP
ctmj-53	94	60	the	the	DET
ctmj-53	94	61	only	only	ADJ
ctmj-53	94	62	drug	drug	NOUN
ctmj-53	94	63	enriched	enrich	VERB
ctmj-53	94	64	across	across	ADP
ctmj-53	94	65	all	all	DET
ctmj-53	94	66	three	three	NUM
ctmj-53	94	67	datasets	dataset	NOUN
ctmj-53	94	68	;	;	PUNCT
ctmj-53	94	69	(	(	PUNCT
ctmj-53	94	70	e	e	NOUN
ctmj-53	94	71	-	-	NOUN
ctmj-53	94	72	g	g	NOUN
ctmj-53	94	73	)	)	PUNCT
ctmj-53	94	74	enrichment	enrichment	NOUN
ctmj-53	94	75	scores	score	NOUN
ctmj-53	94	76	of	of	ADP
ctmj-53	94	77	c6	c6	NOUN
ctmj-53	94	78	-	-	NOUN
ctmj-53	94	79	ceramides	ceramide	NOUN
ctmj-53	94	80	in	in	ADP
ctmj-53	94	81	the	the	DET
ctmj-53	94	82	three	three	NUM
ctmj-53	94	83	datasets	dataset	NOUN
ctmj-53	94	84	.	.	PUNCT
ctmj-53	95	1	figure	figure	VERB
ctmj-53	95	2	3	3	NUM
ctmj-53	95	3	:	:	PUNCT
ctmj-53	95	4	identification	identification	NOUN
ctmj-53	95	5	of	of	ADP
ctmj-53	95	6	msr1	msr1	PROPN
ctmj-53	95	7	as	as	ADP
ctmj-53	95	8	a	a	DET
ctmj-53	95	9	potential	potential	ADJ
ctmj-53	95	10	therapeutic	therapeutic	ADJ
ctmj-53	95	11	target	target	NOUN
ctmj-53	95	12	of	of	ADP
ctmj-53	95	13	c6	c6	NOUN
ctmj-53	95	14	-	-	PUNCT
ctmj-53	95	15	ceramide	ceramide	NOUN
ctmj-53	95	16	in	in	ADP
ctmj-53	95	17	nasopharyngeal	nasopharyngeal	ADJ
ctmj-53	95	18	carcinoma	carcinoma	NOUN
ctmj-53	95	19	;	;	PUNCT
ctmj-53	95	20	(	(	PUNCT
ctmj-53	95	21	a	a	X
ctmj-53	95	22	)	)	PUNCT
ctmj-53	95	23	chemical	chemical	NOUN
ctmj-53	95	24	structure	structure	NOUN
ctmj-53	95	25	of	of	ADP
ctmj-53	95	26	the	the	DET
ctmj-53	95	27	c6ceramide	c6ceramide	NOUN
ctmj-53	95	28	small	small	ADJ
ctmj-53	95	29	molecule	molecule	NOUN
ctmj-53	95	30	;	;	PUNCT
ctmj-53	95	31	(	(	PUNCT
ctmj-53	95	32	b	b	X
ctmj-53	95	33	)	)	PUNCT
ctmj-53	95	34	venn	venn	PROPN
ctmj-53	95	35	diagram	diagram	PROPN
ctmj-53	95	36	showing	show	VERB
ctmj-53	95	37	the	the	DET
ctmj-53	95	38	intersection	intersection	NOUN
ctmj-53	95	39	of	of	ADP
ctmj-53	95	40	upregulated	upregulated	ADJ
ctmj-53	95	41	genes	gene	NOUN
ctmj-53	95	42	in	in	ADP
ctmj-53	95	43	three	three	NUM
ctmj-53	95	44	npc	npc	NOUN
ctmj-53	95	45	datasets	dataset	NOUN
ctmj-53	95	46	with	with	ADP
ctmj-53	95	47	potential	potential	ADJ
ctmj-53	95	48	target	target	NOUN
ctmj-53	95	49	genes	gene	NOUN
ctmj-53	95	50	of	of	ADP
ctmj-53	95	51	c6	c6	NOUN
ctmj-53	95	52	-	-	PUNCT
ctmj-53	95	53	ceramide	ceramide	NOUN
ctmj-53	95	54	;	;	PUNCT
ctmj-53	95	55	(	(	PUNCT
ctmj-53	95	56	c	c	X
ctmj-53	95	57	)	)	PUNCT
ctmj-53	95	58	molecular	molecular	ADJ
ctmj-53	95	59	docking	docking	NOUN
ctmj-53	95	60	diagram	diagram	NOUN
ctmj-53	95	61	depicting	depict	VERB
ctmj-53	95	62	the	the	DET
ctmj-53	95	63	chinese	chinese	ADJ
ctmj-53	95	64	traditional	traditional	ADJ
ctmj-53	95	65	medicine	medicine	NOUN
ctmj-53	95	66	journal	journal	NOUN
ctmj-53	95	67	|	|	ADV
ctmj-53	95	68	2020	2020	NUM
ctmj-53	95	69	|	|	ADV
ctmj-53	95	70	vol	vol	NOUN
ctmj-53	95	71	3	3	NUM
ctmj-53	96	1	|	|	ADV
ctmj-53	96	2	issue	issue	VERB
ctmj-53	96	3	5	5	NUM
ctmj-53	96	4	issn	issn	X
ctmj-53	96	5	:	:	PUNCT
ctmj-53	96	6	2693	2693	NUM
ctmj-53	96	7	6356	6356	NUM
ctmj-53	96	8	2020	2020	NUM
ctmj-53	96	9	|	|	ADV
ctmj-53	96	10	vol	vol	NOUN
ctmj-53	96	11	3	3	NUM
ctmj-53	97	1	|	|	ADV
ctmj-53	97	2	issue	issue	VERB
ctmj-53	97	3	5	5	NUM
ctmj-53	97	4	ctmj	ctmj	NOUN
ctmj-53	97	5	|	|	ADV
ctmj-53	97	6	traditionalmedicinejournals.com	traditionalmedicinejournals.com	X
ctmj-53	97	7	potential	potential	ADJ
ctmj-53	97	8	binding	bind	VERB
ctmj-53	97	9	interaction	interaction	NOUN
ctmj-53	97	10	between	between	ADP
ctmj-53	97	11	c6	c6	NOUN
ctmj-53	97	12	-	-	PUNCT
ctmj-53	97	13	ceramide	ceramide	NOUN
ctmj-53	97	14	and	and	CCONJ
ctmj-53	97	15	msr1	msr1	PROPN
ctmj-53	97	16	to	to	PART
ctmj-53	97	17	investigate	investigate	VERB
ctmj-53	97	18	the	the	DET
ctmj-53	97	19	effect	effect	NOUN
ctmj-53	97	20	of	of	ADP
ctmj-53	97	21	c6	c6	NOUN
ctmj-53	97	22	-	-	PUNCT
ctmj-53	97	23	ceramide	ceramide	NOUN
ctmj-53	97	24	on	on	ADP
ctmj-53	97	25	npc	npc	NOUN
ctmj-53	97	26	cells	cell	NOUN
ctmj-53	97	27	,	,	PUNCT
ctmj-53	97	28	two	two	NUM
ctmj-53	97	29	cell	cell	NOUN
ctmj-53	97	30	lines	line	NOUN
ctmj-53	97	31	were	be	AUX
ctmj-53	97	32	exposed	expose	VERB
ctmj-53	97	33	to	to	ADP
ctmj-53	97	34	increasing	increase	VERB
ctmj-53	97	35	amounts	amount	NOUN
ctmj-53	97	36	of	of	ADP
ctmj-53	97	37	the	the	DET
ctmj-53	97	38	drug	drug	NOUN
ctmj-53	97	39	.	.	PUNCT
ctmj-53	98	1	the	the	DET
ctmj-53	98	2	results	result	NOUN
ctmj-53	98	3	of	of	ADP
ctmj-53	98	4	cck8	cck8	PROPN
ctmj-53	98	5	assay	assay	NOUN
ctmj-53	98	6	showed	show	VERB
ctmj-53	98	7	decreased	decrease	VERB
ctmj-53	98	8	cell	cell	NOUN
ctmj-53	98	9	viability	viability	NOUN
ctmj-53	98	10	with	with	ADP
ctmj-53	98	11	higher	high	ADJ
ctmj-53	98	12	c6	c6	PROPN
ctmj-53	98	13	ceramide	ceramide	NOUN
ctmj-53	98	14	doses	dose	NOUN
ctmj-53	98	15	(	(	PUNCT
ctmj-53	98	16	figure	figure	NOUN
ctmj-53	98	17	4	4	NUM
ctmj-53	98	18	e	e	NOUN
ctmj-53	98	19	)	)	PUNCT
ctmj-53	98	20	,	,	PUNCT
ctmj-53	98	21	indicating	indicate	VERB
ctmj-53	98	22	that	that	SCONJ
ctmj-53	98	23	c6	c6	PROPN
ctmj-53	98	24	ceramide	ceramide	NOUN
ctmj-53	98	25	has	have	VERB
ctmj-53	98	26	anti	anti	ADJ
ctmj-53	98	27	-	-	ADJ
ctmj-53	98	28	proliferative	proliferative	ADJ
ctmj-53	98	29	effect	effect	NOUN
ctmj-53	98	30	.	.	PUNCT
ctmj-53	99	1	to	to	PART
ctmj-53	99	2	further	far	ADV
ctmj-53	99	3	investigate	investigate	VERB
ctmj-53	99	4	if	if	SCONJ
ctmj-53	99	5	this	this	DET
ctmj-53	99	6	effect	effect	NOUN
ctmj-53	99	7	involved	involve	VERB
ctmj-53	99	8	msr1	msr1	PROPN
ctmj-53	99	9	,	,	PUNCT
ctmj-53	99	10	nasopharyngeal	nasopharyngeal	ADJ
ctmj-53	99	11	carcinoma	carcinoma	NOUN
ctmj-53	99	12	cells	cell	NOUN
ctmj-53	99	13	were	be	AUX
ctmj-53	99	14	transfected	transfecte	VERB
ctmj-53	99	15	with	with	ADP
ctmj-53	99	16	pcdna	pcdna	NOUN
ctmj-53	99	17	-	-	PUNCT
ctmj-53	99	18	msr1	msr1	PROPN
ctmj-53	99	19	(	(	PUNCT
ctmj-53	99	20	for	for	ADP
ctmj-53	99	21	msr1	msr1	PROPN
ctmj-53	99	22	overexpression	overexpression	NOUN
ctmj-53	99	23	)	)	PUNCT
ctmj-53	99	24	or	or	CCONJ
ctmj-53	99	25	control	control	VERB
ctmj-53	99	26	pcdna	pcdna	NOUN
ctmj-53	99	27	-	-	PUNCT
ctmj-53	99	28	nc	nc	PROPN
ctmj-53	99	29	.	.	PUNCT
ctmj-53	100	1	the	the	DET
ctmj-53	100	2	results	result	NOUN
ctmj-53	100	3	of	of	ADP
ctmj-53	100	4	qpcr	qpcr	ADV
ctmj-53	100	5	confirmed	confirm	VERB
ctmj-53	100	6	increased	increase	VERB
ctmj-53	100	7	msr1	msr1	PROPN
ctmj-53	100	8	mrna	mrna	PROPN
ctmj-53	100	9	in	in	ADP
ctmj-53	100	10	pcdna	pcdna	NOUN
ctmj-53	100	11	-	-	PUNCT
ctmj-53	100	12	msr1	msr1	NOUN
ctmj-53	100	13	versus	versus	ADP
ctmj-53	100	14	pcdna	pcdna	NOUN
ctmj-53	100	15	-	-	PUNCT
ctmj-53	100	16	nc	nc	NOUN
ctmj-53	100	17	cells	cell	NOUN
ctmj-53	100	18	(	(	PUNCT
ctmj-53	100	19	figure	figure	NOUN
ctmj-53	100	20	4	4	NUM
ctmj-53	100	21	f	f	NOUN
ctmj-53	100	22	)	)	PUNCT
ctmj-53	100	23	.	.	PUNCT
ctmj-53	101	1	cells	cell	NOUN
ctmj-53	101	2	were	be	AUX
ctmj-53	101	3	then	then	ADV
ctmj-53	101	4	divided	divide	VERB
ctmj-53	101	5	into	into	ADP
ctmj-53	101	6	four	four	NUM
ctmj-53	101	7	groups	group	NOUN
ctmj-53	101	8	:	:	PUNCT
ctmj-53	101	9	pcdna	pcdna	NOUN
ctmj-53	101	10	-	-	PUNCT
ctmj-53	101	11	nc	nc	PROPN
ctmj-53	101	12	,	,	PUNCT
ctmj-53	101	13	pcdnamsr1	pcdnamsr1	NOUN
ctmj-53	101	14	,	,	PUNCT
ctmj-53	101	15	c6	c6	NOUN
ctmj-53	101	16	-	-	PUNCT
ctmj-53	101	17	ceramide	ceramide	NOUN
ctmj-53	101	18	treatment	treatment	NOUN
ctmj-53	101	19	and	and	CCONJ
ctmj-53	101	20	pcdna	pcdna	NOUN
ctmj-53	101	21	-	-	PUNCT
ctmj-53	101	22	msr1	msr1	PROPN
ctmj-53	101	23	+	+	CCONJ
ctmj-53	101	24	c6	c6	NOUN
ctmj-53	101	25	-	-	PUNCT
ctmj-53	101	26	ceramide	ceramide	NOUN
ctmj-53	101	27	.	.	PUNCT
ctmj-53	102	1	results	result	NOUN
ctmj-53	102	2	of	of	ADP
ctmj-53	102	3	qpcr	qpcr	ADV
ctmj-53	102	4	showed	show	VERB
ctmj-53	102	5	msr1	msr1	PROPN
ctmj-53	102	6	mrna	mrna	PROPN
ctmj-53	102	7	was	be	AUX
ctmj-53	102	8	significantly	significantly	ADV
ctmj-53	102	9	increased	increase	VERB
ctmj-53	102	10	in	in	ADP
ctmj-53	102	11	the	the	DET
ctmj-53	102	12	pcdnamsr1	pcdnamsr1	NOUN
ctmj-53	102	13	group	group	NOUN
ctmj-53	102	14	compared	compare	VERB
ctmj-53	102	15	to	to	ADP
ctmj-53	102	16	the	the	DET
ctmj-53	102	17	pcdna	pcdna	NOUN
ctmj-53	102	18	-	-	PUNCT
ctmj-53	102	19	nc	nc	PROPN
ctmj-53	102	20	group	group	NOUN
ctmj-53	102	21	.	.	PUNCT
ctmj-53	103	1	however	however	ADV
ctmj-53	103	2	,	,	PUNCT
ctmj-53	103	3	msr1	msr1	PROPN
ctmj-53	103	4	amounts	amount	NOUN
ctmj-53	103	5	were	be	AUX
ctmj-53	103	6	significantly	significantly	ADV
ctmj-53	103	7	lower	low	ADJ
ctmj-53	103	8	in	in	ADP
ctmj-53	103	9	the	the	DET
ctmj-53	103	10	c6	c6	NOUN
ctmj-53	103	11	-	-	PUNCT
ctmj-53	103	12	ceramide	ceramide	NOUN
ctmj-53	103	13	treatment	treatment	NOUN
ctmj-53	103	14	category	category	NOUN
ctmj-53	103	15	versus	versus	ADP
ctmj-53	103	16	the	the	DET
ctmj-53	103	17	pcdna	pcdna	NOUN
ctmj-53	103	18	-	-	PUNCT
ctmj-53	103	19	msr1	msr1	PROPN
ctmj-53	103	20	group	group	NOUN
ctmj-53	103	21	,	,	PUNCT
ctmj-53	103	22	while	while	SCONJ
ctmj-53	103	23	the	the	DET
ctmj-53	103	24	pcdna	pcdna	NOUN
ctmj-53	103	25	-	-	PUNCT
ctmj-53	103	26	msr1	msr1	NOUN
ctmj-53	103	27	+	+	CCONJ
ctmj-53	103	28	c6	c6	PROPN
ctmj-53	103	29	-	-	PUNCT
ctmj-53	103	30	ceramide	ceramide	NOUN
ctmj-53	103	31	group	group	NOUN
ctmj-53	103	32	exhibited	exhibit	VERB
ctmj-53	103	33	an	an	DET
ctmj-53	103	34	intermediate	intermediate	ADJ
ctmj-53	103	35	level	level	NOUN
ctmj-53	103	36	of	of	ADP
ctmj-53	103	37	msr1	msr1	PROPN
ctmj-53	103	38	expression	expression	NOUN
ctmj-53	103	39	(	(	PUNCT
ctmj-53	103	40	figure	figure	NOUN
ctmj-53	103	41	4	4	NUM
ctmj-53	103	42	g	g	NOUN
ctmj-53	103	43	)	)	PUNCT
ctmj-53	103	44	.	.	PUNCT
ctmj-53	104	1	these	these	DET
ctmj-53	104	2	results	result	NOUN
ctmj-53	104	3	indicated	indicate	VERB
ctmj-53	104	4	that	that	SCONJ
ctmj-53	104	5	c6	c6	NOUN
ctmj-53	104	6	-	-	PUNCT
ctmj-53	104	7	ceramide	ceramide	NOUN
ctmj-53	104	8	inhibited	inhibit	VERB
ctmj-53	104	9	the	the	DET
ctmj-53	104	10	upregulation	upregulation	NOUN
ctmj-53	104	11	of	of	ADP
ctmj-53	104	12	msr1	msr1	PROPN
ctmj-53	104	13	gene	gene	NOUN
ctmj-53	104	14	expression	expression	NOUN
ctmj-53	104	15	in	in	ADP
ctmj-53	104	16	npc	npc	NOUN
ctmj-53	104	17	cells	cell	NOUN
ctmj-53	104	18	caused	cause	VERB
ctmj-53	104	19	by	by	ADP
ctmj-53	104	20	msr1	msr1	PROPN
ctmj-53	104	21	overexpression	overexpression	NOUN
ctmj-53	104	22	.	.	PUNCT
ctmj-53	105	1	in	in	ADP
ctmj-53	105	2	other	other	ADJ
ctmj-53	105	3	words	word	NOUN
ctmj-53	105	4	,	,	PUNCT
ctmj-53	105	5	msr1	msr1	PROPN
ctmj-53	105	6	may	may	AUX
ctmj-53	105	7	be	be	AUX
ctmj-53	105	8	a	a	DET
ctmj-53	105	9	potential	potential	ADJ
ctmj-53	105	10	target	target	NOUN
ctmj-53	105	11	gene	gene	NOUN
ctmj-53	105	12	of	of	ADP
ctmj-53	105	13	c6	c6	NOUN
ctmj-53	105	14	-	-	PUNCT
ctmj-53	105	15	ceramide	ceramide	NOUN
ctmj-53	105	16	on	on	ADP
ctmj-53	105	17	npc	npc	NOUN
ctmj-53	105	18	cells	cell	NOUN
ctmj-53	105	19	.	.	PUNCT
ctmj-53	106	1	msr1	msr1	PROPN
ctmj-53	106	2	modulates	modulate	VERB
ctmj-53	106	3	pi3k	pi3k	PROPN
ctmj-53	106	4	/	/	SYM
ctmj-53	106	5	akt	akt	PROPN
ctmj-53	106	6	signaling	signal	VERB
ctmj-53	106	7	in	in	ADP
ctmj-53	106	8	npc	npc	NOUN
ctmj-53	106	9	cells	cell	NOUN
ctmj-53	106	10	the	the	DET
ctmj-53	106	11	study	study	NOUN
ctmj-53	106	12	previously	previously	ADV
ctmj-53	106	13	demonstrated	demonstrate	VERB
ctmj-53	106	14	that	that	SCONJ
ctmj-53	106	15	msr1	msr1	PROPN
ctmj-53	106	16	knockdown	knockdown	NOUN
ctmj-53	106	17	reduces	reduce	VERB
ctmj-53	106	18	npc	npc	NOUN
ctmj-53	106	19	cell	cell	NOUN
ctmj-53	106	20	viability	viability	NOUN
ctmj-53	106	21	.	.	PUNCT
ctmj-53	107	1	here	here	ADV
ctmj-53	107	2	,	,	PUNCT
ctmj-53	107	3	the	the	DET
ctmj-53	107	4	study	study	NOUN
ctmj-53	107	5	investigated	investigate	VERB
ctmj-53	107	6	the	the	DET
ctmj-53	107	7	interaction	interaction	NOUN
ctmj-53	107	8	between	between	ADP
ctmj-53	107	9	msr1	msr1	PROPN
ctmj-53	107	10	and	and	CCONJ
ctmj-53	107	11	the	the	DET
ctmj-53	107	12	pi3k	pi3k	PROPN
ctmj-53	107	13	/	/	SYM
ctmj-53	107	14	akt	akt	PROPN
ctmj-53	107	15	signaling	signal	VERB
ctmj-53	107	16	pathway	pathway	NOUN
ctmj-53	107	17	.	.	PUNCT
ctmj-53	108	1	compared	compare	VERB
ctmj-53	108	2	to	to	ADP
ctmj-53	108	3	control	control	NOUN
ctmj-53	108	4	cells	cell	NOUN
ctmj-53	108	5	,	,	PUNCT
ctmj-53	108	6	pi3k	pi3k	PROPN
ctmj-53	108	7	and	and	CCONJ
ctmj-53	108	8	akt	akt	PROPN
ctmj-53	108	9	expression	expression	NOUN
ctmj-53	108	10	reduced	reduce	VERB
ctmj-53	108	11	with	with	ADP
ctmj-53	108	12	msr1	msr1	PROPN
ctmj-53	108	13	knockdown	knockdown	NOUN
ctmj-53	108	14	but	but	CCONJ
ctmj-53	108	15	increased	increase	VERB
ctmj-53	108	16	with	with	ADP
ctmj-53	108	17	msr1	msr1	PROPN
ctmj-53	108	18	overexpression	overexpression	NOUN
ctmj-53	108	19	(	(	PUNCT
ctmj-53	108	20	figure	figure	NOUN
ctmj-53	108	21	5	5	NUM
ctmj-53	108	22	)	)	PUNCT
ctmj-53	108	23	.	.	PUNCT
ctmj-53	109	1	these	these	DET
ctmj-53	109	2	data	datum	NOUN
ctmj-53	109	3	indicate	indicate	VERB
ctmj-53	109	4	that	that	SCONJ
ctmj-53	109	5	modulating	modulate	VERB
ctmj-53	109	6	msr1	msr1	NOUN
ctmj-53	109	7	reciprocally	reciprocally	ADV
ctmj-53	109	8	regulates	regulate	VERB
ctmj-53	109	9	pi3k	pi3k	PROPN
ctmj-53	109	10	and	and	CCONJ
ctmj-53	109	11	akt	akt	PROPN
ctmj-53	109	12	levels	level	NOUN
ctmj-53	109	13	in	in	ADP
ctmj-53	109	14	npc	npc	NOUN
ctmj-53	109	15	cells	cell	NOUN
ctmj-53	109	16	.	.	PUNCT
ctmj-53	110	1	thus	thus	ADV
ctmj-53	110	2	,	,	PUNCT
ctmj-53	110	3	msr1	msr1	PROPN
ctmj-53	110	4	appears	appear	VERB
ctmj-53	110	5	to	to	PART
ctmj-53	110	6	exert	exert	VERB
ctmj-53	110	7	downstream	downstream	ADJ
ctmj-53	110	8	effects	effect	NOUN
ctmj-53	110	9	on	on	ADP
ctmj-53	110	10	npc	npc	NOUN
ctmj-53	110	11	cells	cell	NOUN
ctmj-53	110	12	via	via	ADP
ctmj-53	110	13	the	the	DET
ctmj-53	110	14	activation	activation	NOUN
ctmj-53	110	15	of	of	ADP
ctmj-53	110	16	pi3k	pi3k	PROPN
ctmj-53	110	17	/	/	SYM
ctmj-53	110	18	akt	akt	PROPN
ctmj-53	110	19	pathway	pathway	NOUN
ctmj-53	110	20	.	.	PUNCT
ctmj-53	111	1	chinese	chinese	ADJ
ctmj-53	111	2	traditional	traditional	ADJ
ctmj-53	111	3	medicine	medicine	NOUN
ctmj-53	111	4	journal	journal	NOUN
ctmj-53	111	5	|	|	ADV
ctmj-53	111	6	2020	2020	NUM
ctmj-53	112	1	|	|	ADV
ctmj-53	112	2	vol	vol	NOUN
ctmj-53	112	3	3	3	NUM
ctmj-53	112	4	|	|	ADV
ctmj-53	112	5	issue	issue	VERB
ctmj-53	112	6	5	5	NUM
ctmj-53	112	7	issn	issn	X
ctmj-53	112	8	:	:	PUNCT
ctmj-53	112	9	2693	2693	NUM
ctmj-53	112	10	6356	6356	NUM
ctmj-53	112	11	2020	2020	NUM
ctmj-53	112	12	|	|	ADV
ctmj-53	112	13	vol	vol	NOUN
ctmj-53	112	14	3	3	NUM
ctmj-53	112	15	|	|	ADV
ctmj-53	112	16	issue	issue	VERB
ctmj-53	112	17	5	5	NUM
ctmj-53	112	18	ctmj	ctmj	NOUN
ctmj-53	113	1	|	|	ADV
ctmj-53	113	2	traditionalmedicinejournals.com	traditionalmedicinejournals.com	X
ctmj-53	113	3	figure	figure	NOUN
ctmj-53	113	4	4	4	NUM
ctmj-53	113	5	:	:	PUNCT
ctmj-53	113	6	effect	effect	NOUN
ctmj-53	113	7	of	of	ADP
ctmj-53	113	8	msr1	msr1	PROPN
ctmj-53	113	9	knockdown	knockdown	NOUN
ctmj-53	113	10	and	and	CCONJ
ctmj-53	113	11	c6	c6	NOUN
ctmj-53	113	12	-	-	PUNCT
ctmj-53	113	13	ceramide	ceramide	NOUN
ctmj-53	113	14	treatment	treatment	NOUN
ctmj-53	113	15	on	on	ADP
ctmj-53	113	16	npc	npc	NOUN
ctmj-53	113	17	cells	cell	NOUN
ctmj-53	113	18	.	.	PUNCT
ctmj-53	114	1	msr1	msr1	PROPN
ctmj-53	114	2	mrna	mrna	PROPN
ctmj-53	114	3	(	(	PUNCT
ctmj-53	114	4	a	a	NOUN
ctmj-53	114	5	)	)	PUNCT
ctmj-53	114	6	and	and	CCONJ
ctmj-53	114	7	protein	protein	NOUN
ctmj-53	114	8	(	(	PUNCT
ctmj-53	114	9	b	b	NOUN
ctmj-53	114	10	)	)	PUNCT
ctmj-53	114	11	expression	expression	NOUN
ctmj-53	114	12	in	in	ADP
ctmj-53	114	13	npc	npc	NOUN
ctmj-53	114	14	cell	cell	NOUN
ctmj-53	114	15	lines	line	NOUN
ctmj-53	114	16	compared	compare	VERB
ctmj-53	114	17	to	to	ADP
ctmj-53	114	18	np69	np69	ADJ
ctmj-53	114	19	cells	cell	NOUN
ctmj-53	114	20	;	;	PUNCT
ctmj-53	114	21	(	(	PUNCT
ctmj-53	114	22	c	c	X
ctmj-53	114	23	)	)	PUNCT
ctmj-53	114	24	msr1	msr1	PROPN
ctmj-53	114	25	knockdown	knockdown	NOUN
ctmj-53	114	26	efficiency	efficiency	NOUN
ctmj-53	114	27	in	in	ADP
ctmj-53	114	28	npc	npc	NOUN
ctmj-53	114	29	cells	cell	NOUN
ctmj-53	114	30	by	by	ADP
ctmj-53	114	31	shrna	shrna	NOUN
ctmj-53	114	32	;	;	PUNCT
ctmj-53	114	33	(	(	PUNCT
ctmj-53	114	34	d	d	X
ctmj-53	114	35	)	)	PUNCT
ctmj-53	114	36	cell	cell	NOUN
ctmj-53	114	37	viability	viability	NOUN
ctmj-53	114	38	of	of	ADP
ctmj-53	114	39	npc	npc	NOUN
ctmj-53	114	40	cells	cell	NOUN
ctmj-53	114	41	following	follow	VERB
ctmj-53	114	42	msr1	msr1	PROPN
ctmj-53	114	43	knockdown	knockdown	NOUN
ctmj-53	114	44	;	;	PUNCT
ctmj-53	114	45	(	(	PUNCT
ctmj-53	114	46	e	e	NOUN
ctmj-53	114	47	)	)	PUNCT
ctmj-53	114	48	viability	viability	NOUN
ctmj-53	114	49	of	of	ADP
ctmj-53	114	50	npc	npc	NOUN
ctmj-53	114	51	cells	cell	NOUN
ctmj-53	114	52	treated	treat	VERB
ctmj-53	114	53	with	with	ADP
ctmj-53	114	54	c6	c6	NOUN
ctmj-53	114	55	-	-	PUNCT
ctmj-53	114	56	ceramide	ceramide	NOUN
ctmj-53	114	57	;	;	PUNCT
ctmj-53	114	58	(	(	PUNCT
ctmj-53	114	59	f	f	X
ctmj-53	114	60	)	)	PUNCT
ctmj-53	114	61	msr1	msr1	PROPN
ctmj-53	114	62	overexpression	overexpression	NOUN
ctmj-53	114	63	in	in	ADP
ctmj-53	114	64	npc	npc	NOUN
ctmj-53	114	65	cells	cell	NOUN
ctmj-53	114	66	by	by	ADP
ctmj-53	114	67	plasmid	plasmid	ADJ
ctmj-53	114	68	transfection	transfection	NOUN
ctmj-53	114	69	;	;	PUNCT
ctmj-53	114	70	(	(	PUNCT
ctmj-53	114	71	g	g	NOUN
ctmj-53	114	72	)	)	PUNCT
ctmj-53	114	73	msr1	msr1	PROPN
ctmj-53	114	74	expression	expression	NOUN
ctmj-53	114	75	in	in	ADP
ctmj-53	114	76	npc	npc	NOUN
ctmj-53	114	77	cells	cell	NOUN
ctmj-53	114	78	with	with	ADP
ctmj-53	114	79	msr1	msr1	PROPN
ctmj-53	114	80	overexpression	overexpression	NOUN
ctmj-53	114	81	and	and	CCONJ
ctmj-53	114	82	c6	c6	NOUN
ctmj-53	114	83	-	-	PUNCT
ctmj-53	114	84	ceramide	ceramide	NOUN
ctmj-53	114	85	treatment	treatment	NOUN
ctmj-53	114	86	figure	figure	NOUN
ctmj-53	114	87	5	5	NUM
ctmj-53	114	88	:	:	PUNCT
ctmj-53	114	89	msr1	msr1	PROPN
ctmj-53	114	90	regulates	regulate	VERB
ctmj-53	114	91	pi3k	pi3k	PROPN
ctmj-53	114	92	and	and	CCONJ
ctmj-53	114	93	akt	akt	PROPN
ctmj-53	114	94	expression	expression	NOUN
ctmj-53	114	95	in	in	ADP
ctmj-53	114	96	npc	npc	NOUN
ctmj-53	114	97	cells	cell	NOUN
ctmj-53	114	98	(	(	PUNCT
ctmj-53	114	99	a	a	X
ctmj-53	114	100	)	)	PUNCT
ctmj-53	114	101	pi3k	pi3k	PROPN
ctmj-53	114	102	and	and	CCONJ
ctmj-53	114	103	akt	akt	PROPN
ctmj-53	114	104	mrna	mrna	PROPN
ctmj-53	114	105	levels	level	NOUN
ctmj-53	114	106	following	follow	VERB
ctmj-53	114	107	msr1	msr1	PROPN
ctmj-53	114	108	knockdown	knockdown	NOUN
ctmj-53	114	109	or	or	CCONJ
ctmj-53	114	110	overexpression	overexpression	NOUN
ctmj-53	114	111	in	in	ADP
ctmj-53	114	112	npc	npc	NOUN
ctmj-53	114	113	cells	cell	NOUN
ctmj-53	114	114	;	;	PUNCT
ctmj-53	114	115	(	(	PUNCT
ctmj-53	114	116	b	b	X
ctmj-53	114	117	)	)	PUNCT
ctmj-53	114	118	pi3k	pi3k	PROPN
ctmj-53	114	119	and	and	CCONJ
ctmj-53	114	120	(	(	PUNCT
ctmj-53	114	121	c	c	X
ctmj-53	114	122	)	)	PUNCT
ctmj-53	114	123	akt	akt	PROPN
ctmj-53	114	124	protein	protein	NOUN
ctmj-53	114	125	levels	level	NOUN
ctmj-53	114	126	in	in	ADP
ctmj-53	114	127	npc	npc	NOUN
ctmj-53	114	128	cells	cell	NOUN
ctmj-53	114	129	after	after	ADP
ctmj-53	114	130	msr1	msr1	PROPN
ctmj-53	114	131	knockdown	knockdown	NOUN
ctmj-53	114	132	and	and	CCONJ
ctmj-53	114	133	overexpression	overexpression	NOUN
ctmj-53	114	134	chinese	chinese	ADJ
ctmj-53	114	135	traditional	traditional	ADJ
ctmj-53	114	136	medicine	medicine	NOUN
ctmj-53	114	137	journal	journal	NOUN
ctmj-53	114	138	|	|	ADV
ctmj-53	114	139	2020	2020	NUM
ctmj-53	114	140	|	|	ADV
ctmj-53	114	141	vol	vol	NOUN
ctmj-53	114	142	3	3	NUM
ctmj-53	114	143	|	|	ADV
ctmj-53	114	144	issue	issue	VERB
ctmj-53	114	145	5	5	NUM
ctmj-53	114	146	issn	issn	X
ctmj-53	114	147	:	:	PUNCT
ctmj-53	114	148	2693	2693	NUM
ctmj-53	114	149	6356	6356	NUM
ctmj-53	114	150	2020	2020	NUM
ctmj-53	115	1	|	|	ADV
ctmj-53	115	2	vol	vol	NOUN
ctmj-53	115	3	3	3	NUM
ctmj-53	115	4	|	|	ADV
ctmj-53	115	5	issue	issue	VERB
ctmj-53	115	6	5	5	NUM
ctmj-53	115	7	ctmj	ctmj	NOUN
ctmj-53	115	8	|	|	ADV
ctmj-53	115	9	traditionalmedicinejournals.com	traditionalmedicinejournals.com	X
ctmj-53	115	10	disccusion	disccusion	NOUN
ctmj-53	115	11	nasopharyngeal	nasopharyngeal	ADJ
ctmj-53	115	12	carcinoma	carcinoma	NOUN
ctmj-53	115	13	is	be	AUX
ctmj-53	115	14	rarely	rarely	ADV
ctmj-53	115	15	detected	detect	VERB
ctmj-53	115	16	early	early	ADJ
ctmj-53	115	17	and	and	CCONJ
ctmj-53	115	18	current	current	ADJ
ctmj-53	115	19	therapies	therapy	NOUN
ctmj-53	115	20	have	have	VERB
ctmj-53	115	21	limited	limit	VERB
ctmj-53	115	22	efficacy	efficacy	NOUN
ctmj-53	115	23	in	in	ADP
ctmj-53	115	24	advanced	advanced	ADJ
ctmj-53	115	25	disease	disease	NOUN
ctmj-53	115	26	,	,	PUNCT
ctmj-53	115	27	contributing	contribute	VERB
ctmj-53	115	28	to	to	ADP
ctmj-53	115	29	high	high	ADJ
ctmj-53	115	30	mortality	mortality	NOUN
ctmj-53	115	31	.	.	PUNCT
ctmj-53	116	1	approximately	approximately	ADV
ctmj-53	116	2	95.5	95.5	NUM
ctmj-53	116	3	%	%	NOUN
ctmj-53	116	4	of	of	ADP
ctmj-53	116	5	npc	npc	NOUN
ctmj-53	116	6	cases	case	NOUN
ctmj-53	116	7	present	present	ADJ
ctmj-53	116	8	at	at	ADP
ctmj-53	116	9	late	late	ADJ
ctmj-53	116	10	stages	stage	NOUN
ctmj-53	116	11	,	,	PUNCT
ctmj-53	116	12	with	with	ADP
ctmj-53	116	13	5	5	NUM
ctmj-53	116	14	-	-	PUNCT
ctmj-53	116	15	year	year	NOUN
ctmj-53	116	16	overall	overall	ADJ
ctmj-53	116	17	and	and	CCONJ
ctmj-53	116	18	metastatic	metastatic	ADJ
ctmj-53	116	19	survival	survival	NOUN
ctmj-53	116	20	rates	rate	NOUN
ctmj-53	116	21	of	of	ADP
ctmj-53	116	22	only	only	ADV
ctmj-53	116	23	61	61	NUM
ctmj-53	116	24	and	and	CCONJ
ctmj-53	116	25	50	50	NUM
ctmj-53	116	26	%	%	NOUN
ctmj-53	116	27	,	,	PUNCT
ctmj-53	116	28	respectively	respectively	ADV
ctmj-53	116	29	[	[	X
ctmj-53	116	30	13	13	NUM
ctmj-53	116	31	]	]	PUNCT
ctmj-53	116	32	.	.	PUNCT
ctmj-53	117	1	elucidating	elucidate	VERB
ctmj-53	117	2	npc	npc	NOUN
ctmj-53	117	3	pathogenesis	pathogenesis	NOUN
ctmj-53	117	4	and	and	CCONJ
ctmj-53	117	5	identifying	identify	VERB
ctmj-53	117	6	novel	novel	ADJ
ctmj-53	117	7	therapeutic	therapeutic	ADJ
ctmj-53	117	8	targets	target	NOUN
ctmj-53	117	9	are	be	AUX
ctmj-53	117	10	critical	critical	ADJ
ctmj-53	117	11	to	to	PART
ctmj-53	117	12	improve	improve	VERB
ctmj-53	117	13	patient	patient	NOUN
ctmj-53	117	14	’s	’s	PART
ctmj-53	117	15	outcomes	outcome	NOUN
ctmj-53	117	16	.	.	PUNCT
ctmj-53	118	1	here	here	ADV
ctmj-53	118	2	,	,	PUNCT
ctmj-53	118	3	by	by	ADP
ctmj-53	118	4	integrating	integrate	VERB
ctmj-53	118	5	three	three	NUM
ctmj-53	118	6	npc	npc	NOUN
ctmj-53	118	7	datasets	dataset	NOUN
ctmj-53	118	8	,	,	PUNCT
ctmj-53	118	9	26	26	NUM
ctmj-53	118	10	upregulated	upregulate	VERB
ctmj-53	118	11	and	and	CCONJ
ctmj-53	118	12	344	344	NUM
ctmj-53	118	13	downregulated	downregulate	VERB
ctmj-53	118	14	genes	gene	NOUN
ctmj-53	118	15	were	be	AUX
ctmj-53	118	16	identified	identify	VERB
ctmj-53	118	17	.	.	PUNCT
ctmj-53	119	1	gsea	gsea	NOUN
ctmj-53	119	2	nominated	nominate	VERB
ctmj-53	119	3	the	the	DET
ctmj-53	119	4	small	small	ADJ
ctmj-53	119	5	molecule	molecule	NOUN
ctmj-53	119	6	c6	c6	PROPN
ctmj-53	119	7	ceramide	ceramide	NOUN
ctmj-53	119	8	as	as	ADP
ctmj-53	119	9	a	a	DET
ctmj-53	119	10	top	top	ADJ
ctmj-53	119	11	potential	potential	ADJ
ctmj-53	119	12	npc	npc	NOUN
ctmj-53	119	13	therapeutic	therapeutic	ADJ
ctmj-53	119	14	drug	drug	NOUN
ctmj-53	119	15	across	across	ADP
ctmj-53	119	16	datasets	dataset	NOUN
ctmj-53	119	17	.	.	PUNCT
ctmj-53	120	1	by	by	ADP
ctmj-53	120	2	overlapping	overlap	VERB
ctmj-53	120	3	differentially	differentially	ADV
ctmj-53	120	4	upregulated	upregulate	VERB
ctmj-53	120	5	genes	gene	NOUN
ctmj-53	120	6	with	with	ADP
ctmj-53	120	7	predicted	predict	VERB
ctmj-53	120	8	c6	c6	PROPN
ctmj-53	120	9	-	-	PUNCT
ctmj-53	120	10	ceramide	ceramide	NOUN
ctmj-53	120	11	targets	target	NOUN
ctmj-53	120	12	,	,	PUNCT
ctmj-53	120	13	the	the	DET
ctmj-53	120	14	study	study	NOUN
ctmj-53	120	15	identified	identify	VERB
ctmj-53	120	16	msr1	msr1	PROPN
ctmj-53	120	17	as	as	ADP
ctmj-53	120	18	a	a	DET
ctmj-53	120	19	candidate	candidate	NOUN
ctmj-53	120	20	downstream	downstream	ADJ
ctmj-53	120	21	effector	effector	NOUN
ctmj-53	120	22	.	.	PUNCT
ctmj-53	121	1	the	the	DET
ctmj-53	121	2	study	study	NOUN
ctmj-53	121	3	therefore	therefore	ADV
ctmj-53	121	4	investigated	investigate	VERB
ctmj-53	121	5	the	the	DET
ctmj-53	121	6	functional	functional	ADJ
ctmj-53	121	7	effects	effect	NOUN
ctmj-53	121	8	of	of	ADP
ctmj-53	121	9	c6	c6	NOUN
ctmj-53	121	10	-	-	PUNCT
ctmj-53	121	11	ceramide	ceramide	NOUN
ctmj-53	121	12	and	and	CCONJ
ctmj-53	121	13	msr1	msr1	PROPN
ctmj-53	121	14	in	in	ADP
ctmj-53	121	15	npc	npc	PROPN
ctmj-53	121	16	.	.	PUNCT
ctmj-53	122	1	macrophage	macrophage	ADJ
ctmj-53	122	2	scavenger	scavenger	NOUN
ctmj-53	122	3	receptor	receptor	NOUN
ctmj-53	122	4	1	1	NUM
ctmj-53	122	5	is	be	AUX
ctmj-53	122	6	expressed	express	VERB
ctmj-53	122	7	primarily	primarily	ADV
ctmj-53	122	8	in	in	ADP
ctmj-53	122	9	phagocytic	phagocytic	ADJ
ctmj-53	122	10	and	and	CCONJ
ctmj-53	122	11	antigen	antigen	ADV
ctmj-53	122	12	-	-	PUNCT
ctmj-53	122	13	presenting	present	VERB
ctmj-53	122	14	cells	cell	NOUN
ctmj-53	122	15	,	,	PUNCT
ctmj-53	122	16	including	include	VERB
ctmj-53	122	17	dendritic	dendritic	ADJ
ctmj-53	122	18	cells	cell	NOUN
ctmj-53	122	19	,	,	PUNCT
ctmj-53	122	20	macrophages	macrophage	NOUN
ctmj-53	122	21	and	and	CCONJ
ctmj-53	122	22	lung	lung	NOUN
ctmj-53	122	23	endothelium	endothelium	NOUN
ctmj-53	122	24	[	[	X
ctmj-53	122	25	14	14	NUM
ctmj-53	122	26	]	]	PUNCT
ctmj-53	122	27	.	.	PUNCT
ctmj-53	123	1	it	it	PRON
ctmj-53	123	2	recognizes	recognize	VERB
ctmj-53	123	3	molecules	molecule	NOUN
ctmj-53	123	4	and	and	CCONJ
ctmj-53	123	5	participate	participate	VERB
ctmj-53	123	6	in	in	ADP
ctmj-53	123	7	disease	disease	NOUN
ctmj-53	123	8	pathogenesis	pathogenesis	NOUN
ctmj-53	123	9	[	[	X
ctmj-53	123	10	15	15	NUM
ctmj-53	123	11	]	]	PUNCT
ctmj-53	123	12	.	.	PUNCT
ctmj-53	124	1	cluster	cluster	NOUN
ctmj-53	124	2	of	of	ADP
ctmj-53	124	3	differentiation	differentiation	NOUN
ctmj-53	124	4	204	204	NUM
ctmj-53	124	5	(	(	PUNCT
ctmj-53	124	6	cd204	cd204	PROPN
ctmj-53	124	7	)	)	PUNCT
ctmj-53	124	8	is	be	AUX
ctmj-53	124	9	a	a	DET
ctmj-53	124	10	protein	protein	NOUN
ctmj-53	124	11	encoded	encode	VERB
ctmj-53	124	12	by	by	ADP
ctmj-53	124	13	the	the	DET
ctmj-53	124	14	msr1	msr1	PROPN
ctmj-53	124	15	gene	gene	NOUN
ctmj-53	124	16	.	.	PUNCT
ctmj-53	125	1	compared	compare	VERB
ctmj-53	125	2	to	to	ADP
ctmj-53	125	3	normal	normal	ADJ
ctmj-53	125	4	tissues	tissue	NOUN
ctmj-53	125	5	,	,	PUNCT
ctmj-53	125	6	its	its	PRON
ctmj-53	125	7	expression	expression	NOUN
ctmj-53	125	8	in	in	ADP
ctmj-53	125	9	various	various	ADJ
ctmj-53	125	10	breast	breast	NOUN
ctmj-53	125	11	cancer	cancer	NOUN
ctmj-53	125	12	subtypes	subtype	NOUN
ctmj-53	125	13	is	be	AUX
ctmj-53	125	14	markedly	markedly	ADV
ctmj-53	125	15	higher	high	ADJ
ctmj-53	125	16	.	.	PUNCT
ctmj-53	126	1	furthermore	furthermore	ADV
ctmj-53	126	2	,	,	PUNCT
ctmj-53	126	3	cd204	cd204	PROPN
ctmj-53	126	4	is	be	AUX
ctmj-53	126	5	overexpressed	overexpresse	VERB
ctmj-53	126	6	in	in	ADP
ctmj-53	126	7	tumorassociated	tumorassociate	VERB
ctmj-53	126	8	macrophages	macrophage	NOUN
ctmj-53	126	9	(	(	PUNCT
ctmj-53	126	10	tam	tam	NOUN
ctmj-53	126	11	)	)	PUNCT
ctmj-53	126	12	and	and	CCONJ
ctmj-53	126	13	is	be	AUX
ctmj-53	126	14	considered	consider	VERB
ctmj-53	126	15	a	a	DET
ctmj-53	126	16	potential	potential	ADJ
ctmj-53	126	17	therapeutic	therapeutic	ADJ
ctmj-53	126	18	target	target	NOUN
ctmj-53	126	19	within	within	ADP
ctmj-53	126	20	the	the	DET
ctmj-53	126	21	tumor	tumor	NOUN
ctmj-53	126	22	microenvironment	microenvironment	NOUN
ctmj-53	126	23	[	[	X
ctmj-53	126	24	16	16	NUM
ctmj-53	126	25	]	]	PUNCT
ctmj-53	126	26	.	.	PUNCT
ctmj-53	127	1	other	other	ADJ
ctmj-53	127	2	studies	study	NOUN
ctmj-53	127	3	suggest	suggest	VERB
ctmj-53	127	4	that	that	SCONJ
ctmj-53	127	5	msr1	msr1	PROPN
ctmj-53	127	6	-	-	PUNCT
ctmj-53	127	7	mediated	mediate	VERB
ctmj-53	127	8	activation	activation	NOUN
ctmj-53	127	9	of	of	ADP
ctmj-53	127	10	pi3k	pi3k	PROPN
ctmj-53	127	11	/	/	SYM
ctmj-53	127	12	akt	akt	PROPN
ctmj-53	127	13	,	,	PUNCT
ctmj-53	127	14	nf	nf	PROPN
ctmj-53	127	15	-	-	PUNCT
ctmj-53	127	16	κb	κb	NOUN
ctmj-53	127	17	and	and	CCONJ
ctmj-53	127	18	pparα	pparα	NOUN
ctmj-53	127	19	signaling	signal	VERB
ctmj-53	127	20	pathways	pathway	NOUN
ctmj-53	127	21	helps	help	VERB
ctmj-53	127	22	macrophages	macrophage	NOUN
ctmj-53	127	23	adapt	adapt	VERB
ctmj-53	127	24	to	to	PART
ctmj-53	127	25	diverse	diverse	VERB
ctmj-53	127	26	microenvironments	microenvironment	NOUN
ctmj-53	128	1	[	[	X
ctmj-53	128	2	3,17	3,17	NUM
ctmj-53	128	3	]	]	PUNCT
ctmj-53	128	4	.	.	PUNCT
ctmj-53	129	1	collectively	collectively	ADV
ctmj-53	129	2	,	,	PUNCT
ctmj-53	129	3	these	these	DET
ctmj-53	129	4	studies	study	NOUN
ctmj-53	129	5	indicate	indicate	VERB
ctmj-53	129	6	that	that	SCONJ
ctmj-53	129	7	msr1	msr1	PROPN
ctmj-53	129	8	plays	play	VERB
ctmj-53	129	9	a	a	DET
ctmj-53	129	10	crucial	crucial	ADJ
ctmj-53	129	11	role	role	NOUN
ctmj-53	129	12	in	in	ADP
ctmj-53	129	13	cancer	cancer	NOUN
ctmj-53	129	14	treatment	treatment	NOUN
ctmj-53	129	15	.	.	PUNCT
ctmj-53	130	1	building	build	VERB
ctmj-53	130	2	on	on	ADP
ctmj-53	130	3	this	this	DET
ctmj-53	130	4	prior	prior	ADJ
ctmj-53	130	5	work	work	NOUN
ctmj-53	130	6	,	,	PUNCT
ctmj-53	130	7	this	this	DET
ctmj-53	130	8	study	study	NOUN
ctmj-53	130	9	examined	examine	VERB
ctmj-53	130	10	msr1	msr1	PROPN
ctmj-53	130	11	gene	gene	NOUN
ctmj-53	130	12	transcription	transcription	NOUN
ctmj-53	130	13	in	in	ADP
ctmj-53	130	14	one	one	NUM
ctmj-53	130	15	regular	regular	ADJ
ctmj-53	130	16	nasal	nasal	ADJ
ctmj-53	130	17	epithelial	epithelial	ADJ
ctmj-53	130	18	cell	cell	NOUN
ctmj-53	130	19	line	line	NOUN
ctmj-53	130	20	and	and	CCONJ
ctmj-53	130	21	four	four	NUM
ctmj-53	130	22	npc	npc	NOUN
ctmj-53	130	23	cell	cell	NOUN
ctmj-53	130	24	types	type	NOUN
ctmj-53	130	25	.	.	PUNCT
ctmj-53	131	1	msr1	msr1	PROPN
ctmj-53	131	2	mrna	mrna	PROPN
ctmj-53	131	3	amounts	amount	NOUN
ctmj-53	131	4	were	be	AUX
ctmj-53	131	5	much	much	ADV
ctmj-53	131	6	higher	high	ADJ
ctmj-53	131	7	in	in	ADP
ctmj-53	131	8	the	the	DET
ctmj-53	131	9	npc	npc	NOUN
ctmj-53	131	10	lines	line	NOUN
ctmj-53	131	11	in	in	ADP
ctmj-53	131	12	comparison	comparison	NOUN
ctmj-53	131	13	to	to	ADP
ctmj-53	131	14	the	the	DET
ctmj-53	131	15	typical	typical	ADJ
ctmj-53	131	16	cells	cell	NOUN
ctmj-53	131	17	.	.	PUNCT
ctmj-53	132	1	western	western	ADJ
ctmj-53	132	2	blot	blot	NOUN
ctmj-53	132	3	analysis	analysis	NOUN
ctmj-53	132	4	further	far	ADV
ctmj-53	132	5	showed	show	VERB
ctmj-53	132	6	msr1	msr1	PROPN
ctmj-53	132	7	overexpression	overexpression	NOUN
ctmj-53	132	8	in	in	ADP
ctmj-53	132	9	npc	npc	NOUN
ctmj-53	132	10	cells	cell	NOUN
ctmj-53	132	11	.	.	PUNCT
ctmj-53	133	1	these	these	DET
ctmj-53	133	2	data	datum	NOUN
ctmj-53	133	3	indicate	indicate	VERB
ctmj-53	133	4	high	high	ADJ
ctmj-53	133	5	msr1	msr1	NOUN
ctmj-53	133	6	expression	expression	NOUN
ctmj-53	133	7	in	in	ADP
ctmj-53	133	8	npc	npc	NOUN
ctmj-53	133	9	cells	cell	NOUN
ctmj-53	133	10	.	.	PUNCT
ctmj-53	134	1	thereafter	thereafter	ADV
ctmj-53	134	2	,	,	PUNCT
ctmj-53	134	3	the	the	DET
ctmj-53	134	4	connection	connection	NOUN
ctmj-53	134	5	between	between	ADP
ctmj-53	134	6	msr1	msr1	PROPN
ctmj-53	134	7	and	and	CCONJ
ctmj-53	134	8	npc	npc	NOUN
ctmj-53	134	9	carcinogenesis	carcinogenesis	NOUN
ctmj-53	134	10	was	be	AUX
ctmj-53	134	11	investigated	investigate	VERB
ctmj-53	134	12	.	.	PUNCT
ctmj-53	135	1	msr1	msr1	PROPN
ctmj-53	135	2	knockdown	knockdown	PROPN
ctmj-53	135	3	significantly	significantly	ADV
ctmj-53	135	4	reduced	reduce	VERB
ctmj-53	135	5	msr1	msr1	PROPN
ctmj-53	135	6	levels	level	NOUN
ctmj-53	135	7	and	and	CCONJ
ctmj-53	135	8	inhibited	inhibit	VERB
ctmj-53	135	9	npc	npc	NOUN
ctmj-53	135	10	cell	cell	NOUN
ctmj-53	135	11	viability	viability	NOUN
ctmj-53	135	12	,	,	PUNCT
ctmj-53	135	13	indicating	indicate	VERB
ctmj-53	135	14	msr1	msr1	PROPN
ctmj-53	135	15	is	be	AUX
ctmj-53	135	16	indeed	indeed	ADV
ctmj-53	135	17	involved	involve	VERB
ctmj-53	135	18	in	in	ADP
ctmj-53	135	19	npc	npc	NOUN
ctmj-53	135	20	carcinogenesis	carcinogenesis	NOUN
ctmj-53	135	21	.	.	PUNCT
ctmj-53	136	1	previous	previous	ADJ
ctmj-53	136	2	studies	study	NOUN
ctmj-53	136	3	have	have	AUX
ctmj-53	136	4	demonstrated	demonstrate	VERB
ctmj-53	136	5	that	that	SCONJ
ctmj-53	136	6	msr1	msr1	PROPN
ctmj-53	136	7	may	may	AUX
ctmj-53	136	8	boost	boost	VERB
ctmj-53	136	9	nuclear	nuclear	ADJ
ctmj-53	136	10	translocation	translocation	NOUN
ctmj-53	136	11	of	of	ADP
ctmj-53	136	12	βcatenin	βcatenin	ADJ
ctmj-53	136	13	,	,	PUNCT
ctmj-53	136	14	hence	hence	ADV
ctmj-53	136	15	promoting	promote	VERB
ctmj-53	136	16	stimulation	stimulation	NOUN
ctmj-53	136	17	of	of	ADP
ctmj-53	136	18	pi3k	pi3k	PROPN
ctmj-53	136	19	/	/	SYM
ctmj-53	136	20	akt	akt	PROPN
ctmj-53	136	21	pathway	pathway	NOUN
ctmj-53	137	1	[	[	X
ctmj-53	137	2	16	16	NUM
ctmj-53	137	3	]	]	PUNCT
ctmj-53	137	4	.	.	PUNCT
ctmj-53	138	1	the	the	DET
ctmj-53	138	2	pi3k	pi3k	PROPN
ctmj-53	138	3	/	/	SYM
ctmj-53	138	4	akt	akt	PROPN
ctmj-53	138	5	pathway	pathway	NOUN
ctmj-53	138	6	activation	activation	NOUN
ctmj-53	138	7	are	be	AUX
ctmj-53	138	8	crucial	crucial	ADJ
ctmj-53	138	9	for	for	ADP
ctmj-53	138	10	tumorigenesis	tumorigenesis	NOUN
ctmj-53	138	11	.	.	PUNCT
ctmj-53	139	1	therefore	therefore	ADV
ctmj-53	139	2	,	,	PUNCT
ctmj-53	139	3	the	the	DET
ctmj-53	139	4	investigation	investigation	NOUN
ctmj-53	139	5	further	far	ADV
ctmj-53	139	6	examined	examine	VERB
ctmj-53	139	7	the	the	DET
ctmj-53	139	8	effect	effect	NOUN
ctmj-53	139	9	of	of	ADP
ctmj-53	139	10	msr1	msr1	PROPN
ctmj-53	139	11	on	on	ADP
ctmj-53	139	12	the	the	DET
ctmj-53	139	13	pi3k	pi3k	PROPN
ctmj-53	139	14	/	/	SYM
ctmj-53	139	15	akt	akt	PROPN
ctmj-53	139	16	pathway	pathway	NOUN
ctmj-53	139	17	during	during	ADP
ctmj-53	139	18	npc	npc	PROPN
ctmj-53	139	19	development	development	NOUN
ctmj-53	139	20	by	by	ADP
ctmj-53	139	21	overexpressing	overexpresse	VERB
ctmj-53	139	22	or	or	CCONJ
ctmj-53	139	23	knockdown	knockdown	NOUN
ctmj-53	139	24	of	of	ADP
ctmj-53	139	25	msr1	msr1	PROPN
ctmj-53	139	26	in	in	ADP
ctmj-53	139	27	npc	npc	NOUN
ctmj-53	139	28	cells	cell	NOUN
ctmj-53	139	29	.	.	PUNCT
ctmj-53	140	1	msr1	msr1	PROPN
ctmj-53	140	2	overexpression	overexpression	NOUN
ctmj-53	140	3	resulted	result	VERB
ctmj-53	140	4	in	in	ADP
ctmj-53	140	5	increased	increase	VERB
ctmj-53	140	6	expression	expression	NOUN
ctmj-53	140	7	of	of	ADP
ctmj-53	140	8	msr1	msr1	PROPN
ctmj-53	140	9	,	,	PUNCT
ctmj-53	140	10	pi3k	pi3k	PROPN
ctmj-53	140	11	and	and	CCONJ
ctmj-53	140	12	akt	akt	PROPN
ctmj-53	140	13	compared	compare	VERB
ctmj-53	140	14	to	to	ADP
ctmj-53	140	15	control	control	NOUN
ctmj-53	140	16	cells	cell	NOUN
ctmj-53	140	17	.	.	PUNCT
ctmj-53	141	1	in	in	ADP
ctmj-53	141	2	contrast	contrast	NOUN
ctmj-53	141	3	,	,	PUNCT
ctmj-53	141	4	msr1	msr1	PROPN
ctmj-53	141	5	knockdown	knockdown	PROPN
ctmj-53	141	6	significantly	significantly	ADV
ctmj-53	141	7	reduced	reduce	VERB
ctmj-53	141	8	pi3k	pi3k	PROPN
ctmj-53	141	9	and	and	CCONJ
ctmj-53	141	10	akt	akt	PROPN
ctmj-53	141	11	protein	protein	NOUN
ctmj-53	141	12	levels	level	NOUN
ctmj-53	141	13	.	.	PUNCT
ctmj-53	142	1	these	these	DET
ctmj-53	142	2	findings	finding	NOUN
ctmj-53	142	3	reveal	reveal	VERB
ctmj-53	142	4	that	that	SCONJ
ctmj-53	142	5	msr1	msr1	PROPN
ctmj-53	142	6	also	also	ADV
ctmj-53	142	7	promotes	promote	VERB
ctmj-53	142	8	npc	npc	NOUN
ctmj-53	142	9	pathogenesis	pathogenesis	NOUN
ctmj-53	142	10	by	by	ADP
ctmj-53	142	11	stimulating	stimulate	VERB
ctmj-53	142	12	pi3k	pi3k	PROPN
ctmj-53	142	13	/	/	SYM
ctmj-53	142	14	akt	akt	NOUN
ctmj-53	142	15	signaling	signal	VERB
ctmj-53	142	16	pathway	pathway	NOUN
ctmj-53	142	17	in	in	ADP
ctmj-53	142	18	npc	npc	NOUN
ctmj-53	142	19	cells	cell	NOUN
ctmj-53	142	20	.	.	PUNCT
ctmj-53	143	1	c6ceramide	c6ceramide	NOUN
ctmj-53	143	2	is	be	AUX
ctmj-53	143	3	a	a	DET
ctmj-53	143	4	cell	cell	NOUN
ctmj-53	143	5	-	-	PUNCT
ctmj-53	143	6	permeable	permeable	ADJ
ctmj-53	143	7	ceramide	ceramide	NOUN
ctmj-53	143	8	analogue	analogue	NOUN
ctmj-53	143	9	that	that	PRON
ctmj-53	143	10	mimics	mimic	VERB
ctmj-53	143	11	endogenous	endogenous	ADJ
ctmj-53	143	12	ceramides	ceramide	NOUN
ctmj-53	143	13	[	[	X
ctmj-53	143	14	18	18	NUM
ctmj-53	143	15	]	]	PUNCT
ctmj-53	143	16	.	.	PUNCT
ctmj-53	144	1	the	the	DET
ctmj-53	144	2	antitumor	antitumor	PROPN
ctmj-53	144	3	effects	effect	NOUN
ctmj-53	144	4	of	of	ADP
ctmj-53	144	5	c6	c6	NOUN
ctmj-53	144	6	-	-	PUNCT
ctmj-53	144	7	ceramide	ceramide	NOUN
ctmj-53	144	8	have	have	AUX
ctmj-53	144	9	been	be	AUX
ctmj-53	144	10	demonstrated	demonstrate	VERB
ctmj-53	144	11	in	in	ADP
ctmj-53	144	12	various	various	ADJ
ctmj-53	144	13	tumor	tumor	NOUN
ctmj-53	144	14	models	model	NOUN
ctmj-53	144	15	[	[	X
ctmj-53	144	16	19	19	NUM
ctmj-53	144	17	]	]	PUNCT
ctmj-53	144	18	,	,	PUNCT
ctmj-53	144	19	but	but	CCONJ
ctmj-53	144	20	its	its	PRON
ctmj-53	144	21	effects	effect	NOUN
ctmj-53	144	22	on	on	ADP
ctmj-53	144	23	npc	npc	NOUN
ctmj-53	144	24	are	be	AUX
ctmj-53	144	25	unknown	unknown	ADJ
ctmj-53	144	26	.	.	PUNCT
ctmj-53	145	1	in	in	ADP
ctmj-53	145	2	this	this	DET
ctmj-53	145	3	study	study	NOUN
ctmj-53	145	4	,	,	PUNCT
ctmj-53	145	5	gsea	gsea	ADJ
ctmj-53	145	6	analysis	analysis	NOUN
ctmj-53	145	7	of	of	ADP
ctmj-53	145	8	three	three	NUM
ctmj-53	145	9	geo	geo	PROPN
ctmj-53	145	10	datasets	dataset	NOUN
ctmj-53	145	11	revealed	reveal	VERB
ctmj-53	145	12	c6	c6	NOUN
ctmj-53	145	13	-	-	PUNCT
ctmj-53	145	14	ceramide	ceramide	NOUN
ctmj-53	145	15	as	as	ADP
ctmj-53	145	16	a	a	DET
ctmj-53	145	17	feasible	feasible	ADJ
ctmj-53	145	18	npc	npc	NOUN
ctmj-53	145	19	treatment	treatment	NOUN
ctmj-53	145	20	.	.	PUNCT
ctmj-53	146	1	this	this	DET
ctmj-53	146	2	investigation	investigation	NOUN
ctmj-53	146	3	then	then	ADV
ctmj-53	146	4	investigated	investigate	VERB
ctmj-53	146	5	the	the	DET
ctmj-53	146	6	implications	implication	NOUN
ctmj-53	146	7	of	of	ADP
ctmj-53	146	8	c6	c6	NOUN
ctmj-53	146	9	-	-	PUNCT
ctmj-53	146	10	ceramide	ceramide	NOUN
ctmj-53	146	11	upon	upon	SCONJ
ctmj-53	146	12	npc	npc	NOUN
ctmj-53	146	13	cells	cell	NOUN
ctmj-53	146	14	in	in	ADP
ctmj-53	146	15	vitro	vitro	X
ctmj-53	146	16	.	.	PUNCT
ctmj-53	147	1	treatment	treatment	NOUN
ctmj-53	147	2	with	with	ADP
ctmj-53	147	3	a	a	DET
ctmj-53	147	4	specific	specific	ADJ
ctmj-53	147	5	c6	c6	NOUN
ctmj-53	147	6	-	-	PUNCT
ctmj-53	147	7	ceramide	ceramide	NOUN
ctmj-53	147	8	concentration	concentration	NOUN
ctmj-53	147	9	decreased	decrease	VERB
ctmj-53	147	10	npc	npc	NOUN
ctmj-53	147	11	cell	cell	NOUN
ctmj-53	147	12	viability	viability	NOUN
ctmj-53	147	13	.	.	PUNCT
ctmj-53	148	1	these	these	DET
ctmj-53	148	2	data	datum	NOUN
ctmj-53	148	3	demonstrate	demonstrate	VERB
ctmj-53	148	4	c6	c6	NOUN
ctmj-53	148	5	-	-	PUNCT
ctmj-53	148	6	ceramide	ceramide	NOUN
ctmj-53	148	7	exerts	exert	VERB
ctmj-53	148	8	cytotoxicity	cytotoxicity	NOUN
ctmj-53	148	9	and	and	CCONJ
ctmj-53	148	10	significantly	significantly	ADV
ctmj-53	148	11	reduces	reduce	VERB
ctmj-53	148	12	npc	npc	NOUN
ctmj-53	148	13	cell	cell	NOUN
ctmj-53	148	14	viability	viability	NOUN
ctmj-53	148	15	.	.	PUNCT
ctmj-53	149	1	previous	previous	ADJ
ctmj-53	149	2	studies	study	NOUN
ctmj-53	149	3	have	have	AUX
ctmj-53	149	4	also	also	ADV
ctmj-53	149	5	demonstrated	demonstrate	VERB
ctmj-53	149	6	c6ceramide	c6ceramide	PROPN
ctmj-53	149	7	liposomes	liposome	NOUN
ctmj-53	149	8	induce	induce	VERB
ctmj-53	149	9	cell	cell	NOUN
ctmj-53	149	10	death	death	NOUN
ctmj-53	149	11	in	in	ADP
ctmj-53	149	12	chronic	chronic	ADJ
ctmj-53	149	13	lymphocytic	lymphocytic	ADJ
ctmj-53	149	14	leukemia	leukemia	NOUN
ctmj-53	149	15	cells	cell	NOUN
ctmj-53	149	16	[	[	X
ctmj-53	149	17	20	20	NUM
ctmj-53	149	18	]	]	PUNCT
ctmj-53	149	19	.	.	PUNCT
ctmj-53	150	1	next	next	ADV
ctmj-53	150	2	,	,	PUNCT
ctmj-53	150	3	this	this	DET
ctmj-53	150	4	study	study	NOUN
ctmj-53	150	5	investigated	investigate	VERB
ctmj-53	150	6	links	link	NOUN
ctmj-53	150	7	between	between	ADP
ctmj-53	150	8	c6ceramide	c6ceramide	NOUN
ctmj-53	150	9	cytotoxicity	cytotoxicity	NOUN
ctmj-53	150	10	and	and	CCONJ
ctmj-53	150	11	msr1	msr1	NOUN
ctmj-53	150	12	expression	expression	NOUN
ctmj-53	150	13	.	.	PUNCT
ctmj-53	151	1	msr1	msr1	PROPN
ctmj-53	151	2	overexpression	overexpression	NOUN
ctmj-53	151	3	alone	alone	ADV
ctmj-53	151	4	increased	increase	VERB
ctmj-53	151	5	msr1	msr1	NOUN
ctmj-53	151	6	expression	expression	NOUN
ctmj-53	151	7	.	.	PUNCT
ctmj-53	152	1	in	in	ADP
ctmj-53	152	2	contrast	contrast	NOUN
ctmj-53	152	3	,	,	PUNCT
ctmj-53	152	4	treatment	treatment	NOUN
ctmj-53	152	5	with	with	ADP
ctmj-53	152	6	c6ceramide	c6ceramide	PROPN
ctmj-53	152	7	alone	alone	ADV
ctmj-53	152	8	markedly	markedly	ADV
ctmj-53	152	9	reduced	reduce	VERB
ctmj-53	152	10	msr1	msr1	NOUN
ctmj-53	152	11	expression	expression	NOUN
ctmj-53	152	12	.	.	PUNCT
ctmj-53	153	1	co	co	NOUN
ctmj-53	153	2	-	-	NOUN
ctmj-53	153	3	treatment	treatment	NOUN
ctmj-53	153	4	with	with	ADP
ctmj-53	153	5	overexpression	overexpression	NOUN
ctmj-53	153	6	and	and	CCONJ
ctmj-53	153	7	c6	c6	NOUN
ctmj-53	153	8	-	-	PUNCT
ctmj-53	153	9	ceramide	ceramide	NOUN
ctmj-53	153	10	resulted	result	VERB
ctmj-53	153	11	in	in	ADP
ctmj-53	153	12	msr1	msr1	PROPN
ctmj-53	153	13	levels	level	NOUN
ctmj-53	153	14	between	between	ADP
ctmj-53	153	15	individual	individual	ADJ
ctmj-53	153	16	treatment	treatment	NOUN
ctmj-53	153	17	groups	group	NOUN
ctmj-53	153	18	.	.	PUNCT
ctmj-53	154	1	this	this	PRON
ctmj-53	154	2	indicates	indicate	VERB
ctmj-53	154	3	c6	c6	PROPN
ctmj-53	154	4	-	-	PUNCT
ctmj-53	154	5	ceramide	ceramide	NOUN
ctmj-53	154	6	could	could	AUX
ctmj-53	154	7	mitigate	mitigate	VERB
ctmj-53	154	8	increased	increase	VERB
ctmj-53	154	9	msr1	msr1	NOUN
ctmj-53	154	10	expression	expression	NOUN
ctmj-53	154	11	induced	induce	VERB
ctmj-53	154	12	by	by	ADP
ctmj-53	154	13	overexpression	overexpression	NOUN
ctmj-53	154	14	in	in	ADP
ctmj-53	154	15	npc	npc	NOUN
ctmj-53	154	16	cells	cell	NOUN
ctmj-53	154	17	.	.	PUNCT
ctmj-53	155	1	these	these	DET
ctmj-53	155	2	studies	study	NOUN
ctmj-53	155	3	indicate	indicate	VERB
ctmj-53	155	4	c6	c6	NOUN
ctmj-53	155	5	-	-	PUNCT
ctmj-53	155	6	ceramide	ceramide	NOUN
ctmj-53	155	7	may	may	AUX
ctmj-53	155	8	have	have	VERB
ctmj-53	155	9	therapeutic	therapeutic	ADJ
ctmj-53	155	10	efficacy	efficacy	NOUN
ctmj-53	155	11	by	by	ADP
ctmj-53	155	12	targeting	target	VERB
ctmj-53	155	13	msr1	msr1	PROPN
ctmj-53	155	14	in	in	ADP
ctmj-53	155	15	npc	npc	PROPN
ctmj-53	155	16	.	.	PUNCT
ctmj-53	156	1	conclusion	conclusion	NOUN
ctmj-53	156	2	using	use	VERB
ctmj-53	156	3	gsea	gsea	NOUN
ctmj-53	157	1	,	,	PUNCT
ctmj-53	157	2	this	this	DET
ctmj-53	157	3	investigation	investigation	NOUN
ctmj-53	157	4	has	have	AUX
ctmj-53	157	5	identified	identify	VERB
ctmj-53	157	6	c6	c6	PROPN
ctmj-53	157	7	ceramide	ceramide	NOUN
ctmj-53	157	8	and	and	CCONJ
ctmj-53	157	9	its	its	PRON
ctmj-53	157	10	target	target	NOUN
ctmj-53	157	11	gene	gene	NOUN
ctmj-53	157	12	,	,	PUNCT
ctmj-53	157	13	msr1	msr1	PROPN
ctmj-53	157	14	,	,	PUNCT
ctmj-53	157	15	as	as	ADP
ctmj-53	157	16	therapeutic	therapeutic	ADJ
ctmj-53	157	17	candidates	candidate	NOUN
ctmj-53	157	18	for	for	ADP
ctmj-53	157	19	npc	npc	NOUN
ctmj-53	157	20	.	.	PUNCT
ctmj-53	158	1	the	the	DET
ctmj-53	158	2	findings	finding	NOUN
ctmj-53	158	3	verified	verify	VERB
ctmj-53	158	4	their	their	PRON
ctmj-53	158	5	functional	functional	ADJ
ctmj-53	158	6	effect	effect	NOUN
ctmj-53	158	7	in	in	ADP
ctmj-53	158	8	vitro	vitro	NOUN
ctmj-53	158	9	,	,	PUNCT
ctmj-53	158	10	employing	employ	VERB
ctmj-53	158	11	npc	npc	NOUN
ctmj-53	158	12	cell	cell	NOUN
ctmj-53	158	13	line	line	NOUN
ctmj-53	158	14	experiments	experiment	NOUN
ctmj-53	158	15	.	.	PUNCT
ctmj-53	159	1	msr1	msr1	PROPN
ctmj-53	159	2	knockdown	knockdown	PROPN
ctmj-53	159	3	inhibits	inhibit	VERB
ctmj-53	159	4	npc	npc	NOUN
ctmj-53	159	5	cell	cell	NOUN
ctmj-53	159	6	proliferation	proliferation	NOUN
ctmj-53	159	7	,	,	PUNCT
ctmj-53	159	8	while	while	SCONJ
ctmj-53	159	9	c6	c6	NOUN
ctmj-53	159	10	-	-	PUNCT
ctmj-53	159	11	ceramide	ceramide	NOUN
ctmj-53	159	12	exhibits	exhibit	VERB
ctmj-53	159	13	anti	anti	ADJ
ctmj-53	159	14	-	-	ADJ
ctmj-53	159	15	npc	npc	ADJ
ctmj-53	159	16	effect	effect	NOUN
ctmj-53	159	17	by	by	ADP
ctmj-53	159	18	regulating	regulate	VERB
ctmj-53	159	19	msr1	msr1	PROPN
ctmj-53	159	20	expression	expression	NOUN
ctmj-53	159	21	.	.	PUNCT
ctmj-53	160	1	although	although	SCONJ
ctmj-53	160	2	this	this	DET
ctmj-53	160	3	study	study	NOUN
ctmj-53	160	4	lacks	lack	VERB
ctmj-53	160	5	patient	patient	ADJ
ctmj-53	160	6	sample	sample	NOUN
ctmj-53	160	7	data	datum	NOUN
ctmj-53	160	8	and	and	CCONJ
ctmj-53	160	9	detailed	detailed	ADJ
ctmj-53	160	10	mechanistic	mechanistic	ADJ
ctmj-53	160	11	analysis	analysis	NOUN
ctmj-53	160	12	,	,	PUNCT
ctmj-53	160	13	it	it	PRON
ctmj-53	160	14	provides	provide	VERB
ctmj-53	160	15	foundational	foundational	ADJ
ctmj-53	160	16	data	datum	NOUN
ctmj-53	160	17	and	and	CCONJ
ctmj-53	160	18	reveals	reveal	VERB
ctmj-53	160	19	new	new	ADJ
ctmj-53	160	20	research	research	NOUN
ctmj-53	160	21	avenues	avenue	NOUN
ctmj-53	160	22	for	for	ADP
ctmj-53	160	23	targeting	target	VERB
ctmj-53	160	24	msr1	msr1	NOUN
ctmj-53	160	25	and	and	CCONJ
ctmj-53	160	26	ceramide	ceramide	NOUN
ctmj-53	160	27	signaling	signal	VERB
ctmj-53	160	28	in	in	ADP
ctmj-53	160	29	npc	npc	NOUN
ctmj-53	160	30	treatment	treatment	NOUN
ctmj-53	160	31	.	.	PUNCT
ctmj-53	161	1	going	go	VERB
ctmj-53	161	2	forward	forward	ADV
ctmj-53	161	3	,	,	PUNCT
ctmj-53	161	4	validation	validation	NOUN
ctmj-53	161	5	in	in	ADP
ctmj-53	161	6	patient	patient	ADJ
ctmj-53	161	7	tumor	tumor	NOUN
ctmj-53	161	8	tissues	tissue	NOUN
ctmj-53	161	9	and	and	CCONJ
ctmj-53	161	10	elucidation	elucidation	NOUN
ctmj-53	161	11	of	of	ADP
ctmj-53	161	12	the	the	DET
ctmj-53	161	13	precise	precise	ADJ
ctmj-53	161	14	molecular	molecular	ADJ
ctmj-53	161	15	mechanisms	mechanism	NOUN
ctmj-53	161	16	chinese	chinese	ADJ
ctmj-53	161	17	traditional	traditional	ADJ
ctmj-53	161	18	medicine	medicine	NOUN
ctmj-53	161	19	journal	journal	NOUN
ctmj-53	161	20	|	|	ADV
ctmj-53	161	21	2020	2020	NUM
ctmj-53	162	1	|	|	ADV
ctmj-53	162	2	vol	vol	NOUN
ctmj-53	162	3	3	3	NUM
ctmj-53	162	4	|	|	ADV
ctmj-53	162	5	issue	issue	VERB
ctmj-53	162	6	5	5	NUM
ctmj-53	162	7	issn	issn	X
ctmj-53	162	8	:	:	PUNCT
ctmj-53	162	9	2693	2693	NUM
ctmj-53	162	10	6356	6356	NUM
ctmj-53	162	11	2020	2020	NUM
ctmj-53	162	12	|	|	ADV
ctmj-53	162	13	vol	vol	NOUN
ctmj-53	162	14	3	3	NUM
ctmj-53	162	15	|	|	ADV
ctmj-53	162	16	issue	issue	VERB
ctmj-53	162	17	5	5	NUM
ctmj-53	162	18	ctmj	ctmj	NOUN
ctmj-53	162	19	|	|	ADV
ctmj-53	162	20	traditionalmedicinejournals.com	traditionalmedicinejournals.com	X
ctmj-53	162	21	mediating	mediate	VERB
ctmj-53	162	22	msr1	msr1	PROPN
ctmj-53	162	23	and	and	CCONJ
ctmj-53	162	24	c6	c6	PROPN
ctmj-53	162	25	-	-	PUNCT
ctmj-53	162	26	ceramide	ceramide	NOUN
ctmj-53	162	27	effect	effect	NOUN
ctmj-53	162	28	will	will	AUX
ctmj-53	162	29	provide	provide	VERB
ctmj-53	162	30	critical	critical	ADJ
ctmj-53	162	31	insight	insight	NOUN
ctmj-53	162	32	into	into	ADP
ctmj-53	162	33	their	their	PRON
ctmj-53	162	34	therapeutic	therapeutic	ADJ
ctmj-53	162	35	potential	potential	NOUN
ctmj-53	162	36	.	.	PUNCT
ctmj-53	163	1	this	this	DET
ctmj-53	163	2	work	work	NOUN
ctmj-53	163	3	establishes	establish	VERB
ctmj-53	163	4	a	a	DET
ctmj-53	163	5	rationale	rationale	NOUN
ctmj-53	163	6	for	for	ADP
ctmj-53	163	7	further	further	ADJ
ctmj-53	163	8	exploration	exploration	NOUN
ctmj-53	163	9	of	of	ADP
ctmj-53	163	10	msr1	msr1	PROPN
ctmj-53	163	11	and	and	CCONJ
ctmj-53	163	12	ceramides	ceramide	NOUN
ctmj-53	163	13	as	as	ADP
ctmj-53	163	14	novel	novel	ADJ
ctmj-53	163	15	targets	target	NOUN
ctmj-53	163	16	in	in	ADP
ctmj-53	163	17	npc	npc	PROPN
ctmj-53	163	18	.	.	PUNCT
ctmj-53	164	1	references	reference	NOUN
ctmj-53	164	2	1	1	NUM
ctmj-53	164	3	.	.	PUNCT
ctmj-53	165	1	xu	xu	PROPN
ctmj-53	166	1	s	s	PROPN
ctmj-53	166	2	,	,	PUNCT
ctmj-53	166	3	he	he	PRON
ctmj-53	166	4	w.	w.	NOUN
ctmj-53	166	5	effect	effect	NOUN
ctmj-53	166	6	of	of	ADP
ctmj-53	166	7	mir-200c	mir-200c	NOUN
ctmj-53	166	8	on	on	ADP
ctmj-53	166	9	nasopharyngeal	nasopharyngeal	ADJ
ctmj-53	166	10	carcinoma	carcinoma	NOUN
ctmj-53	166	11	and	and	CCONJ
ctmj-53	166	12	the	the	DET
ctmj-53	166	13	probable	probable	ADJ
ctmj-53	166	14	molecular	molecular	ADJ
ctmj-53	166	15	regulatory	regulatory	ADJ
ctmj-53	166	16	mechanism	mechanism	NOUN
ctmj-53	166	17	involved	involve	VERB
ctmj-53	166	18	.	.	PUNCT
ctmj-53	167	1	trop	trop	X
ctmj-53	167	2	j	j	PROPN
ctmj-53	167	3	pharm	pharm	PROPN
ctmj-53	167	4	res	re	VERB
ctmj-53	167	5	2021	2021	NUM
ctmj-53	167	6	;	;	PUNCT
ctmj-53	167	7	20	20	NUM
ctmj-53	167	8	:	:	SYM
ctmj-53	167	9	4146	4146	NUM
ctmj-53	167	10	.	.	PUNCT
ctmj-53	168	1	2	2	X
ctmj-53	168	2	.	.	X
ctmj-53	168	3	liao	liao	PROPN
ctmj-53	168	4	k	k	PROPN
ctmj-53	168	5	,	,	PUNCT
ctmj-53	168	6	zheng	zheng	PROPN
ctmj-53	168	7	r	r	PROPN
ctmj-53	168	8	,	,	PUNCT
ctmj-53	168	9	feng	feng	PROPN
ctmj-53	168	10	j	j	PROPN
ctmj-53	168	11	,	,	PUNCT
ctmj-53	168	12	liu	liu	PROPN
ctmj-53	168	13	h	h	PROPN
ctmj-53	168	14	,	,	PUNCT
ctmj-53	168	15	xie	xie	PROPN
ctmj-53	168	16	g.	g.	PROPN
ctmj-53	168	17	effect	effect	NOUN
ctmj-53	168	18	of	of	ADP
ctmj-53	168	19	overexpression	overexpression	NOUN
ctmj-53	168	20	of	of	ADP
ctmj-53	168	21	rac1	rac1	PROPN
ctmj-53	168	22	on	on	ADP
ctmj-53	168	23	radiosensitivity	radiosensitivity	NOUN
ctmj-53	168	24	of	of	ADP
ctmj-53	168	25	nasopharyngeal	nasopharyngeal	ADJ
ctmj-53	168	26	carcinoma	carcinoma	NOUN
ctmj-53	168	27	xenografts	xenograft	NOUN
ctmj-53	168	28	in	in	ADP
ctmj-53	168	29	nude	nude	ADJ
ctmj-53	168	30	mice	mouse	NOUN
ctmj-53	168	31	and	and	CCONJ
ctmj-53	168	32	the	the	DET
ctmj-53	168	33	underlying	underlying	ADJ
ctmj-53	168	34	mechanism	mechanism	NOUN
ctmj-53	168	35	.	.	PUNCT
ctmj-53	169	1	trop	trop	X
ctmj-53	169	2	j	j	PROPN
ctmj-53	169	3	pharm	pharm	PROPN
ctmj-53	169	4	res	re	VERB
ctmj-53	169	5	2023	2023	NUM
ctmj-53	169	6	;	;	PUNCT
ctmj-53	169	7	22	22	NUM
ctmj-53	169	8	:	:	PUNCT
ctmj-53	169	9	789	789	NUM
ctmj-53	169	10	-	-	SYM
ctmj-53	169	11	794	794	NUM
ctmj-53	169	12	.	.	PUNCT
ctmj-53	170	1	3	3	X
ctmj-53	170	2	.	.	X
ctmj-53	170	3	kelley	kelley	PROPN
ctmj-53	170	4	jl	jl	PROPN
ctmj-53	170	5	,	,	PUNCT
ctmj-53	170	6	ozment	ozment	NOUN
ctmj-53	170	7	tr	tr	VERB
ctmj-53	170	8	,	,	PUNCT
ctmj-53	170	9	li	li	PROPN
ctmj-53	170	10	c	c	PROPN
ctmj-53	170	11	,	,	PUNCT
ctmj-53	170	12	schweitzer	schweitzer	PROPN
ctmj-53	170	13	jb	jb	PROPN
ctmj-53	170	14	,	,	PUNCT
ctmj-53	170	15	williams	williams	PROPN
ctmj-53	170	16	dl	dl	PROPN
ctmj-53	170	17	.	.	PROPN
ctmj-53	170	18	scavenger	scavenger	NOUN
ctmj-53	170	19	receptor	receptor	NOUN
ctmj-53	170	20	-	-	PUNCT
ctmj-53	170	21	a	a	PRON
ctmj-53	170	22	(	(	PUNCT
ctmj-53	170	23	cd204	cd204	PROPN
ctmj-53	170	24	):	):	PUNCT
ctmj-53	170	25	a	a	DET
ctmj-53	170	26	twoedged	twoedge	VERB
ctmj-53	170	27	sword	sword	NOUN
ctmj-53	170	28	in	in	ADP
ctmj-53	170	29	health	health	NOUN
ctmj-53	170	30	and	and	CCONJ
ctmj-53	170	31	disease	disease	NOUN
ctmj-53	170	32	.	.	PUNCT
ctmj-53	171	1	crit	crit	PROPN
ctmj-53	171	2	rev	rev	PROPN
ctmj-53	171	3	immunol	immunol	NOUN
ctmj-53	171	4	2014	2014	NUM
ctmj-53	171	5	;	;	PUNCT
ctmj-53	171	6	34	34	NUM
ctmj-53	171	7	:	:	SYM
ctmj-53	171	8	241261	241261	NUM
ctmj-53	171	9	.	.	PUNCT
ctmj-53	172	1	4	4	X
ctmj-53	172	2	.	.	X
ctmj-53	172	3	dong	dong	PROPN
ctmj-53	172	4	p	p	PROPN
ctmj-53	172	5	,	,	PUNCT
ctmj-53	172	6	ma	ma	PROPN
ctmj-53	172	7	l	l	PROPN
ctmj-53	172	8	,	,	PUNCT
ctmj-53	172	9	liu	liu	PROPN
ctmj-53	172	10	l	l	PROPN
ctmj-53	172	11	,	,	PUNCT
ctmj-53	172	12	zhao	zhao	PROPN
ctmj-53	172	13	g	g	PROPN
ctmj-53	172	14	,	,	PUNCT
ctmj-53	172	15	zhang	zhang	PROPN
ctmj-53	172	16	s	s	PROPN
ctmj-53	172	17	,	,	PUNCT
ctmj-53	172	18	dong	dong	PROPN
ctmj-53	172	19	l	l	PROPN
ctmj-53	172	20	,	,	PUNCT
ctmj-53	172	21	xue	xue	PROPN
ctmj-53	172	22	r	r	PROPN
ctmj-53	172	23	,	,	PUNCT
ctmj-53	172	24	chen	chen	PROPN
ctmj-53	172	25	s.	s.	PROPN
ctmj-53	172	26	cd86⁺/cd206⁺	cd86⁺/cd206⁺	PROPN
ctmj-53	172	27	,	,	PUNCT
ctmj-53	172	28	diametrically	diametrically	ADV
ctmj-53	172	29	polarized	polarize	VERB
ctmj-53	172	30	tumorassociated	tumorassociate	VERB
ctmj-53	172	31	macrophages	macrophage	NOUN
ctmj-53	172	32	,	,	PUNCT
ctmj-53	172	33	predict	predict	VERB
ctmj-53	172	34	hepatocellular	hepatocellular	ADJ
ctmj-53	172	35	carcinoma	carcinoma	NOUN
ctmj-53	172	36	patient	patient	ADJ
ctmj-53	172	37	prognosis	prognosis	NOUN
ctmj-53	172	38	.	.	PUNCT
ctmj-53	173	1	int	int	PROPN
ctmj-53	173	2	j	j	PROPN
ctmj-53	173	3	mol	mol	ADP
ctmj-53	173	4	sci	sci	PROPN
ctmj-53	173	5	2016	2016	NUM
ctmj-53	173	6	;	;	PUNCT
ctmj-53	173	7	17	17	NUM
ctmj-53	173	8	:	:	SYM
ctmj-53	173	9	320	320	NUM
ctmj-53	173	10	.	.	NOUN
ctmj-53	173	11	5	5	NUM
ctmj-53	173	12	.	.	X
ctmj-53	174	1	ji	ji	PROPN
ctmj-53	174	2	q	q	PROPN
ctmj-53	174	3	,	,	PUNCT
ctmj-53	174	4	huang	huang	PROPN
ctmj-53	174	5	k	k	PROPN
ctmj-53	174	6	,	,	PUNCT
ctmj-53	174	7	jiang	jiang	PROPN
ctmj-53	174	8	y	y	PROPN
ctmj-53	174	9	,	,	PUNCT
ctmj-53	174	10	lei	lei	PROPN
ctmj-53	174	11	k	k	PROPN
ctmj-53	174	12	,	,	PUNCT
ctmj-53	174	13	tu	tu	PROPN
ctmj-53	174	14	z	z	PROPN
ctmj-53	174	15	,	,	PUNCT
ctmj-53	174	16	luo	luo	PROPN
ctmj-53	174	17	h	h	PROPN
ctmj-53	174	18	,	,	PUNCT
ctmj-53	174	19	zhu	zhu	PROPN
ctmj-53	174	20	x.	x.	NOUN
ctmj-53	174	21	comprehensive	comprehensive	ADJ
ctmj-53	174	22	analysis	analysis	NOUN
ctmj-53	174	23	of	of	ADP
ctmj-53	174	24	the	the	DET
ctmj-53	174	25	prognostic	prognostic	ADJ
ctmj-53	174	26	and	and	CCONJ
ctmj-53	174	27	role	role	NOUN
ctmj-53	174	28	in	in	ADP
ctmj-53	174	29	immune	immune	ADJ
ctmj-53	174	30	cell	cell	NOUN
ctmj-53	174	31	infiltration	infiltration	NOUN
ctmj-53	174	32	of	of	ADP
ctmj-53	174	33	msr1	msr1	PROPN
ctmj-53	174	34	expression	expression	NOUN
ctmj-53	174	35	in	in	ADP
ctmj-53	174	36	lowergrade	lowergrade	NOUN
ctmj-53	174	37	gliomas	glioma	NOUN
ctmj-53	174	38	.	.	PUNCT
ctmj-53	175	1	cancer	cancer	NOUN
ctmj-53	175	2	med	me	VERB
ctmj-53	175	3	2022	2022	NUM
ctmj-53	175	4	;	;	PUNCT
ctmj-53	175	5	11	11	NUM
ctmj-53	175	6	:	:	SYM
ctmj-53	175	7	20202035	20202035	NUM
ctmj-53	175	8	.	.	PUNCT
ctmj-53	176	1	6	6	X
ctmj-53	176	2	.	.	X
ctmj-53	176	3	seimon	seimon	PROPN
ctmj-53	176	4	ta	ta	PROPN
ctmj-53	176	5	,	,	PUNCT
ctmj-53	176	6	obstfeld	obstfeld	VERB
ctmj-53	176	7	a	a	PRON
ctmj-53	176	8	,	,	PUNCT
ctmj-53	176	9	moore	moore	PROPN
ctmj-53	176	10	kj	kj	PROPN
ctmj-53	176	11	,	,	PUNCT
ctmj-53	176	12	golenbock	golenbock	NOUN
ctmj-53	176	13	dt	dt	NOUN
ctmj-53	176	14	,	,	PUNCT
ctmj-53	176	15	tabas	tabas	PROPN
ctmj-53	176	16	i.	i.	PROPN
ctmj-53	176	17	combinatorial	combinatorial	PROPN
ctmj-53	176	18	pattern	pattern	NOUN
ctmj-53	176	19	recognition	recognition	NOUN
ctmj-53	176	20	receptor	receptor	NOUN
ctmj-53	176	21	signaling	signal	VERB
ctmj-53	176	22	alters	alter	VERB
ctmj-53	176	23	the	the	DET
ctmj-53	176	24	balance	balance	NOUN
ctmj-53	176	25	of	of	ADP
ctmj-53	176	26	life	life	NOUN
ctmj-53	176	27	and	and	CCONJ
ctmj-53	176	28	death	death	NOUN
ctmj-53	176	29	in	in	ADP
ctmj-53	176	30	macrophages	macrophage	NOUN
ctmj-53	176	31	.	.	PUNCT
ctmj-53	177	1	proc	proc	PROPN
ctmj-53	177	2	natl	natl	PROPN
ctmj-53	177	3	acad	acad	PROPN
ctmj-53	177	4	sci	sci	PROPN
ctmj-53	177	5	u	u	PROPN
ctmj-53	177	6	s	s	PROPN
ctmj-53	177	7	a	a	DET
ctmj-53	177	8	2006	2006	NUM
ctmj-53	177	9	;	;	PUNCT
ctmj-53	177	10	103	103	NUM
ctmj-53	177	11	:	:	SYM
ctmj-53	177	12	19794	19794	NUM
ctmj-53	177	13	-	-	SYM
ctmj-53	177	14	19799	19799	NUM
ctmj-53	177	15	.	.	PUNCT
ctmj-53	178	1	7	7	X
ctmj-53	178	2	.	.	X
ctmj-53	178	3	fox	fox	PROPN
ctmj-53	178	4	te	te	PROPN
ctmj-53	178	5	,	,	PUNCT
ctmj-53	178	6	houck	houck	PROPN
ctmj-53	178	7	kl	kl	PROPN
ctmj-53	178	8	,	,	PUNCT
ctmj-53	178	9	o'neill	o'neill	PROPN
ctmj-53	178	10	sm	sm	PROPN
ctmj-53	178	11	,	,	PUNCT
ctmj-53	178	12	nagarajan	nagarajan	NOUN
ctmj-53	178	13	m	m	PROPN
ctmj-53	178	14	,	,	PUNCT
ctmj-53	178	15	stover	stover	NOUN
ctmj-53	178	16	tc	tc	NOUN
ctmj-53	178	17	,	,	PUNCT
ctmj-53	178	18	pomianowski	pomianowski	PROPN
ctmj-53	178	19	pt	pt	PROPN
ctmj-53	178	20	,	,	PUNCT
ctmj-53	178	21	unal	unal	ADJ
ctmj-53	178	22	o	o	PROPN
ctmj-53	178	23	,	,	PUNCT
ctmj-53	178	24	yun	yun	PROPN
ctmj-53	178	25	jk	jk	PROPN
ctmj-53	178	26	,	,	PUNCT
ctmj-53	178	27	naides	naide	NOUN
ctmj-53	178	28	sj	sj	PROPN
ctmj-53	178	29	,	,	PUNCT
ctmj-53	178	30	kester	kester	PROPN
ctmj-53	178	31	m.	m.	PROPN
ctmj-53	178	32	ceramide	ceramide	NOUN
ctmj-53	178	33	recruits	recruit	NOUN
ctmj-53	178	34	and	and	CCONJ
ctmj-53	178	35	activates	activate	VERB
ctmj-53	178	36	protein	protein	NOUN
ctmj-53	178	37	kinase	kinase	NOUN
ctmj-53	178	38	c	c	PROPN
ctmj-53	178	39	zeta	zeta	PROPN
ctmj-53	178	40	(	(	PUNCT
ctmj-53	178	41	pkc	pkc	PROPN
ctmj-53	178	42	zeta	zeta	PROPN
ctmj-53	178	43	)	)	PUNCT
ctmj-53	178	44	within	within	ADP
ctmj-53	178	45	structured	structured	ADJ
ctmj-53	178	46	membrane	membrane	NOUN
ctmj-53	178	47	microdomains	microdomain	NOUN
ctmj-53	178	48	.	.	PUNCT
ctmj-53	179	1	j	j	PROPN
ctmj-53	179	2	biol	biol	PROPN
ctmj-53	179	3	chem	chem	NOUN
ctmj-53	179	4	2007	2007	NUM
ctmj-53	179	5	;	;	PUNCT
ctmj-53	179	6	282	282	NUM
ctmj-53	179	7	:	:	SYM
ctmj-53	179	8	12450	12450	NUM
ctmj-53	179	9	-	-	SYM
ctmj-53	179	10	12457	12457	NUM
ctmj-53	179	11	.	.	PUNCT
ctmj-53	180	1	8	8	X
ctmj-53	180	2	.	.	X
ctmj-53	180	3	tran	tran	PROPN
ctmj-53	180	4	ma	ma	PROPN
ctmj-53	180	5	,	,	PUNCT
ctmj-53	180	6	smith	smith	PROPN
ctmj-53	180	7	cd	cd	PROPN
ctmj-53	180	8	,	,	PUNCT
ctmj-53	180	9	kester	kester	PROPN
ctmj-53	180	10	m	m	PROPN
ctmj-53	180	11	,	,	PUNCT
ctmj-53	180	12	robertson	robertson	PROPN
ctmj-53	180	13	gp	gp	NOUN
ctmj-53	180	14	.	.	PUNCT
ctmj-53	180	15	combining	combine	VERB
ctmj-53	180	16	nanoliposomal	nanoliposomal	ADJ
ctmj-53	180	17	ceramide	ceramide	NOUN
ctmj-53	180	18	with	with	ADP
ctmj-53	180	19	sorafenib	sorafenib	NOUN
ctmj-53	180	20	synergistically	synergistically	ADV
ctmj-53	180	21	inhibits	inhibit	VERB
ctmj-53	180	22	melanoma	melanoma	NOUN
ctmj-53	180	23	and	and	CCONJ
ctmj-53	180	24	breast	breast	NOUN
ctmj-53	180	25	cancer	cancer	NOUN
ctmj-53	180	26	cell	cell	NOUN
ctmj-53	180	27	survival	survival	NOUN
ctmj-53	180	28	to	to	PART
ctmj-53	180	29	decrease	decrease	VERB
ctmj-53	180	30	tumor	tumor	NOUN
ctmj-53	180	31	development	development	NOUN
ctmj-53	180	32	.	.	PUNCT
ctmj-53	181	1	clin	clin	PROPN
ctmj-53	181	2	cancer	cancer	NOUN
ctmj-53	181	3	res	re	NOUN
ctmj-53	181	4	2008	2008	NUM
ctmj-53	181	5	;	;	PUNCT
ctmj-53	181	6	14	14	NUM
ctmj-53	181	7	:	:	SYM
ctmj-53	181	8	3571	3571	NUM
ctmj-53	181	9	-	-	SYM
ctmj-53	181	10	3581	3581	NUM
ctmj-53	181	11	.	.	PUNCT
ctmj-53	182	1	9	9	X
ctmj-53	182	2	.	.	X
ctmj-53	182	3	stover	stover	NOUN
ctmj-53	182	4	tc	tc	PROPN
ctmj-53	182	5	,	,	PUNCT
ctmj-53	182	6	sharma	sharma	PROPN
ctmj-53	182	7	a	a	X
ctmj-53	182	8	,	,	PUNCT
ctmj-53	182	9	robertson	robertson	PROPN
ctmj-53	182	10	gp	gp	PROPN
ctmj-53	182	11	,	,	PUNCT
ctmj-53	182	12	kester	kester	PROPN
ctmj-53	182	13	m.	m.	PROPN
ctmj-53	182	14	systemic	systemic	ADJ
ctmj-53	182	15	delivery	delivery	NOUN
ctmj-53	182	16	of	of	ADP
ctmj-53	182	17	liposomal	liposomal	ADJ
ctmj-53	182	18	short	short	ADJ
ctmj-53	182	19	-	-	PUNCT
ctmj-53	182	20	chain	chain	NOUN
ctmj-53	182	21	ceramide	ceramide	NOUN
ctmj-53	182	22	limits	limit	NOUN
ctmj-53	182	23	solid	solid	ADJ
ctmj-53	182	24	tumor	tumor	NOUN
ctmj-53	182	25	growth	growth	NOUN
ctmj-53	182	26	in	in	ADP
ctmj-53	182	27	murine	murine	ADJ
ctmj-53	182	28	models	model	NOUN
ctmj-53	182	29	of	of	ADP
ctmj-53	182	30	breast	breast	NOUN
ctmj-53	182	31	adenocarcinoma	adenocarcinoma	NOUN
ctmj-53	182	32	.	.	PUNCT
ctmj-53	183	1	clin	clin	PROPN
ctmj-53	183	2	cancer	cancer	NOUN
ctmj-53	183	3	res	re	NOUN
ctmj-53	183	4	2005	2005	NUM
ctmj-53	183	5	;	;	PUNCT
ctmj-53	183	6	11	11	NUM
ctmj-53	183	7	:	:	SYM
ctmj-53	183	8	3465	3465	NUM
ctmj-53	183	9	-	-	SYM
ctmj-53	183	10	3474	3474	NUM
ctmj-53	183	11	.	.	PUNCT
ctmj-53	184	1	10	10	NUM
ctmj-53	184	2	.	.	PUNCT
ctmj-53	185	1	hartmann	hartmann	PROPN
ctmj-53	185	2	d	d	PROPN
ctmj-53	185	3	,	,	PUNCT
ctmj-53	185	4	lucks	lucks	PROPN
ctmj-53	185	5	j	j	PROPN
ctmj-53	185	6	,	,	PUNCT
ctmj-53	185	7	fuchs	fuchs	PROPN
ctmj-53	185	8	s	s	PROPN
ctmj-53	185	9	,	,	PUNCT
ctmj-53	185	10	schiffmann	schiffmann	PROPN
ctmj-53	185	11	s	s	PROPN
ctmj-53	185	12	,	,	PUNCT
ctmj-53	185	13	schreiber	schreiber	PROPN
ctmj-53	185	14	y	y	PROPN
ctmj-53	185	15	,	,	PUNCT
ctmj-53	185	16	ferreirós	ferreirós	PROPN
ctmj-53	185	17	n	n	NUM
ctmj-53	185	18	,	,	PUNCT
ctmj-53	185	19	merkens	merkens	PROPN
ctmj-53	185	20	j	j	PROPN
ctmj-53	185	21	,	,	PUNCT
ctmj-53	185	22	marschalek	marschalek	ADJ
ctmj-53	185	23	r	r	NOUN
ctmj-53	185	24	,	,	PUNCT
ctmj-53	185	25	geisslinger	geisslinger	NOUN
ctmj-53	185	26	g	g	NOUN
ctmj-53	185	27	,	,	PUNCT
ctmj-53	185	28	grösch	grösch	PROPN
ctmj-53	185	29	s.	s.	PROPN
ctmj-53	185	30	long	long	PROPN
ctmj-53	185	31	chain	chain	NOUN
ctmj-53	185	32	ceramides	ceramide	NOUN
ctmj-53	185	33	and	and	CCONJ
ctmj-53	185	34	very	very	ADV
ctmj-53	185	35	long	long	ADJ
ctmj-53	185	36	chain	chain	NOUN
ctmj-53	185	37	ceramides	ceramide	NOUN
ctmj-53	185	38	have	have	VERB
ctmj-53	185	39	opposite	opposite	ADJ
ctmj-53	185	40	effects	effect	NOUN
ctmj-53	185	41	on	on	ADP
ctmj-53	185	42	human	human	ADJ
ctmj-53	185	43	breast	breast	NOUN
ctmj-53	185	44	and	and	CCONJ
ctmj-53	185	45	colon	colon	NOUN
ctmj-53	185	46	cancer	cancer	NOUN
ctmj-53	185	47	cell	cell	NOUN
ctmj-53	185	48	growth	growth	NOUN
ctmj-53	185	49	.	.	PUNCT
ctmj-53	186	1	int	int	PROPN
ctmj-53	186	2	j	j	PROPN
ctmj-53	186	3	biochem	biochem	PROPN
ctmj-53	186	4	cell	cell	NOUN
ctmj-53	186	5	biol	biol	PROPN
ctmj-53	186	6	2012	2012	NUM
ctmj-53	186	7	;	;	PUNCT
ctmj-53	186	8	44	44	NUM
ctmj-53	186	9	:	:	SYM
ctmj-53	186	10	620	620	NUM
ctmj-53	186	11	-	-	SYM
ctmj-53	186	12	628	628	NUM
ctmj-53	186	13	.	.	PUNCT
ctmj-53	186	14	11	11	NUM
ctmj-53	186	15	.	.	PUNCT
ctmj-53	187	1	kang	kang	PROPN
ctmj-53	187	2	kh	kh	PROPN
ctmj-53	187	3	,	,	PUNCT
ctmj-53	187	4	lee	lee	PROPN
ctmj-53	187	5	jh	jh	PROPN
ctmj-53	187	6	,	,	PUNCT
ctmj-53	187	7	kim	kim	PROPN
ctmj-53	187	8	kc	kc	PROPN
ctmj-53	187	9	,	,	PUNCT
ctmj-53	187	10	ham	ham	PROPN
ctmj-53	187	11	sw	sw	PROPN
ctmj-53	187	12	,	,	PUNCT
ctmj-53	187	13	kim	kim	PROPN
ctmj-53	187	14	my	my	PRON
ctmj-53	187	15	,	,	PUNCT
ctmj-53	187	16	choi	choi	PROPN
ctmj-53	187	17	kh	kh	PROPN
ctmj-53	187	18	.	.	PROPN
ctmj-53	187	19	induction	induction	NOUN
ctmj-53	187	20	of	of	ADP
ctmj-53	187	21	p73beta	p73beta	PROPN
ctmj-53	187	22	by	by	ADP
ctmj-53	187	23	a	a	DET
ctmj-53	187	24	naphthoquinone	naphthoquinone	NOUN
ctmj-53	187	25	analog	analog	NOUN
ctmj-53	187	26	is	be	AUX
ctmj-53	187	27	mediated	mediate	VERB
ctmj-53	187	28	by	by	ADP
ctmj-53	187	29	e2f-1	e2f-1	NOUN
ctmj-53	187	30	and	and	CCONJ
ctmj-53	187	31	triggers	trigger	VERB
ctmj-53	187	32	apoptosis	apoptosis	NOUN
ctmj-53	187	33	in	in	ADP
ctmj-53	187	34	hela	hela	ADJ
ctmj-53	187	35	cells	cell	NOUN
ctmj-53	187	36	.	.	PUNCT
ctmj-53	188	1	febs	febs	PROPN
ctmj-53	188	2	lett	lett	PROPN
ctmj-53	188	3	2002	2002	NUM
ctmj-53	188	4	;	;	PUNCT
ctmj-53	188	5	522	522	NUM
ctmj-53	188	6	:	:	PUNCT
ctmj-53	188	7	161	161	NUM
ctmj-53	188	8	-	-	SYM
ctmj-53	188	9	167	167	NUM
ctmj-53	188	10	.	.	PUNCT
ctmj-53	189	1	12	12	NUM
ctmj-53	189	2	.	.	PUNCT
ctmj-53	190	1	cheng	cheng	PROPN
ctmj-53	190	2	z	z	PROPN
ctmj-53	190	3	,	,	PUNCT
ctmj-53	190	4	wen	wen	PROPN
ctmj-53	190	5	y	y	PROPN
ctmj-53	190	6	,	,	PUNCT
ctmj-53	190	7	liang	liang	PROPN
ctmj-53	190	8	b	b	PROPN
ctmj-53	190	9	,	,	PUNCT
ctmj-53	190	10	chen	chen	PROPN
ctmj-53	190	11	s	s	PROPN
ctmj-53	190	12	,	,	PUNCT
ctmj-53	190	13	liu	liu	PROPN
ctmj-53	190	14	y	y	PROPN
ctmj-53	190	15	,	,	PUNCT
ctmj-53	190	16	wang	wang	PROPN
ctmj-53	190	17	z	z	PROPN
ctmj-53	190	18	,	,	PUNCT
ctmj-53	190	19	cheng	cheng	PROPN
ctmj-53	190	20	j	j	PROPN
ctmj-53	190	21	,	,	PUNCT
ctmj-53	190	22	tang	tang	PROPN
ctmj-53	191	1	x	x	X
ctmj-53	191	2	,	,	PUNCT
ctmj-53	191	3	xin	xin	PROPN
ctmj-53	191	4	h	h	PROPN
ctmj-53	191	5	,	,	PUNCT
ctmj-53	191	6	deng	deng	PROPN
ctmj-53	191	7	l.	l.	PROPN
ctmj-53	191	8	gene	gene	PROPN
ctmj-53	191	9	expression	expression	NOUN
ctmj-53	191	10	profile	profile	NOUN
ctmj-53	191	11	-	-	PUNCT
ctmj-53	191	12	based	base	VERB
ctmj-53	191	13	drug	drug	NOUN
ctmj-53	191	14	screen	screen	NOUN
ctmj-53	191	15	identifies	identify	VERB
ctmj-53	191	16	saha	saha	PROPN
ctmj-53	191	17	as	as	ADP
ctmj-53	191	18	a	a	DET
ctmj-53	191	19	novel	novel	ADJ
ctmj-53	191	20	treatment	treatment	NOUN
ctmj-53	191	21	for	for	ADP
ctmj-53	191	22	nafld	nafld	PROPN
ctmj-53	191	23	.	.	PUNCT
ctmj-53	192	1	mol	mol	ADP
ctmj-53	192	2	omics	omics	PROPN
ctmj-53	192	3	2019	2019	NUM
ctmj-53	192	4	;	;	PUNCT
ctmj-53	192	5	15	15	NUM
ctmj-53	192	6	:	:	SYM
ctmj-53	192	7	50	50	NUM
ctmj-53	192	8	-	-	SYM
ctmj-53	192	9	58	58	NUM
ctmj-53	192	10	.	.	PUNCT
ctmj-53	193	1	13	13	NUM
ctmj-53	193	2	.	.	PUNCT
ctmj-53	194	1	gong	gong	PROPN
ctmj-53	194	2	d	d	PROPN
ctmj-53	194	3	,	,	PUNCT
ctmj-53	194	4	zhu	zhu	PROPN
ctmj-53	194	5	h	h	NOUN
ctmj-53	194	6	,	,	PUNCT
ctmj-53	194	7	zeng	zeng	PROPN
ctmj-53	194	8	l	l	PROPN
ctmj-53	194	9	,	,	PUNCT
ctmj-53	194	10	hu	hu	PROPN
ctmj-53	194	11	r	r	PROPN
ctmj-53	194	12	,	,	PUNCT
ctmj-53	194	13	hu	hu	PROPN
ctmj-53	194	14	j	j	PROPN
ctmj-53	194	15	,	,	PUNCT
ctmj-53	194	16	ding	ding	PROPN
ctmj-53	194	17	j.	j.	PROPN
ctmj-53	194	18	overexpression	overexpression	NOUN
ctmj-53	194	19	of	of	ADP
ctmj-53	194	20	hoxa10	hoxa10	NOUN
ctmj-53	194	21	promotes	promote	VERB
ctmj-53	194	22	the	the	DET
ctmj-53	194	23	growth	growth	NOUN
ctmj-53	194	24	and	and	CCONJ
ctmj-53	194	25	metastasis	metastasis	NOUN
ctmj-53	194	26	of	of	ADP
ctmj-53	194	27	nasopharyngeal	nasopharyngeal	ADJ
ctmj-53	194	28	carcinoma	carcinoma	NOUN
ctmj-53	194	29	.	.	PUNCT
ctmj-53	195	1	exp	exp	NOUN
ctmj-53	195	2	biol	biol	PROPN
ctmj-53	195	3	med	me	VERB
ctmj-53	195	4	2021	2021	NUM
ctmj-53	195	5	;	;	PUNCT
ctmj-53	195	6	246	246	NUM
ctmj-53	195	7	:	:	SYM
ctmj-53	195	8	2454	2454	NUM
ctmj-53	195	9	-	-	SYM
ctmj-53	195	10	2462	2462	NUM
ctmj-53	195	11	.	.	PUNCT
ctmj-53	196	1	14	14	NUM
ctmj-53	196	2	.	.	PUNCT
ctmj-53	197	1	peiser	peiser	PROPN
ctmj-53	197	2	l	l	PROPN
ctmj-53	197	3	,	,	PUNCT
ctmj-53	197	4	de	de	PROPN
ctmj-53	197	5	winther	winther	PROPN
ctmj-53	197	6	mp	mp	PROPN
ctmj-53	197	7	,	,	PUNCT
ctmj-53	197	8	makepeace	makepeace	PROPN
ctmj-53	197	9	k	k	PROPN
ctmj-53	197	10	,	,	PUNCT
ctmj-53	197	11	hollinshead	hollinshead	PROPN
ctmj-53	197	12	m	m	PROPN
ctmj-53	197	13	,	,	PUNCT
ctmj-53	197	14	coull	coull	NOUN
ctmj-53	197	15	p	p	NOUN
ctmj-53	197	16	,	,	PUNCT
ctmj-53	197	17	plested	pleste	VERB
ctmj-53	197	18	j	j	PROPN
ctmj-53	197	19	,	,	PUNCT
ctmj-53	197	20	kodama	kodama	PROPN
ctmj-53	197	21	t	t	PROPN
ctmj-53	197	22	,	,	PUNCT
ctmj-53	197	23	moxon	moxon	PROPN
ctmj-53	197	24	er	er	INTJ
ctmj-53	197	25	,	,	PUNCT
ctmj-53	197	26	gordon	gordon	PROPN
ctmj-53	197	27	s.	s.	PROPN
ctmj-53	197	28	the	the	DET
ctmj-53	197	29	class	class	NOUN
ctmj-53	197	30	a	a	DET
ctmj-53	197	31	macrophage	macrophage	ADJ
ctmj-53	197	32	scavenger	scavenger	NOUN
ctmj-53	197	33	receptor	receptor	NOUN
ctmj-53	197	34	is	be	AUX
ctmj-53	197	35	a	a	DET
ctmj-53	197	36	major	major	ADJ
ctmj-53	197	37	pattern	pattern	NOUN
ctmj-53	197	38	recognition	recognition	NOUN
ctmj-53	197	39	receptor	receptor	NOUN
ctmj-53	197	40	for	for	ADP
ctmj-53	197	41	neisseria	neisseria	NOUN
ctmj-53	197	42	meningitidis	meningitidi	NOUN
ctmj-53	197	43	which	which	PRON
ctmj-53	197	44	is	be	AUX
ctmj-53	197	45	independent	independent	ADJ
ctmj-53	197	46	of	of	ADP
ctmj-53	197	47	lipopolysaccharide	lipopolysaccharide	NOUN
ctmj-53	197	48	and	and	CCONJ
ctmj-53	197	49	not	not	PART
ctmj-53	197	50	required	require	VERB
ctmj-53	197	51	for	for	ADP
ctmj-53	197	52	secretory	secretory	ADJ
ctmj-53	197	53	responses	response	NOUN
ctmj-53	197	54	.	.	PUNCT
ctmj-53	198	1	infect	infect	VERB
ctmj-53	198	2	immun	immun	PROPN
ctmj-53	198	3	2002	2002	NUM
ctmj-53	198	4	;	;	PUNCT
ctmj-53	198	5	70	70	NUM
ctmj-53	198	6	:	:	PUNCT
ctmj-53	198	7	5346	5346	NUM
ctmj-53	198	8	-	-	SYM
ctmj-53	198	9	5354	5354	NUM
ctmj-53	198	10	.	.	PUNCT
ctmj-53	199	1	15	15	NUM
ctmj-53	199	2	.	.	PUNCT
ctmj-53	200	1	kunjathoor	kunjathoor	PROPN
ctmj-53	200	2	vv	vv	PROPN
ctmj-53	200	3	,	,	PUNCT
ctmj-53	200	4	febbraio	febbraio	PROPN
ctmj-53	200	5	m	m	PROPN
ctmj-53	200	6	,	,	PUNCT
ctmj-53	200	7	podrez	podrez	NOUN
ctmj-53	200	8	ea	ea	NOUN
ctmj-53	200	9	,	,	PUNCT
ctmj-53	200	10	moore	moore	PROPN
ctmj-53	200	11	kj	kj	PROPN
ctmj-53	200	12	,	,	PUNCT
ctmj-53	200	13	andersson	andersson	PROPN
ctmj-53	200	14	l	l	PROPN
ctmj-53	200	15	,	,	PUNCT
ctmj-53	200	16	koehn	koehn	VERB
ctmj-53	200	17	s	s	PROPN
ctmj-53	200	18	,	,	PUNCT
ctmj-53	200	19	rhee	rhee	PROPN
ctmj-53	200	20	js	js	PROPN
ctmj-53	200	21	,	,	PUNCT
ctmj-53	200	22	silverstein	silverstein	ADJ
ctmj-53	200	23	r	r	NOUN
ctmj-53	200	24	,	,	PUNCT
ctmj-53	200	25	hoff	hoff	PROPN
ctmj-53	200	26	hf	hf	PROPN
ctmj-53	200	27	,	,	PUNCT
ctmj-53	200	28	freeman	freeman	PROPN
ctmj-53	200	29	mw	mw	PROPN
ctmj-53	200	30	.	.	PROPN
ctmj-53	200	31	scavenger	scavenger	NOUN
ctmj-53	200	32	receptors	receptor	NOUN
ctmj-53	200	33	class	class	NOUN
ctmj-53	200	34	a	a	NOUN
ctmj-53	200	35	-	-	PUNCT
ctmj-53	200	36	i	i	NOUN
ctmj-53	200	37	/	/	SYM
ctmj-53	200	38	ii	ii	PROPN
ctmj-53	200	39	and	and	CCONJ
ctmj-53	200	40	cd36	cd36	PROPN
ctmj-53	200	41	are	be	AUX
ctmj-53	200	42	the	the	DET
ctmj-53	200	43	principal	principal	ADJ
ctmj-53	200	44	receptors	receptor	NOUN
ctmj-53	200	45	responsible	responsible	ADJ
ctmj-53	200	46	for	for	ADP
ctmj-53	200	47	the	the	DET
ctmj-53	200	48	uptake	uptake	NOUN
ctmj-53	200	49	of	of	ADP
ctmj-53	200	50	modified	modify	VERB
ctmj-53	200	51	low	low	ADJ
ctmj-53	200	52	-	-	PUNCT
ctmj-53	200	53	density	density	NOUN
ctmj-53	200	54	lipoprotein	lipoprotein	NOUN
ctmj-53	200	55	leading	lead	VERB
ctmj-53	200	56	to	to	ADP
ctmj-53	200	57	lipid	lipid	NOUN
ctmj-53	200	58	loading	loading	NOUN
ctmj-53	200	59	in	in	ADP
ctmj-53	200	60	macrophages	macrophage	NOUN
ctmj-53	200	61	.	.	PUNCT
ctmj-53	201	1	j	j	PROPN
ctmj-53	201	2	biol	biol	PROPN
ctmj-53	201	3	chen	chen	PROPN
ctmj-53	201	4	2002	2002	NUM
ctmj-53	201	5	;	;	PUNCT
ctmj-53	201	6	277	277	NUM
ctmj-53	201	7	:	:	PUNCT
ctmj-53	201	8	4998249988	4998249988	NUM
ctmj-53	201	9	.	.	PUNCT
ctmj-53	202	1	16	16	NUM
ctmj-53	202	2	.	.	PUNCT
ctmj-53	203	1	he	he	PRON
ctmj-53	203	2	y	y	PROPN
ctmj-53	203	3	,	,	PUNCT
ctmj-53	203	4	zhou	zhou	PROPN
ctmj-53	203	5	s	s	PROPN
ctmj-53	203	6	,	,	PUNCT
ctmj-53	203	7	deng	deng	PROPN
ctmj-53	203	8	f	f	PROPN
ctmj-53	203	9	,	,	PUNCT
ctmj-53	203	10	zhao	zhao	PROPN
ctmj-53	203	11	s	s	PROPN
ctmj-53	203	12	,	,	PUNCT
ctmj-53	203	13	chen	chen	PROPN
ctmj-53	203	14	w	w	PROPN
ctmj-53	203	15	,	,	PUNCT
ctmj-53	203	16	wang	wang	PROPN
ctmj-53	203	17	d	d	PROPN
ctmj-53	203	18	,	,	PUNCT
ctmj-53	203	19	chen	chen	PROPN
ctmj-53	203	20	x	x	PROPN
ctmj-53	203	21	,	,	PUNCT
ctmj-53	203	22	hou	hou	PROPN
ctmj-53	203	23	j	j	PROPN
ctmj-53	203	24	,	,	PUNCT
ctmj-53	203	25	zhang	zhang	PROPN
ctmj-53	203	26	j	j	PROPN
ctmj-53	203	27	,	,	PUNCT
ctmj-53	203	28	zhang	zhang	PROPN
ctmj-53	203	29	w	w	PROPN
ctmj-53	203	30	,	,	PUNCT
ctmj-53	203	31	et	et	PROPN
ctmj-53	203	32	al	al	PROPN
ctmj-53	203	33	.	.	PROPN
ctmj-53	204	1	clinical	clinical	ADJ
ctmj-53	204	2	and	and	CCONJ
ctmj-53	204	3	transcriptional	transcriptional	ADJ
ctmj-53	204	4	signatures	signature	NOUN
ctmj-53	204	5	of	of	ADP
ctmj-53	204	6	human	human	ADJ
ctmj-53	204	7	cd204	cd204	PROPN
ctmj-53	204	8	reveal	reveal	VERB
ctmj-53	204	9	an	an	DET
ctmj-53	204	10	applicable	applicable	ADJ
ctmj-53	204	11	marker	marker	NOUN
ctmj-53	204	12	for	for	ADP
ctmj-53	204	13	the	the	DET
ctmj-53	204	14	protumor	protumor	NOUN
ctmj-53	204	15	phenotype	phenotype	NOUN
ctmj-53	204	16	of	of	ADP
ctmj-53	204	17	tumorassociated	tumorassociate	VERB
ctmj-53	204	18	macrophages	macrophage	NOUN
ctmj-53	204	19	in	in	ADP
ctmj-53	204	20	breast	breast	NOUN
ctmj-53	204	21	cancer	cancer	NOUN
ctmj-53	204	22	.	.	PUNCT
ctmj-53	205	1	aging	age	VERB
ctmj-53	205	2	(	(	PUNCT
ctmj-53	205	3	albany	albany	PROPN
ctmj-53	205	4	ny	ny	PROPN
ctmj-53	205	5	)	)	PUNCT
ctmj-53	205	6	2019	2019	NUM
ctmj-53	205	7	;	;	PUNCT
ctmj-53	205	8	11	11	NUM
ctmj-53	205	9	:	:	SYM
ctmj-53	205	10	10883	10883	NUM
ctmj-53	205	11	-	-	SYM
ctmj-53	205	12	10901	10901	NUM
ctmj-53	205	13	.	.	PUNCT
ctmj-53	206	1	chinese	chinese	ADJ
ctmj-53	206	2	traditional	traditional	ADJ
ctmj-53	206	3	medicine	medicine	NOUN
ctmj-53	206	4	journal	journal	NOUN
ctmj-53	206	5	|	|	ADV
ctmj-53	206	6	2020	2020	NUM
ctmj-53	207	1	|	|	ADV
ctmj-53	207	2	vol	vol	NOUN
ctmj-53	207	3	3	3	NUM
ctmj-53	207	4	|	|	ADV
ctmj-53	207	5	issue	issue	VERB
ctmj-53	207	6	5	5	NUM
ctmj-53	207	7	issn	issn	X
ctmj-53	207	8	:	:	PUNCT
ctmj-53	207	9	2693	2693	NUM
ctmj-53	207	10	6356	6356	NUM
ctmj-53	207	11	2020	2020	NUM
ctmj-53	207	12	|	|	ADV
ctmj-53	207	13	vol	vol	NOUN
ctmj-53	207	14	3	3	NUM
ctmj-53	207	15	|	|	ADV
ctmj-53	207	16	issue	issue	VERB
ctmj-53	207	17	5	5	NUM
ctmj-53	207	18	ctmj	ctmj	NOUN
ctmj-53	207	19	|	|	ADV
ctmj-53	207	20	traditionalmedicinejournals.com	traditionalmedicinejournals.com	X
ctmj-53	207	21	17	17	NUM
ctmj-53	207	22	.	.	PUNCT
ctmj-53	208	1	wang	wang	PROPN
ctmj-53	208	2	x	x	PROPN
ctmj-53	208	3	,	,	PUNCT
ctmj-53	208	4	de	de	PROPN
ctmj-53	208	5	carvalho	carvalho	PROPN
ctmj-53	208	6	ribeiro	ribeiro	PROPN
ctmj-53	208	7	m	m	PROPN
ctmj-53	208	8	,	,	PUNCT
ctmj-53	208	9	irachetavellve	irachetavellve	VERB
ctmj-53	208	10	a	a	PRON
ctmj-53	208	11	,	,	PUNCT
ctmj-53	208	12	lowe	lowe	PROPN
ctmj-53	208	13	p	p	PROPN
ctmj-53	208	14	,	,	PUNCT
ctmj-53	208	15	ambade	ambade	VERB
ctmj-53	208	16	a	a	PRON
ctmj-53	208	17	,	,	PUNCT
ctmj-53	208	18	satishchandran	satishchandran	NOUN
ctmj-53	208	19	a	a	NOUN
ctmj-53	208	20	,	,	PUNCT
ctmj-53	208	21	bukong	bukong	PROPN
ctmj-53	208	22	t	t	PROPN
ctmj-53	208	23	,	,	PUNCT
ctmj-53	208	24	catalano	catalano	PROPN
ctmj-53	208	25	d	d	PROPN
ctmj-53	208	26	,	,	PUNCT
ctmj-53	208	27	kodys	kodys	PROPN
ctmj-53	208	28	k	k	PROPN
ctmj-53	208	29	,	,	PUNCT
ctmj-53	208	30	szabo	szabo	PROPN
ctmj-53	208	31	g.	g.	PROPN
ctmj-53	208	32	macrophage	macrophage	ADV
ctmj-53	208	33	-	-	PUNCT
ctmj-53	208	34	specific	specific	ADJ
ctmj-53	208	35	hif-1α	hif-1α	NOUN
ctmj-53	208	36	contributes	contribute	VERB
ctmj-53	208	37	to	to	ADP
ctmj-53	208	38	impaired	impair	VERB
ctmj-53	208	39	autophagic	autophagic	ADJ
ctmj-53	208	40	flux	flux	NOUN
ctmj-53	208	41	in	in	ADP
ctmj-53	208	42	non	non	ADJ
ctmj-53	208	43	-	-	ADJ
ctmj-53	208	44	alcoholic	alcoholic	ADJ
ctmj-53	208	45	steatohepatitis	steatohepatitis	NOUN
ctmj-53	208	46	.	.	PUNCT
ctmj-53	209	1	hepatol	hepatol	ADJ
ctmj-53	209	2	2019	2019	NUM
ctmj-53	209	3	;	;	PUNCT
ctmj-53	209	4	69	69	NUM
ctmj-53	209	5	:	:	PUNCT
ctmj-53	209	6	545	545	NUM
ctmj-53	209	7	-	-	SYM
ctmj-53	209	8	563	563	NUM
ctmj-53	209	9	.	.	NOUN
ctmj-53	210	1	18	18	NUM
ctmj-53	210	2	.	.	PUNCT
ctmj-53	210	3	morad	morad	PROPN
ctmj-53	210	4	sa	sa	PROPN
ctmj-53	210	5	,	,	PUNCT
ctmj-53	210	6	ryan	ryan	PROPN
ctmj-53	210	7	te	te	PROPN
ctmj-53	210	8	,	,	PUNCT
ctmj-53	210	9	neufer	neufer	VERB
ctmj-53	210	10	pd	pd	PROPN
ctmj-53	210	11	,	,	PUNCT
ctmj-53	210	12	zeczycki	zeczycki	PROPN
ctmj-53	210	13	tn	tn	PROPN
ctmj-53	210	14	,	,	PUNCT
ctmj-53	210	15	davis	davis	PROPN
ctmj-53	210	16	ts	ts	PROPN
ctmj-53	210	17	,	,	PUNCT
ctmj-53	210	18	macdougall	macdougall	PROPN
ctmj-53	210	19	mr	mr	PROPN
ctmj-53	210	20	,	,	PUNCT
ctmj-53	210	21	fox	fox	PROPN
ctmj-53	210	22	te	te	PROPN
ctmj-53	210	23	,	,	PUNCT
ctmj-53	210	24	tan	tan	PROPN
ctmj-53	210	25	sf	sf	PROPN
ctmj-53	210	26	,	,	PUNCT
ctmj-53	210	27	feith	feith	NOUN
ctmj-53	210	28	dj	dj	NOUN
ctmj-53	210	29	,	,	PUNCT
ctmj-53	210	30	loughran	loughran	ADJ
ctmj-53	210	31	tp	tp	NOUN
ctmj-53	210	32	,	,	PUNCT
ctmj-53	210	33	et	et	PROPN
ctmj-53	210	34	al	al	PROPN
ctmj-53	210	35	.	.	PUNCT
ctmj-53	210	36	ceramide	ceramide	NOUN
ctmj-53	210	37	-	-	PUNCT
ctmj-53	210	38	tamoxifen	tamoxifen	NOUN
ctmj-53	210	39	regimen	regimen	NOUN
ctmj-53	210	40	targets	target	VERB
ctmj-53	210	41	bioenergetic	bioenergetic	ADJ
ctmj-53	210	42	elements	element	NOUN
ctmj-53	210	43	in	in	ADP
ctmj-53	210	44	acute	acute	ADJ
ctmj-53	210	45	myelogenous	myelogenous	ADJ
ctmj-53	210	46	leukemia	leukemia	NOUN
ctmj-53	210	47	.	.	PUNCT
ctmj-53	211	1	j	j	PROPN
ctmj-53	211	2	lipid	lipid	PROPN
ctmj-53	211	3	res	re	VERB
ctmj-53	211	4	2016	2016	NUM
ctmj-53	211	5	;	;	PUNCT
ctmj-53	211	6	57	57	NUM
ctmj-53	211	7	:	:	SYM
ctmj-53	211	8	12311242	12311242	NUM
ctmj-53	211	9	.	.	PUNCT
ctmj-53	212	1	19	19	NUM
ctmj-53	212	2	.	.	PUNCT
ctmj-53	213	1	adiseshaiah	adiseshaiah	PROPN
ctmj-53	213	2	pp	pp	ADV
ctmj-53	213	3	,	,	PUNCT
ctmj-53	213	4	clogston	clogston	PROPN
ctmj-53	213	5	jd	jd	PROPN
ctmj-53	213	6	,	,	PUNCT
ctmj-53	213	7	mcleland	mcleland	PROPN
ctmj-53	213	8	cb	cb	PROPN
ctmj-53	213	9	,	,	PUNCT
ctmj-53	213	10	rodriguez	rodriguez	PROPN
ctmj-53	213	11	j	j	PROPN
ctmj-53	213	12	,	,	PUNCT
ctmj-53	213	13	potter	potter	PROPN
ctmj-53	213	14	tm	tm	PROPN
ctmj-53	213	15	,	,	PUNCT
ctmj-53	213	16	neun	neun	NOUN
ctmj-53	213	17	bw	bw	PROPN
ctmj-53	213	18	,	,	PUNCT
ctmj-53	213	19	skoczen	skoczen	PROPN
ctmj-53	213	20	sl	sl	PROPN
ctmj-53	213	21	,	,	PUNCT
ctmj-53	213	22	shanmugavelandy	shanmugavelandy	PROPN
ctmj-53	213	23	ss	ss	PROPN
ctmj-53	213	24	,	,	PUNCT
ctmj-53	213	25	kester	kester	PROPN
ctmj-53	213	26	m	m	PROPN
ctmj-53	213	27	,	,	PUNCT
ctmj-53	213	28	stern	stern	PROPN
ctmj-53	213	29	st	st	PROPN
ctmj-53	213	30	,	,	PUNCT
ctmj-53	213	31	et	et	PROPN
ctmj-53	213	32	al	al	PROPN
ctmj-53	213	33	.	.	PROPN
ctmj-53	213	34	synergistic	synergistic	ADJ
ctmj-53	213	35	combination	combination	NOUN
ctmj-53	213	36	therapy	therapy	NOUN
ctmj-53	213	37	with	with	ADP
ctmj-53	213	38	nanoliposomal	nanoliposomal	ADJ
ctmj-53	213	39	c6	c6	NOUN
ctmj-53	213	40	-	-	PUNCT
ctmj-53	213	41	ceramide	ceramide	NOUN
ctmj-53	213	42	and	and	CCONJ
ctmj-53	213	43	vinblastine	vinblastine	NOUN
ctmj-53	213	44	is	be	AUX
ctmj-53	213	45	associated	associate	VERB
ctmj-53	213	46	with	with	ADP
ctmj-53	213	47	autophagy	autophagy	ADJ
ctmj-53	213	48	dysfunction	dysfunction	NOUN
ctmj-53	213	49	in	in	ADP
ctmj-53	213	50	hepatocarcinoma	hepatocarcinoma	NOUN
ctmj-53	213	51	and	and	CCONJ
ctmj-53	213	52	colorectal	colorectal	ADJ
ctmj-53	213	53	cancer	cancer	NOUN
ctmj-53	213	54	models	model	NOUN
ctmj-53	213	55	.	.	PUNCT
ctmj-53	214	1	cancer	cancer	NOUN
ctmj-53	214	2	lett	lett	PROPN
ctmj-53	214	3	2013	2013	NUM
ctmj-53	214	4	;	;	PUNCT
ctmj-53	214	5	337	337	NUM
ctmj-53	214	6	:	:	PUNCT
ctmj-53	214	7	254	254	NUM
ctmj-53	214	8	-	-	SYM
ctmj-53	214	9	65	65	NUM
ctmj-53	214	10	.	.	NOUN
ctmj-53	214	11	20	20	NUM
ctmj-53	214	12	.	.	X
ctmj-53	215	1	ryland	ryland	PROPN
ctmj-53	215	2	lk	lk	PROPN
ctmj-53	215	3	,	,	PUNCT
ctmj-53	215	4	doshi	doshi	PROPN
ctmj-53	215	5	ua	ua	PROPN
ctmj-53	215	6	,	,	PUNCT
ctmj-53	215	7	shanmugavelandy	shanmugavelandy	PROPN
ctmj-53	215	8	ss	ss	PROPN
ctmj-53	215	9	,	,	PUNCT
ctmj-53	215	10	fox	fox	PROPN
ctmj-53	215	11	te	te	PROPN
ctmj-53	215	12	,	,	PUNCT
ctmj-53	215	13	aliaga	aliaga	PROPN
ctmj-53	215	14	c	c	PROPN
ctmj-53	215	15	,	,	PUNCT
ctmj-53	215	16	broeg	broeg	PROPN
ctmj-53	215	17	k	k	PROPN
ctmj-53	215	18	,	,	PUNCT
ctmj-53	215	19	baab	baab	PROPN
ctmj-53	215	20	kt	kt	PROPN
ctmj-53	215	21	,	,	PUNCT
ctmj-53	215	22	young	young	PROPN
ctmj-53	215	23	m	m	PROPN
ctmj-53	215	24	,	,	PUNCT
ctmj-53	215	25	khan	khan	PROPN
ctmj-53	215	26	o	o	PROPN
ctmj-53	215	27	,	,	PUNCT
ctmj-53	215	28	haakenson	haakenson	PROPN
ctmj-53	215	29	jk	jk	PROPN
ctmj-53	215	30	,	,	PUNCT
ctmj-53	215	31	et	et	PROPN
ctmj-53	215	32	al	al	PROPN
ctmj-53	215	33	.	.	PUNCT
ctmj-53	216	1	c6	c6	PROPN
ctmj-53	216	2	-	-	PUNCT
ctmj-53	216	3	ceramide	ceramide	NOUN
ctmj-53	216	4	nanoliposomes	nanoliposome	NOUN
ctmj-53	216	5	target	target	VERB
ctmj-53	216	6	the	the	DET
ctmj-53	216	7	warburg	warburg	NOUN
ctmj-53	216	8	effect	effect	NOUN
ctmj-53	216	9	in	in	ADP
ctmj-53	216	10	chronic	chronic	ADJ
ctmj-53	216	11	lymphocytic	lymphocytic	ADJ
ctmj-53	216	12	leukemia	leukemia	NOUN
ctmj-53	216	13	.	.	PUNCT
ctmj-53	217	1	plos	plos	PROPN
ctmj-53	217	2	one	one	NUM
ctmj-53	217	3	2013	2013	NUM
ctmj-53	217	4	;	;	PUNCT
ctmj-53	217	5	8	8	NUM
ctmj-53	217	6	:	:	PUNCT
ctmj-53	217	7	e84648	e84648	NOUN
ctmj-53	217	8	.	.	PUNCT